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Many of the 70,000 adolescents and young adults (AYAs) diagnosed with cancer each year do 
not receive services to address the full scope of needs they experience during and after cancer 
treatment. Such unmet needs result in negative outcomes for this population, including higher distress, 
poorer health-related quality of life, and higher physical symptom burden. Although interventions have 
been used to improve care coordination for AYAs (e.g., patient-reported outcome measures), limitations 
to their usability and usefulness have frustrated their real-world implementation and impact on AYA 
outcomes. 
To facilitate a more systematic and patient-centered approach to coordinating care for AYAs, we 
developed the AYA Needs Assessment & Service Bridge (AYA NA-SB), a care coordination intervention 
which includes (1) a holistic needs assessment, and (2) a suite of referral pathways connecting AYAs to 
services and resources based on the needs they report. To optimize the usability and usefulness of AYA 
NA-SB, I leveraged user-centered design (UCD), an iterative process for intervention development that 
relies heavily on the engagement of prospective users (e.g., cancer program providers and staff and 
AYAs). 
At the study’s onset, I convened a multidisciplinary design team comprised of researchers, 
cancer care providers, and AYAs from whom I solicited input throughout data collection and analysis. 
First, I used mixed methods to examine user interactions with an initial prototype, the Cancer Needs 
Questionnaire-Young People (i.e., usability testing). Second, I used ethnographic contextual inquiry, 
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including ‘guided tours’ and semi-structured interviews with prospective AYA NA-SB users, to assess 
characteristics of users and context which should be considered in the design and implementation of 
AYA NA-SB. Finally, through two prototyping workshops, the design team collaboratively redesigned the 
Cancer Needs Questionnaire-Young People and designed referral pathways to optimize the tool’s 
usability and usefulness.  The product of the project, AYA NA-SB, has the potential to improve care 
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CHAPTER 1: INTRODUCTION 
1.1 Background and Objectives 
Many of the 70,000 adolescents and young adults (AYAs) diagnosed with cancer each year do 
not receive services to address the full scope of needs they experience during and after cancer 
treatment.1-5 AYAs’ unmet needs result in negative outcomes, including higher distress,2,3 poorer health-
related quality of life,6 and higher physical symptom burden.1  AYA cancer needs are age-specific7,8 (i.e., 
different from those reported by children or older adults with cancer), multifaceted3,8 (spanning across 
physical, psychosocial, and practical domains), individual9 (varying across AYAs), and dynamic10 
(fluctuating as AYAs move through their cancer trajectory). Despite the complexity and scope of their 
needs, AYAs often do not use potentially beneficial services and resources, even when access is not an 
issue.11-13 This disconnect between AYA needs and their use of existing services/resources suggests the 
need for a model of care coordination that (1) effectively assesses AYAs’ multifaceted, age-specific, 
individual, and dynamic needs, and (2) uses information about those needs to connect AYAs to services 
and resources.  
A substantial step toward this model of care coordination was taken with the development of 
the first multidimensional measure of unmet needs designed specifically for the AYA population: the 
Cancer Needs Questionnaire - Young People (CNQ-YP).14,15 The development of the CNQ-YP and a 
preliminary study supporting its psychometric properties14 represent promising steps towards improving 
quality of care for AYAs; however, to be a useful tool for care coordination, the CNQ-YP needs an 
accompanying process for matching AYAs to services and resources once needs are identified. In 
addition to its usefulness, the ability of AYA NA-SB to effectively coordinate care and reduce unmet 
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needs depends on (1) its acceptability and perceived appropriateness to AYAs, a population with high 
rates of non-adherence16,17 and low rates of participation in supportive services,4,5 and (2) the feasibility 
of its implementation in cancer care programs where substantial barriers to care coordination exist (e.g., 
staffing and resource constraints, difficulties communicating across multiple disciplines, and “turf wars” 
between pediatric and medical oncologists).18-20 For these perceptual implementation outcomes, 
usability is a key determinant.21  
Using the CNQ-YP as a foundation, I developed the AYA Needs Assessment & Service Bridge 
(AYA NA-SB) to connect AYAs to needed services and resources, thus facilitating more systematic, 
patient-centered care coordination for AYAs diagnosed with cancer. To promote AYA NA-SB’s usability 
and usefulness, I leveraged methods and principles from User-Centered Design (UCD). UCD is a 
methodological framework for intervention development and refinement that relies on the extensive 
and iterative engagement of prospective intervention users (e.g., AYAs; providers).22 I accomplished 
these objectives through three aims: 
Aim 1: Review and refine CNQ-YP. To identify usability and usefulness issues with the CNQ-YP in 
its original form, I engaged prospective AYA NA-SB users (i.e., cancer program providers and 
staff and AYAs) in usability testing including an online survey, cognitive interviews, and an online 
concept mapping exercise.  
Aim 2: Understand users and context. I described AYA NA-SB’s implementation and scale-up 
contexts using ethnographic methods (i.e., guided tours and semi-structured interviews) with 
users. Then, I identified user and contextual factors expected to affect AYA NA-SB usability and 
usefulness (i.e., user and contextual requirements). 
Aim 3: Generate design solutions. Through two prototyping workshops, I collaborated with a 
multidisciplinary “design team” composed of researchers, AYAs, and cancer care providers to 
iteratively design AYA NA-SB based on feedback received during Aim 1 and 2 data collection 
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efforts. This included designing AYA NA-SB content (i.e., the modified CNQ-YP) and AYA NA-SB 
delivery (e.g., who should deliver AYA NA-SB, when, where, how, and how frequently), as well as 
a plan for implementation.  
1.2 Significance  
This study’s use of UCD to proactively design AYA NA-SB for implementation represents an 
important methodological contribution at the intersection of implementation research and UCD. 
Although factors at multiple levels impact implementation, less attention has been paid in 
implementation science to fundamental characteristics of an intervention’s content or delivery which 
may influence its implementation; moreover, methods for ensuring that program features are 
compatible with user needs have not been well articulated.23 Drawing on UCD principles and methods to 
develop AYA NA-SB offered preliminary insights on the extent to which incorporating UCD in 
intervention development and implementation can facilitate successful implementation and, 
subsequently, the achievement of desired intervention outcomes.   
AYA NA-SB has the potential to improve care coordination at the individual level by allowing 
cancer care programs to tailor service delivery and resource provision to the individual needs of AYAs 
they serve. Additionally, AYA NA-SB addresses a critical measurement gap. In the past decade, AYA-
specific programs have emerged at cancer centers across the country to better coordinate cancer care 
for AYAs,18 but the impact of these programs has been largely unstudied to date.24 In large part, the lack 
of evidence on AYA-specific programs is due to a lack of patient-centered metrics.25,26 By eliciting 
patient-reported data on unmet needs at multiple timepoints during AYAs’ treatment, AYA NA-SB will 
generate such patient-centered metrics to assess the effectiveness of AYA-specific programs in 
addressing AYAs’ unmet needs as they emerge. Furthermore, AYA NA-SB will yield critical patient-
reported data to inform the structure and functions of AYA-specific cancer programs.20,27 In sum, by 
harnessing patient-reported data to facilitate the coordination of care for AYAs, AYA NA-SB has the 
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potential to improve processes of care and subsequent outcomes for AYAs, an underserved and 
understudied population.28   
To ensure that the product of this dissertation addresses a critical practice gap, research 
objectives were developed in close collaboration with key stakeholders, including AYAs and providers 
involved in AYA cancer care from around the country. Further, AYA NA-SB was designed with extensive 
input from leaders of the AYA Cancer Support Program at the University of North Carolina (UNC) 
Lineberger’s Comprehensive Cancer Center (i.e., North Carolina Cancer Hospital), who intend to 
implement AYA NA-SB as part of routine care. As such, the development of the AYA NA-SB reflects not 
only a contribution to implementation research, through the innovative use of multidisciplinary 
frameworks and methods to design AYA NA-SB for implementation, but also a pragmatic solution to 
problems faced in “real-world” AYA cancer care practice.  
1.3 Overview of Chapters 
Chapter 2 summarizes the relevant literature, including extant evidence related to experiences 
and outcomes of AYAs with cancer, the changing landscape of AYA oncology, and the potential for 
patient-reported outcome measures to facilitate care coordination for this population. In Chapter 3, I 
describe the conceptual model for this project, which integrates frameworks from implementation 
science and UCD. In Chapter 4, I describe the user-centered approach I employed to develop AYA NA-SB, 
which consisted of three stages forming an iterative and dynamic design cycle. In Chapter 5, I present 
findings from this project. In Chapter 6, I discuss these findings in the context of existing literature as 
well as their implications for future research and practice. 
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CHAPTER 2: REVIEW OF THE LITERATURE 
2.1 Cancer in Adolescents and Young Adults 
Cancer is the leading disease-related cause of death in adolescents and young adults (AYAs).29 
Contrary to common misconception, cancers are more common in the AYA population (i.e., individuals 
between the ages of 15 and 39) than in children under the age of 15.30 Hodgkin lymphoma, melanoma, 
testicular cancer, female genital tract malignancies, thyroid cancer, soft-tissue sarcomas, non-Hodgkin 
lymphoma, leukemia, brain and spinal cord tumors, breast cancer, bone sarcomas, and nongonadal 
germ cell tumors account for 95% of the cancers in this age group.30 
For AYAs, cancer survival rates are not improving as quickly as they are for children and older 
adults, a disparity in cancer outcomes that is widely documented.31,32 Within this population, 
researchers have pointed to poor physical, psychosocial, and behavioral outcomes33,34 These outcomes 
may be even worse for racial and ethnic minorities and AYAs who are uninsured.3536 Negative outcomes 
in AYAs with cancer have been attributed to a range of multilevel factors. Gaps in care include low 
clinical trial enrollment,37,38 poor adherence to treatment plans,39 and a multitude of survival challenges 
experienced by this group.40 Many have pointed to widespread failures of the health care system to 
recognize and meet the unique needs and preferences of this age group7,41 
Despite many extant studies cataloguing the unique needs of this age group, cancer care centers 
in the United States have been slow to implement programs or services to meet these needs.1 Until 
recently, AYAs have tended to occupy a “no-mans land” between medical oncology and pediatric 
oncology, 42 often reporting that existing cancer treatment programs, psychosocial programs, 
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survivorship care are misaligned with their needs and preferences.26,41,43 In short, models of AYA cancer 
care have often not been responsive to the needs of AYAs.2,8 
Demands for improvements in cancer care for this population44-46 have ignited an AYA oncology 
movement.47 In 2012, the National Comprehensive Cancer Network released a set of guidelines for 
delivering cancer care to AYAs.48 Other such guidelines and criteria for optimal AYA cancer care have 
been described.46,49 Critical areas of research have been highlighted including the development of 
measures to assess AYAs’ holistic and supportive care needs and models of care to meet these needs.8  
In the wake of the AYA oncology movement, AYA-specific cancer care programs have emerged within 
cancer centers across the country to address the challenge of coordinating services to meet the unique 
needs of AYAs.18 The composition and functions of these programs vary greatly; however, common 
components include a physical space, provider expertise, coordination between pediatric and medical 
oncology, efforts to increase clinical trial participation, and patient and family advocacy. Although the 
establishment of AYA cancer programs often results in the creation of new, age-specific interventions 
for AYAs, much of the role of these programs tends to be in coordinating services which already exist in 
a given setting. Indeed, existing supportive care programs for adults can be leveraged for the AYA 
population, where needs overlap.20  Yet, AYA programs lack guidance for coordinating services to meet 
the unique needs of this population.  
2.2 AYA Needs  
Many of the 70,000 adolescents and young adults (AYAs) diagnosed with cancer each year do 
not receive services to address the full scope of needs they experience during and after cancer 
treatment.1-5 In addition to complex physical/medical needs (e.g., treatment-related side effects, fertility 
concerns),3 AYAs’ ability to cope with and manage their disease is affected by age-specific issues related 
to family dynamics,50 peer engagement8, sexuality51, body image52, educational and vocational needs53, 
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financial issues6, and extensive information needs.54 AYAs’ unmet needs result in negative outcomes, 
including higher distress,2,3 poorer health-related quality of life,6 and higher physical symptom burden.1  
AYA cancer needs are age-specific7,8 (i.e., different from those reported by children or older 
adults with cancer), multifaceted3,8 (spanning across physical, psychosocial, and practical domains), 
individual9 (varying across AYAs), and dynamic10 (fluctuating as AYAs move through their cancer 
trajectory). Certain characteristics may be associated with greater need. For example, one study found 
that AYAs who were older, male, of non-white race/ethnicity, or of poorer physical health status were 
more likely to report unmet information needs.1 In another study, AYAs who were unemployed, less 
formally educated, and not in a long-term committed relationship were more likely to report unmet 
needs.54 
Despite the scope and complexity of their needs, however, AYAs often do not use services (i.e., 
care provided by health or auxiliary professionals in-house or in the community) and resources (i.e., 
information, materials, facilities, funds, or anything else that helps a patient to manage their illness) – 
even when they face no access barriers such as cost, insurance status, or local service capacity.4,5,11-13,55 
2.3 Care Coordination 
AYAs report barriers to service and resource use including lack of awareness and skepticism 
about the compatibility of services and resources with their own personal needs.13  They may also 
struggle to navigate a large volume of information received upon diagnosis, and multiple providers in a 
complex health system.55,56 Furthermore, in the face of school, work, family, and other demands, AYAs 
may not have the bandwidth to research or proactively seek services and resources.3,43 Even when they 
are actively experiencing unmet needs or distress, AYAs often do not broach these subjects with health 
care providers without prompting.57  
These and other barriers to appropriate service and resource use for AYAs with cancer point to a 
need for improved care coordination for this population.8,58,59 The Agency for Healthcare Research and 
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Quality defines ‘care coordination’ as the deliberate organization of “patient care activities and sharing 
information among all of the participants concerned with a patient's care to achieve safer and more 
effective care”.60 This includes assessing patients’ needs and preferences upfront, and using this 
information to inform care delivery.60 The importance of holistically coordinating care to meet AYA 
needs has been echoed by various clinical practice guidelines and recommendations,26,45-47 as well as by 
cancer patients;61,62  yet, care coordination in AYA cancer care remains suboptimal.8 Cancer programs 
often lack effective interventions to connect AYAs with unmet needs to potentially beneficial services 
and resources.8,26,43 According to Fitch’s Supportive Care Needs Framework, care provided to individuals 
with serious illness should be “based upon, and matched with, an individual’s needs within the context 
of his or her unique situation”.63 From this perspective, effectively caring for AYAs with cancer requires 
tailoring service and resource delivery to meet the unique and changing needs of each individual. To 
bridge the disconnect between AYA needs and their use of services and resources in a way that fits 
within this person-centered framework, a model of care coordination is needed that (1) effectively 
assesses AYAs’ multifaceted, age-specific, individual, and dynamic needs, and (2) uses information about 
those needs to connect AYAs to services and resources.  
2.4 Patient-Reported Outcome Measures 
Patient-reported outcome measures (PROMs)- i.e.,  “any report coming directly from the patient 
about a health condition and its treatment”64 - are increasingly recognized as exemplars of patient-
centeredness and as useful care planning interventions in cancer care.65-68  PROMs- such as distress 
screening scales (e.g., Symptom Distress Scale69), multi-symptom measures (e.g., Edmonton Symptom 
Assessment Scale70), and health-related quality of life measures (e.g., EORTC Quality of Life 
Questionnaire71)- offer cancer programs tools for standardizing the assessment of patient needs, 
experiences, and preferences. This more systematic and formalized approach to assessment can 
enhance patient-provider communication and facilitate equitable care delivery, ensuring that cancer 
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programs are responding to the multifaceted, individual, and dynamic needs of their patients.72 Existing 
literature supports some of the projected benefits of PROMs, demonstrating that the use of PROMs in 
routine clinical practice can improve patient-clinician communication, help streamline and shorten 
patient visits, and facilitate more accurate symptom assessment.73,74 These proven benefits of PROMs in 
terms of care processes should, in theory, result in improved patient outcomes (e.g., improved symptom 
burden, quality of life, experience of care). Indeed, a few studies have demonstrated such effects. For 
example, in one randomized controlled trial, the use of a web-based PROM for symptom monitoring 
improved patient quality of life, decreased emergency hospital admissions, and increased survival.75,76  
In recognition of their potential benefits on patient outcomes, researchers77 and consensus 
bodies alike (e.g., National Cancer Institute,78 American Cancer Society, Centers for Medicare and 
Medicaid Services,79 and National Institutes of Health80 ) have called for broader PROM use in cancer 
care practice, including the routine use of PROM information in patient-provider decision making. 
Furthermore, health care organizations may increasingly face quality measurement and reporting 
requirements which include the use of PROMs in routine care.81 Growing interest in the use of PROMs in 
routine care has led to the proliferation of instruments82 and examples of their application.  
However, despite growing interest in and applications of PROMs in cancer care, their 
implementation83-86 and effect on downstream patient outcomes (e.g., improved symptom burden, 
quality of life, experience of care)73,87,88 has often been limited or inconsistent. In a systematic review of 
the impact of routine collection of PROMs in oncology, Chen et al. concluded that “despite some 
encouraging results, there is still a great degree of uncertainty regarding the impact of routinely 
collected PRO[M]s, with feedback, on patient health outcomes”.89 These findings mirror those of a 
systematic review by Luckett et al., in which the effect of PROM collection on cancer patient outcomes 
was limited.90 Still another systematic review by Kotronoulas et al. found mixed, often weak, evidence of 
PROM effectiveness in improving patient outcomes (e.g., symptom burden, quality of life, experience of 
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care).87 More recently, the effect of PROMs on patient outcomes has improved, as clinics leverage 
electronic PROM collection systems integrated with their electronic health records and deploy various 
implementation strategies such as clinician training and audit and feedback.83 However, barriers to 
PROM implementation and effectiveness remain; these barriers may be rooted in characteristics of 
PROMs themselves, such as their usability and usefulness in practice.  
2.5 Usability & Usefulness 
Cancer care programs face a number of barriers to implementing PROMs such as provider-level 
barriers (e.g., time constraints, lack of training, attitudes towards PROMs etc.), patient-level barriers 
(e.g., tool length and complexity, cultural relevance and relevance to patients and cancer type, stage, 
and phase of the cancer journey), and organizational/structural barriers (e.g., electronic health record 
integration).82,91  Lavallee et al. described the challenges associated with using PROMs in routine practice 
including staff and patient burden, workflow barriers, and challenges to interpreting and following up on 
PROM data.72 Some of these barriers to implementation may be rooted in usability issues with the 
instruments themselves.85 Usability, a determinant of implementation,21 is the “extent to which a 
product can be used by specified users to achieve specified goals with effectiveness, efficiency and 
satisfaction in a specified context of use” where effectiveness is the accuracy and completeness with 
which users achieve specified goals, efficiency is the resources expended relative to that accuracy and 
completeness, and satisfaction includes users’ attitudes towards using the product.92 Issues of usability 
include complexity, understandability (e.g., literacy demand), learnability, compatibility with context, 
flexibility, aesthetic, and availability of support services in a clinic.93 Many existing PROMs demonstrate 
flaws along these dimensions. For example, one study found that more than half of the most commonly-
used PROMs use language that is not understandable by those with low literacy rates.94 Question clarity, 
including symptom recall periods, has also hindered the acceptability of PROM interventions.95  In 
another study, patients reported survey length as a major barrier to their perceptions of PROM 
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acceptability.96 Furthermore, existing PROMs used in cancer care may lack critical content and face 
validity; one systematic review of PROMs designed to assess the quality of patient-centered cancer care 
found that none of the PROMs identified were both psychometrically rigorous and inclusive of core 
dimensions of patient-centeredness.97 Similarly, another more recent systematic review of PROM use in 
oncology identified PROM appropriateness and relevance to patients as a major barrier to PROMs’ 
effectiveness in enhancing patient-clinician communication.73 Indeed, PROM development and selection 
does not always involve patient engagement to ensure that PROMs are measuring what matters to 
patients.91,98,99  
Even in cases of successful implementation, the use and impact of PROMs may be hindered by 
their limited usefulness.100,101 Usefulness, also a determinant of implementation, refers to the extent to 
which a tool generates “user-friendly data which can be acted upon by the end user in a manner that 
has a practical value while meeting their particular needs”.102 If PROMs demonstrate benefits in terms of 
care processes but not patient outcomes, this suggests gaps downstream of PROM administration and 
completion.103 In other words, the mere assessment of needs is not enough to influence patient 
outcomes if patient information is not subsequently used. Extant PROM literature suggests a limited 
consideration of usefulness in PROM research and implementation.  The majority of studies reviewed by 
Kotronoulas et al., for example, did not articulate how PROM data was used to devise or evaluate 
treatment plans.87 This lack of a follow-up action after PROM collection was also a theme in another 
more recent review of PROM implementation in cancer care, which found that PROM data 
interpretation guidance was rarely offered and patient-management guidance for addressing issues 
identified by PROMs was only provided in 25% of studies.104 Indeed, sensitivity to change (ability to 
longitudinally track progress105) and importance to clinical care represent two dimensions of usefulness 
prioritized by stakeholders.106 Without an articulated plan for incorporating PROM data into care 
delivery, administering PROMs may needlessly distract from clinical encounters and burden both 
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patients and providers; adding burden without contributing value represents an inefficient use of 
organizational resources and may even be considered unethical.91,107 To be useful, PROM data must be 
embedded in the clinical workflow such that providers can easily access it to inform decision making, 
communication with patients, and multidisciplinary interaction.77 PROM data should also be 
summarized in an accessible format for clinicians.73 Otherwise, providers are unlikely to use that 
information in care planning. Further, PROM information typically must be paired with necessary 
resources such as education, referral services, and treatment plans, and must align with clinical 
processes such as documentation, billing, patient flow, and patient education.77,89 Otherwise, PROMs 
are unlikely to improve downstream patient outcomes.  
PROM properties such as usability and usefulness can significantly influence providers’ attitudes 
towards their adoption and use.108 Providers’ acceptance of PROMs may depend on their ability to 
interpret and act upon PROM data.101 Furthermore, patients may be less engaged in PROM completion if 
they perceive PROMs as having low usability or usefulness.91,107 For example, if clinicians do not review 
PROM information with patients in a timely manner, patients may be less engaged with PROMs 
administered to them in the future. Finally, without an explicit connection between PROM information 
and the follow-up actions that information should trigger (i.e., in the absence of usefulness), the link 
between PROM implementation and improved patient outcomes will not be realized.  In sum, the 
benefits of integrating PROMs into cancer care towards improving care coordination and reducing 
unmet needs will be limited without careful attention to issues of PROM usability and usefulness.   
2.6 The Cancer Needs Questionnaire- Young People 
In recent years, the proliferation of PROMs in response to calls for their use in research and 
practice has resulted in a multitude of tools to choose from.82 However, although PROM use in cancer 
care is increasing,109 until recently, measures specific to AYAs were lacking. For example, many 
multidimensional needs assessment PROMs have been developed for cancer patients and their family 
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members; one systematic review identified 24 instruments110 and another identified 15; none addressed 
the unique needs of AYAs, specifically.67 This is problematic given the range of age-specific needs 
reported by this population.  
In 2012, to address this gap, Clinton-Mcharg et al. developed the first multidimensional PROM 
assessing unmet needs of AYAs with cancer: the Cancer Needs Questionnaire- Young People (CNQ-YP) 
(see Appendix A).14 The development of the CNQ-YP and a preliminary study supporting its 
psychometric properties14 represent promising steps towards implementing a patient-centered 
approach to assessing and addressing the needs of AYAs with cancer. However, the CNQ-YP, like many 
PROMs, has several key shortcomings with respect to its usability and usefulness. First, its length and 
complexity may limit the feasibility of its ongoing administration in real-world practice environments 
which are subject to resource and staffing shortages and competing priorities. Second, it was developed 
and has only been used in Australia, raising concerns about its appropriateness for an American cancer 
care context. Third, only younger AYAs (i.e., adolescents) were involved in the CNQ-YP’s development; 
as such, its acceptability and applicability to older AYAs remains to be seen.14  Perhaps the biggest 
limitation of the CNQ-YP is its limited usefulness for care coordination: the tool lacks a subsequent 
process for connecting AYAs to services and resources once needs are identified.  
Thus, in this study, we adapted the CNQ-YP for implementation in the AYA cancer program at 
the North Carolina Cancer Hospital (NCCH), to promote its usability and usefulness for coordinating care 
for AYAs. This resulted in the AYA Needs Assessment & Service Bridge (AYA NA-SB), a holistic needs 
assessment paired with a suite of explicit referral pathways for connecting AYAs to services and 
resources based on the needs they report.  
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CHAPTER 3: CONCEPTUAL MODEL 
3.1 Implementing EBPs in Context 
Proctor et al.’s popular conceptual model of implementation research demonstrates the 
relationship between an evidence-based practice (EBP), its implementation, and associated outcomes 
(i.e., implementation outcomes, service outcomes, and patient outcomes).111 In terms of 
implementation outcomes, Lyon et al., distinguished between perceptual and behavioral 
implementation outcomes.21 Perceptual implementation outcomes include feasibility (e.g., extent to 
which users believe that AYA NA-SB can be successfully used in cancer programs), acceptability (e.g., 
perception of whether AYA-NA-SB is agreeable, palatable, or satisfactory to users), and appropriateness 
(e.g., perception of AYA-NA-SB’s fit, relevance, or compatibility with the context in which it will be used). 
In theory,21 these perceptual implementation outcomes, which are anchored to the perspective of users, 
influence behavioral implementation outcomes (e.g., fidelity, reach, sustainment). 
Less emphasized in Proctor’s model is the inextricable role of context (i.e., the “set[s] of 
characteristics and circumstances that consist of active and unique factors, within which the 
implementation is embedded”112). EBP implementation is often challenged by poor fit between EBPs 
and their implementation contexts.113 Use of an EBP (i.e., intervention with proven efficacy and 
effectiveness114) in a context for which it is not well-suited can compromise its effectiveness and burden 
users (e.g., patients, providers, healthcare organizations) with elaborate strategies intended to force 
implementation. However, EBPs are seldom designed to address the nuances of multiple, varying, 
complex, and changing practice contexts.113 To accommodate nuanced contexts, EBP developers may 
produce increasingly complex EBPs,115 resulting in EBPs “that are ultimately too expensive, impractical, 
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or even impossible to construct within real‐world constraints”.23 Despite consistent recognition that 
there is no implementation without some adaptation, few methods exist to inform systematic EBP 
adaptation.116  
Implementation scientists have identified various EBP characteristics that influence 
implementation117; such evidence may inform efforts to adapt EBPs to improve implementation. 
However, the relationship between EBP characteristics and implementation outcomes varies across 
EBPs and contexts,117 and the same EBP may demonstrate varying degrees of effectiveness in achieving 
the desired patient outcomes across different contexts.118 All of this suggests that an EBP’s 
implementation and effectiveness are inextricably linked to context. Methods for considering the 
dynamic interplay between EBP and context have not been well articulated.116  
To address discordance between EBPs and contexts, implementation scientists often turn to 
implementation strategies – i.e., “methods or techniques used to enhance the adoption, 
implementation, and sustainability” of EBPs.119,120 However, a “more is better” approach to deploying 
implementation strategies to compensate for poor EBP-context fit may burden EBP users. Moreover, 
implementation strategies have shown only modest effect sizes.121 These findings may be in part due to 
an insufficient consideration of key determinants, such as contextual appropriateness, when selecting or 
designing implementation strategies.122  To this end, implementation scientists have called for methods 
for tailoring implementation strategies to EBPs and contexts.122,123 
Rather than deploying cumbersome EBPs or implementation strategies to improve EBP-context 
fit, implementation scientists should seek to harmonize EBPs, contexts, and strategies (i.e., design each 
with respect to the other two). An analogy (Figure 1) helps illustrate this harmonization: in embroidery, 
decisions about fabric, needle, or thread are interdependent. For example, a lightweight fabric and thin 
thread demand a smaller needle; using a large needle may damage lightweight fabric and thin thread. 
Likewise, too-thin thread may break if used with a thick needle or heavy fabric. Depending on thread 
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count, fabric may require stabilizer or alteration before embroidering. Similarly, an EBP (i.e., the thread), 
context (i.e., the fabric), and implementation strategies (i.e., the needle) should be harmonized to 
minimize user burden and optimize implementation. In Figure 1, the black thread represents an EBP and 
the blue fabric represents context. Just as an embroiderer must first understand the fabric with which 
they are working, researchers and practitioners must obtain a nuanced understanding of context before 
selecting and adapting EBPs and implementation strategies117,124-126. The red needle represents the 
implementation strategies deployed to facilitate implementation. Just as the thread cannot weave itself 
into the fabric, an EBP is unlikely to embed itself into highly complex health care contexts, even if EBP 
usability and contextual appropriateness are high.  In sum, embroidering requires harmony among 
thread, fabric, and needle. Analogously, the successful implementation and sustainment of EBPs 
requires alignment among EBP, context, and implementation strategies. 
Figure 1. Harmonizing EBP, context, and implementation strategies  
 
 
There is a critical need for the development of “relational, and dynamic approaches to 
theorising the complex interplay between the characteristics of interventions, the activities of 
implementers, and the properties of variable broader contexts”127. Indeed, advancing methods for 
harmonizing EBPs, contexts, and implementation strategies has been articulated as a priority for 
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implementation research117,128.  In this study, we sought to achieve this harmonization among AYA NA-
SB, context, and implementation through the use of User-Centered Design (UCD). 
3.2 User-Centered Design 
UCD is an iterative and highly stakeholder-engaged process for creating products or innovations 
which are directly responsive to their intended users and users’ contexts.129 Primary goals of UCD are 
improving EBP usability (ease with which it can be successfully used92) and usefulness (extent to which it 
does what it is intended to do130). Usability and usefulness are theorized as proximal determinants of 
perceptual implementation outcomes (i.e., acceptability, feasibility, and appropriateness; e.g., usability 
promotes acceptability) through which they should also influence distal behavioral implementation 
outcomes (e.g., penetration, reach, sustainment; e.g., acceptability promotes reach)21. In this light, UCD 
may increase the extent to which interventions meet the goals and needs of users, thus facilitating their 
achievement of target service and patient outcomes.131  
Most UCD definitions and frameworks share a common set of principles that can contribute to 
harmonizing EBPs, contexts, and implementation strategies: (1) refining innovations based on user input 
to optimize usability and usefulness;132 (i.e., review and refine prototypes) (2) engaging prospective users 
to achieve a nuanced understanding of context (i.e., understand users and context), and (3) a 
multidisciplinary design team collaborating to generate design solutions. Together, these domains 
comprise an iterative cycle in which an EBP’s design and implementation strategies can be refined until 
optimized for a given context.22 Within each of these domains, UCD offers myriad methods132 and 
strategies133 for harmonizing EBPs, contexts, and implementation strategies (summarized in Table 1). 
Although some of UCD’s discrete methods and principles resemble those traditionally used in 
implementation science (e.g., stakeholder engagement), UCD is unique in its offering of an extensive 
suite of methods that may be leveraged to refine EBPs, contexts, and implementation strategies. 
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Table 1. Applications of UCD in implementation science  




Interventions with demonstrated efficacy 
and effectiveness including programs, 
actions, processes, policies, and 
guidelines114 
• Selecting EBPs that are appropriate for 
users and their context (e.g., by leveraging 
UCD measures of usability such as the 
System Usability Scale134) 
• Redesigning EBPs to better fit users and 
their context (e.g., conducting usability test 




Set of characteristics and circumstances 
that consist of active and unique factors, 
within which the implementation is 
embedded including: 
• Inner  (i.e., intra-organizational) 
context135 
• Outer (i.e., extra-organizational) 
context135 
• Assessing context (e.g., conducting 
ethnography or developing user experience 
models) 
• Preparing context to promote receptivity to 
EBP (e.g., using workflow mapping to 






Methods or techniques used to enhance 
the adoption, implementation and 
sustainability of an EBP119 
• Anticipating needed implementation 
strategies based on context assessment 
(e.g., conducting design workshops to 
identify areas where fit between EBP and 
context is low and problem-solve 
accordingly)  
• Selecting strategies that are appropriate 
given EBP and context (e.g., using the 
Cognitive Walkthrough for Implementation 
Strategies136 to assess strategy usability) 
• Tailoring/designing strategies for EBP and 
context (e.g., by conducting iterative co-
creation sessions with users) 
 
 
UCD flips the typical top-down approach to EBP design and implementation,137  and instead 
relies on “action-oriented rapid prototyping of user-driven insights”138. As a result, UCD may increase 
stakeholder buy-in, generate pragmatic solutions, and facilitate rapid real-world practice improvement. 
Evidence suggests that UCD might be useful for developing EBPs which are more “implementable”.23 
However, UCD’s full potential for advancing the field of implementation science has not yet been 
realized 139,140. In addition to its upstream utility for considering implementation during initial EBP 
development, UCD has other potential downstream uses in implementation science including: (a) 
optimizing an EBP’s design to improve implementation outcomes (e.g., streamlining an EBP to improve 
feasibility), (b) preparing context to promote receptivity toward EBPs (e.g., redesigning workflows to 
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accommodate EBP implementation), and (c) selecting or designing implementation strategies to be 
more attentive to EBP and context (e.g., deploying strategies that increase the contextual 
appropriateness of an EBP) —in effect, harmonizing EBP, context, and implementation strategies, 
advancing key goals of implementation science.  
3.3 This Study’s Conceptual Model 
This conceptual model for this study integrates a UCD framework22 into Proctor et al.’s 
conceptual model for implementation research111 to illustrate more granularly the mediators between 
intervention (i.e., AYA NA-SB) and patient outcomes of interest (i.e., reduction in AYAs’ unmet needs). 
Specifically, I used the embroidery analogy described above to embed context into Proctor’s model and 
highlight the inextricable interplay among EBP, context, and implementation. Additionally, I positioned 
usability and usefulness as target outcomes of the UCD process, and determinants of implementation.21  
Per this study’s integrated conceptual model (Figure 2), leveraging UCD should help to 
harmonize AYA NA-SB, its implementation context, and its implementation; this, in turn, should 
promote AYA NA-SB’s usability and usefulness and, subsequently, implementation. In short, 
incorporating UCD to design AYA NA-SB for implementation in context should facilitate the 
intervention’s achievement of key implementation, service, and patient outcomes.141  





CHAPTER 4: METHODOLOGY 
4.1 Overview 
Leveraging the CNQ-YP as a starting point, I sought to develop AYA NA-SB and a plan for its 
implementation using principles and methods from UCD. Because I had a prototype already (the CNQ-
YP), I approached the UCD process as outlined in Figure 3. Data collection methods, timeline, and users 
engaged for each of these stages are summarized in Table 2 and Figure 4. All procedures were approved 
by the University of North Carolina’s Institutional Review Board (19-0255). 




2. Understand users and 
context
users = AYAs; cancer 
program providers & staff




design solutions = 
AYA NA-SB
1. Review and 
refine prototype




Stage 1: Review and refine prototypes 
I used mixed methods to examine user interactions with the CNQ-YP in its current form (i.e., 
usability testing). Usability testing activities included (1) an online survey assessing AYAs’ needs and 
preferences for a PROM using the CNQ-YP as a prototype for them to react to, (2) cognitive interviews 
with AYAs to obtain more in-depth qualitative data on the usability of the CNQ-YP, and (3) concept 
mapping142 exercises focused on usefulness, in which AYA program providers and staff grouped PROM-
identified AYA needs based on follow-up actions they should trigger.  
Stage 2: Understand users and context  
I used ethnographic contextual inquiry, including ‘guided tours’ and semi-structured interviews 
with prospective users (i.e., AYAs and AYA program providers and staff), to assess characteristics of 
users and context which should be considered in the design and implementation of AYA NA-SB.  
Stage 3: Generate design solutions  
At the study’s onset, I convened a multidisciplinary design team comprised of researchers, 
cancer care providers, and AYAs from whom I solicited input throughout data collection and analysis. 
Through two prototyping workshops, the design team collaboratively redesigned the CNQ-YP with 
usability in mind and redesigned care processes to facilitate the tool’s implementation and usefulness in 
routine care. These workshops resulted in an AYA NA-SB prototype and a preliminary plan for its 
implementation.   
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Table 2. Data collection summary  
UCD Aim Method Deliverable 




• AYA Survey 
• Cognitive interviews with AYAs 
• Concept mapping with 
providers/staff 
Evidence of the usability and 
usefulness of the CNQ-YP 
Understand users and 
context   
Ethnography 
• Guided tours with AYAs and 
providers/staff from NCCH 
• Semi-structured interviews with 
providers/staff from outside of NCCH 
User and contextual requirements 
for AYA NA-SB’s design and 
implementation  
Generate design solutions  Design Team Workshops 
• Workshop #1 
• Workshop #2 
AYA NA-SB prototypes and 
anticipated implementation 
strategies needed 
RESULT A usable and useful PROM linked to 
available services and resources + 





Figure 4. Data collection timeline and users engaged 
 
 
                                                                       
                                                                                                                            
                                                                                            
 
 
Figure 4 demonstrates the iterative engagement of both NCCH and external users to harmonize, EBP, context, and 
implementation strategies. External users were engaged in the review and refinement of the CNQ-YP to avoid 
over-tailoring EBP to one unique context (i.e., to promote generalizability). Because guided tours would inform 
preparation of the implementation context (i.e., NCCH), NCCH users were engaged. Semi-structured interviews 
with external providers were then conducted to explore differences across contexts (i.e., to inform future scale-up 
in other cancer programs). The design team was comprised of NCCH users to allow for in-person collaboration to 


















Figure 4 legend 
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4.2 Stage 1: Review and Refine Prototypes  
Overview 
I conducted three rounds of usability testing to examine user interactions with the CNQ-YP: (1) 
an online survey assessing AYAs’ needs and preferences for a needs assessment using the CNQ-YP as a 
prototype for them to react to; (2) cognitive interviews143 with AYAs to triangulate survey data with in-
depth evidence of their perceptions of the CNQ-YP’s usability and usefulness; and (3) concept 
mapping142 exercises focused on usefulness, in which AYA program providers mapped CNQ-YP-identified 
needs onto services/resources to address the needs.  
AYA survey 
I surveyed AYAs to assess the usability and usefulness of the Australia-developed CNQ-YP among 
AYAs in an American cancer care context. By administering the CNQ-YP and probing respondent 
reactions, I sought to identify missing content and streamline redundant or low-priority content and 
identify any other issues with the CNQ-YP’s usability and usefulness. I considered an online survey an 
appropriate data source to meet these objectives because a broad and diverse sample of AYAs could be 
engaged, increasing the likelihood of AYA NA-SB’s eventual generalizability.144  
Sample. My target sample size for the survey was between 50 and 100 AYAs. Individuals were 
included in the survey sample if they met two inclusion criteria. First, they had to be between the ages 
of 18 and 39 at the time of survey completion. Individuals ages 15-17 years of age were not included; 
however, only this younger group of AYAs were engaged in initial CNQ-YP development so I expected 
their perspectives to have already been captured to some extent. The second inclusion criterion for the 
survey was a cancer diagnosis at some point prior to survey administration. I did not specify at which 
phase respondents should be in their cancer journey, as I was interested in responses of both cancer 
survivors and those actively in treatment. 
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Recruitment. To ensure that I recruited diverse AYAs from across the country (including 
variation across race, ethnicity, age, geographic region, setting of care, etc.), I used several approaches 
to obtain my survey sample: 
o First, I employed a two-stage purposive sampling approach to recruit AYAs in which I 
identified five AYA cancer programs which vary along characteristics identified by Ferrari et 
al. as key areas of variation among AYA programs: location (e.g., state), type of institution 
(e.g., academic medical center; community-based cancer care program), model of care (e.g., 
pediatric oncology-based vs. adult oncology-based), and funding source (e.g., in-house, 
foundation, philanthropic, etc.).27 Within each of these programs, clinical partners at NCCH 
identified key contacts through their existing professional network. Once identified, I 
emailed key contacts a brief description of the project and our requests for recruitment 
support. I followed up with key contacts who did not respond to initial emails using 
Dillman’s approach for maximizing survey response rates which includes initial contact, then 
follow-up with non-responding key contacts at one, three, and seven weeks.145 Next, key 
contacts facilitated the recruitment of AYAs at their respective institutions, using 
recruitment materials (i.e., email language describing the project + survey link) I provided 
them with. After their initial response, I sent email reminders to key contacts at two-week 
intervals, prompting them to redistribute the survey link to AYAs.  
o Second, I recruited AYAs using social media, an approach that has proven viable for this 
population.146 I tweeted the survey link five times over the course of five weeks. I also 
leveraged AYA cancer programs, networks, advocacy groups and individual advocates on 
Twitter (i.e., Stupid Cancer; Critical Mass, Teen Cancer America, and the AYA Cancer Societal 
Movement), asking these individuals and organizations to “retweet” survey information to 
their followers. For example, Teen Cancer America, an organization which partners with 
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hospitals throughout the United States to develop specialized facilities and services for 
teens and young adults with cancer, played an integral role in recruitment, disseminating 
the survey link through all of their social media channels, as well as through their national 
advisory boards comprised of AYAs. Additionally, I enhanced the visibility of Twitter posts 
by connecting to the recruitment Tweets multiple hashtags used commonly by the AYA 
cancer Twitter community (e.g., #ayacancer; #youngadultcancer; #cancersurvivor; #ayacsm).  
o Finally, AYA design team representatives helped to disseminate the survey link to their 
networks (e.g., through listservs and groups pages for cancer support and advocacy groups 
such as First Descents and Cancer Dudes). 
Instrument. I collaborated with the AYA NA-SB design team to develop a survey instrument with 
three sections (see Appendix B). The first section included study information and consent and items 
collecting demographic and clinical information (i.e., age, gender, clinical characteristics, social support, 
educational/vocational status, health insurance status). The second section prompted AYAs to complete 
the CNQ-YP in its original form. The third section included items assessing respondents’ perception of 
the CNQ-YP. To assess general attitudes towards the PROM, I used items from three validated Likert-
type measures of feasibility, acceptability, and appropriateness.147 I assessed usefulness (i.e., 
actionability) through two Likert-type items asking (1) the extent to which respondents thought the 
CNQ-YP accurately captured their needs, and (2) the likelihood that they would use services or resources 
offered to them based on indicated needs. These items were developed specifically for this project. For 
each of these measures, I qualitatively probed respondents on usability and usefulness issues driving 
their concerns with the PROM’s feasibility, acceptability, or appropriateness. 
Before broader dissemination, the tool was reviewed by clinical partners at NCCH and piloted by 
five AYA members of the study’s design team (composition described in later section) to resolve any 
issues with wording, format, content, etc. I asked AYA representatives to take notes as they reviewed 
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the survey independently, capturing any issues or concerns they encountered with the survey 
instrument. They then emailed that feedback to me and I synthesized this information and revised the 
survey instrument accordingly. Although a few minor changes were made to demographic questions 
(i.e., making the sex/gender item more inclusive) and item formatting (i.e., providing more explicit 
instructions for check all that apply items) in response to feedback from piloting, no changes were made 
to CNQ-YP content at this stage, as I wanted respondents to react to the PROM in its original form.  
Procedure. I administered the survey through a secure online platform, Qualtrics (Provo, UT). 
Based on piloting of the survey instrument, I expected the 53-item survey to take approximately 30 
minutes to complete.   
Analysis. I exported survey data from Qualtrics and analyzed it using StataMP 15. I used 
descriptive statistics for respondents’ demographics, needs reported on the CNQ-YP tool, and 
perspectives of the CNQ-YP tool’s feasibility, acceptability, appropriateness, and actionability. For 
feasibility, acceptability, appropriateness, and actionability, I calculated an index score for each 
respondent by calculating an unweighted average score of items corresponding to each construct. I used 
template analysis148 to synthesize responses to free-text items. Template analysis is a group of 
approaches for thematically analyzing and organizing textual data. In this approach, the researcher 
produces a ‘template’ (i.e., list of codes) which represent themes present in the data. Often, some codes 
are defined a priori in an initial template; a priori codes are supplemented and modified as the 
researcher interprets data. Template analysis often includes hierarchical coding, in which codes are 
clustered together under higher-order codes. For survey analysis, excerpts from free-text items were 
coded as usability or usefulness issues. Within each of these higher-order codes, I synthesized excerpts 
to identify emergent themes regarding the CNQ-YP’s usability and usefulness.  
Finally, I conducted bivariate regression analyses to examine (1) the relationship between 
demographic items and number of needs reported as “high” or “very high” on the CNQ-YP, and (2) the 
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relationship between number of needs reported as “high” or “very high” and feasibility, acceptability, 
appropriateness, and actionability ratings. The purpose of these regression analyses was to identify 
patient characteristics which may influence level of need or receptivity to PROMs; this information 
would be useful in later discussions about potential barriers to implementing AYA NA-SB. For bivariate 
analyses of categorical independent variables, the most common responses were selected as referent 
groups.  
Cognitive interviews 
I conducted cognitive interviews with AYAs to supplement survey data on AYAs’ perception of 
the CNQ-YP’s usability and usefulness. The primary objective of these interviews was to explore in more 
depth any issues identified by survey respondents and to identify any remaining wording or 
comprehension issues with CNQ-YP items. Cognitive interviews are widely used in survey or 
questionnaire development to ensure respondents interpret and understand items as intended by 
developers.149 They are particularly useful for developing surveys for diverse populations.150  
To answer survey items, respondents must (1) understand the question (i.e., interpretation), (2) 
recall information pertinent to the question (i.e., memory retrieval), (3) decide on the relevance of 
information recalled (i.e., judgment formation), and (4) translate that information into an answer in the 
format provided by the interviewer (i.e., response editing).143 One cognitive interviewing technique is 
asking participants to “think aloud”, or verbalize their thoughts, as they walk through these four tasks of 
survey response. This approach can identify usability issues such as confusion or error in interpretation 
of items, difficulty recalling information needed to respond to items, or potential sources of bias in a set 
of items (e.g., content subject to social desirability bias).150  Cognitive interviews can also help design or 
revise items that are usable across respondent subgroups; for example, they might be used to examine 
whether items are interpreted similarly across cultures.151 
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Sample. From among the AYA survey sample, I purposively recruited individuals between the 
ages of 18 and 39 with a current or past diagnosis of cancer. Consistent with cognitive interview 
methodology,143 the target sample size was small (i.e., n=5-10); however, I prioritized demographic 
variation when sampling to promote the refined CNQ-YP’s relevance to diverse AYAs. In cognitive 
interviewing, analytical objectives are qualitative, not quantitative. The goal is not to achieve sample 
sizes large enough for statistical analysis but, rather, to engage a variety of participants.149  
Recruitment. At the end of the AYA online survey, respondents were asked whether they would 
be willing to participate in a future phone interview. If so, they were prompted to provide their email 
address to be contacted by a member of the study team. Using basic demographic information from the 
survey (i.e., geographic location, sex, age), I selected and recruited via email cognitive interview 
participants using the Dillman method,145 described above. Once these individuals were contacted, 
email address information was deleted from the AYA survey dataset, to ensure that respondent data 
was not stored in conjunction with identifiable data. Through concurrent recruitment and data 
collection, I continued to recruit AYAs for cognitive interviews until thematic saturation was reached, 
i.e., when subsequent interviews did not generate new data regarding the CNQ-YP’s usability or 
usefulness.   
Instrument. With input from the design team, I developed the cognitive interview guide to 
encourage participants to “think aloud” as they read and reflected on the CNQ-YP itemset and probe 
them to comment on topics such as item content and wording, response options, format, length, 
comprehensiveness, repetitiveness, etc. (Appendix C). AYA design team representatives reviewed the 
instrument prior to conducting the first cognitive interview.  
Procedure. I conducted cognitive interviews using the video-conferencing platform, Zoom; they 
were audio-recorded, and lasted one hour. I navigated the CNQ-YP through the Zoom screen-share 
function, walking the participants through the tool while soliciting their input on each section and item. 
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At the end of each CNQ-YP section, I summarized key takeaways with interviewees for the purposes of 
member checking.152 
Analysis. Immediately following each cognitive interview, I used interview recordings to review 
and expand on interview notes. I then coded cognitive interview notes by section of the CNQ-YP. 
Although cognitive interviews are sometimes transcribed for analysis, it is often sufficient to analyze 
recordings or written notes, rather than transcriptions.149 Given that the goal of cognitive interviews is 
often to generate item-level user feedback on a tool or instrument, it is also common practice in 
cognitive interview analysis to code data by section or item of that tool or instrument.149 Within each 
CNQ-YP section, I coded excerpts as (1) usability/usefulness criticism, (2) usability/usefulness praise, and 
(3) recommendations for improvement. Themes within each of these domains were then summarized in 
a table organizing usability and usefulness input by CNQ-YP section for presentation to the design team 
during our first workshop, described in detail, below (Section 4.4).  
Concept mapping  
To promote the CNQ-YP’s usefulness in practice, I engaged cancer care program providers and 
staff in an online concept mapping exercise. Through concept mapping, stakeholders are engaged in 
various activities to conceptualize constructs and relationships of interest,153 Concept mapping is useful 
for triangulating across diverse stakeholder groups and is similar to “card sorting”, a method frequently 
used in UCD.132,154,155  
Concept mapping has been used in intervention development,156,157 including the development 
of measures158,159 and patient-reported outcome instruments.160,161 It provides “(a) a solid method for 
establishing content validity, (b) [data to] facilitate researcher decision-making, (c) insight into target 
population perspectives that are integrated a priori, and (d) a foundation for analytical and 
interpretative choices”.159  
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Because it engages stakeholders to create visualizations of constructs of interest, concept 
mapping represents a user-centered method for interpreting user data and making design decisions.162 
For example, Onken et al. engaged individuals with serious mental illness in concept mapping to 
generate clusters of community services and supports; these clusters were then interpreted by study 
participants to conceptualize and prioritize services and supports based on their most salient needs.163 
Similarly, the primary objective of concept mapping for this study was to generate data to aid the design 
team in connecting  PROM-identified needs with the follow-up actions those needs should trigger. 
Ultimately, this would help organize our PROM based on follow-up actions needs should trigger, 
optimizing its usefulness for service and resource provision for AYAs.  
Sample. Concept mapping participants included cancer program providers (e.g., oncologists, 
nurses, and social workers) and staff (e.g., program managers and administrators), prospective AYA NA-
SB users who were expected to have the most knowledge about service and resource delivery for this 
population. These user groups were expected to provide key insights to ensure AYA NA-SB usefulness 
(i.e., that patient-reported data collected is explicitly tied to care delivery such that needs inform 
services and resources provided to AYAs). Although AYA feedback would be important in confirming 
concept mapping results during subsequent design team workshops, AYAs were not engaged in concept 
mapping because of extant literature pointing to their low awareness or knowledge of services and 
resources available to address their cancer needs.13 
Recruitment. Recruitment through the key contacts established during AYA survey recruitment 
was intended to achieve the minimum sample size of n=15 needed for concept mapping analyses.153 I 
emailed recruitment information to each of these key contacts, asking them to share the information 
with their colleagues. I also did a web-search to identify additional contacts from 20 AYA programs 
around the country; recruitment information was sent via email to each of these contacts, requesting 
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that they participate in the concept mapping exercise and share the information with other AYA 
providers at their institution. Finally, recruitment information was disseminated through Twitter.  
Data collection. In concept mapping, the first step often involves group brainstorming to 
generate a list of statements or items based on a focus statement or question of interest; participants 
then sort and rate these items, or a subset of them.142 For this project, items were generated prior to 
the onset of concept mapping (i.e., during usability testing). After modifying the CNQ-YP according to 
feedback from the AYA surveys and cognitive interviews and with input from the design team, I pre-
loaded the resulting list of AYA needs into an online secure platform called Concept Systems (CS) Global 
Max©. Appendix D includes this list of needs. Participants then completed two concept mapping 
exercises in CS Global Max©.  
First, participants sorted an electronic deck of cards, each containing one AYA need, into like 
categories (i.e., “follow-up domains”). Although concept mapping studies often take an unstructured 
approach to sorting (e.g., instructing participants to sort items into categories which “make sense to 
you”), I offered a more specific focus statement to concept mapping participants in this study. In this 
study, the goal of concept mapping was to group needs into follow-up domains. Thus, it was necessary 
to provide more structure around the sorting exercise to prompt participants to conceptualize 
constructs in terms of service and resource provision. Specifically, I invited participants to sort AYA 
needs into groups “which they believe could be addressed by the same follow-up action”. For example, 
needs related to depression and anxiety might be grouped together as potentially addressable by 
referral to a mental health professional. After grouping needs into follow-domains, participants were 
asked to label each of the follow-up domains.  
Second, participants rated AYA cancer needs on Likert-type response scales (from one to five) in 
terms of their importance (i.e., severity of consequences if that need goes unmet) and actionability (i.e., 
likelihood that need can be met through a service or resource), key pragmatic properties for measures 
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and instruments.164 Because AYA NA-SB is intended to facilitate service or resource delivery, it was 
particularly important to hone in on needs potentially amenable to services and resources.  
Administration. Participants accessed the web-based concept mapping exercise through 
emailed links to the project in CS Global Max©. I expected the exercise to take approximately 30 
minutes to complete.  
Analysis. CS Global Max© software was used for a three-stage analysis of concept mapping 
data. First, the software places the data in a symmetric similarity matrix comprised of 0s and 1s denoting 
whether or not participants grouped pairs of needs in the same follow-up domain. Matrices for AYA 
needs were then summed within and across participants, resulting in a single overall matrix for the 
sample. Second, the overall matrix was analyzed using multidimensional scaling to create a two-
dimensional visual representation of the distance between AYA needs (points on the map). Proximal 
needs (points) were more frequently grouped in the same follow-up domain than distal ones. The 
software then used hierarchical cluster analysis to characterize how participants grouped needs, 
creating as many potential cluster solutions as there were needs. Cluster solutions group points on the 
point map based on proximity into non-overlapping clusters; each cluster solution contains a different 
number of clusters. In concept mapping, selecting the most useful cluster solution, or number of 
clusters, represents a critical piece of analysis. There is no singular way to do this, however, the analyst 
typically facilitates discussion among a subset of participants, or a group of relevant stakeholders, who 
select the cluster solution that is most useful for the purposes of the project.153 Because it is not feasible 
to present all cluster solutions to stakeholders, this process requires discretion on the part of the analyst 
in determining which cluster solutions make sense to present to stakeholders, given the goals of the 
project. The CS Global Max© software also created “go-zone graphs” by calculating descriptive statistics 
for the importance and actionability ratings and plotting them for each need. Using the mean score for 
each need, the resulting scatterplot featured four quadrants displaying the relative importance and 
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actionability of needs; the quadrants were formed based on the overall mean for importance and 
actionability ratings across all needs.  
Cluster solutions and go-zone graphs were reviewed by the design team during the first design 
team workshop (described in Section 4.4) to inform modifications to the CNQ-YP to enhance the tool’s 
usability and usefulness. I selected a small subset of cluster solutions to present to the design team. For 
a set of fewer than one hundred statements, Kane & Trochim recommend starting by looking at cluster 
solutions ranging from three to 20 clusters.153 Starting with the 20-cluster solution, I examined how the 
grouping of needs changed as the number of clusters decreased. Through this process, I selected five 
cluster solutions in which the grouping of needs made the most sense in terms of service or resource 
provision; I presented these five cluster solutions to the design team.  
4.3 Stage 2: Understand Users and Context  
Once usability testing of the CNQ-YP was complete, I used ethnographic contextual inquiry, 
including guided tours and interviews, to gather detailed information about prospective users and 
contexts to inform the tool’s transformation into our next prototype, AYA NA-SB. The UCD process 
commonly incorporates contextual inquiry to gather detailed data on users and context. Contextual 
inquiry is a “field data-gathering technique that studies a few carefully selected individuals in depth to 
arrive at a fuller understanding of the work practice across all [users]”.165 The core premise of contextual 
inquiry is observing users in their own context and asking them questions about their attitudes, actions, 
and experiences. Specifically, contextual inquiry may be used to elicit data on user characteristics (e.g., 
knowledge, skills, experience, goals), tasks (i.e., activities undertaken to achieve a goal), and 
environment (technical, e.g., physical, social and organizational).166 
In this study, I took an ethnographic approach to contextual inquiry. Ethnography, or research 
conducted in everyday settings, can provide rich data on health care experiences and interactions.167,168 
Ethnographic research focuses less on the quantification of individuals’ words and actions and more on 
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deriving meaning from these words and actions.169 Such methods are applicable to the UCD process 
because they allow a more nuanced understanding of users and context than traditional questionnaires, 
including insights on user behaviors, attitudes, needs, and preferences.129,132,170 Specifically, I conducted 
a focused ethnography, which differs from traditional ethnography because it is time-limited and topic-
specific.171 
Despite its potential value for contextualizing healthcare experiences, ethnography remains 
underused in health services research. In a 10-year review of the use qualitative methods in published 
health services and management research, Weiner et al. found that only four of 3,637 studies used 
ethnographic methods.172 Nonetheless, some have recognized the important role that ethnography can 
play in the co-creation of health care interventions,173 and also in implementation research.174 For 
example, ethnographic methods can facilitate the in-depth study of organizational and contextual 
processes influencing implementation and sustainment,175 particularly the non-rational (i.e., difficult to 
quantify e.g., emotional, collective) dimensions of healthcare interactions which other qualitative 
methods might not capture.176 Finally, ethnography can illuminate the difference between what people 
say and what people do.177  
Guided tours 
To describe users and context, I first conducted “guided tours” with prospective AYA NA-SB 
users at NCCH, an ethnographic method in which study participant leads researcher through their 
environment, commenting on their thoughts and experiences as they go.178 This method offers “details 
and motivations that are implicit to peoples’ work because they have become habitual, who the users 
really are, how they work, and insight into the context of the usage situation.”144 
Sample. Understanding user and contextual factors necessitated the engagement of multiple 
user groups, particularly since providers and patients have reported differing perceptions of AYAs’ 
prioritized needs.179,180 To capture the perspective of those who would be responsible for implementing 
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AYA NA-SB in the future, I conducted guided tours with NCCH providers and staff including an AYA 
oncologist and an AYA social worker and program manager (n=2).  
To capture the patient perspective, I conducted guided tours with AYAs receiving outpatient or 
inpatient care at NCCH (n=8). Although NCCH’s AYA program serves individuals ages 15 to 39, I recruited 
only individuals between 18 and 39 years of age. However, AYAs were purposively sampled to included 
individuals receiving care in both pediatric and adult oncology departments. Since both departments 
serve AYAs, it is important that AYA NA-SB accommodate contextual factors which may vary between 
them (e.g., staffing). AYAs were also purposively sampled such that they varied along gender, 
race/ethnicity, and clinical characteristics.  
Recruitment. The providers with whom guided tours were conducted were my clinical partners 
at NCCH and also members of the study’s design team. As such, their involvement spanned the entire 
project. They also helped to facilitate the recruitment of AYAs for guided tours. First, I provided a list of 
eligibility criteria to them and a one-page document summarizing the study and what participation 
would entail. During visits with AYA patients, clinical partners offered AYAs this recruitment flyer. 
Clinical partners then connected me via email or text message to AYAs interested in participating. I then 
responded to these individuals with additional information about the project and their potential role. I 
followed up with non-responders using the Dillman method, described in a previous section (Section 
4.2). Once AYAs indicated their willingness to participate, I moved forward with scheduling a time to 
meet with them during an upcoming appointment.  
Instrument. Guided tours require flexibility and an unstructured approach to interviewing, such 
that the study participant is in control.178,181 However, with input from the design team, I developed a 
repository of potential questions in advance based on four domains of Maguire et al.’s typology of user 
and contextual factors to consider in UCD: (1) user group characteristics (e.g., “what is your role in 
caring for AYAs with cancer?”), (2) user tasks (e.g., “walk me through what a typical appointment looks 
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like for you”), (3) physical and technical environment (e.g., “where do you currently seek information 
about resources and services available for AYAs?”), and (4) organizational environment (e.g., “does your 
institution support the establishment of systems or processes specifically for AYAs?”).132 Maguire et al.’s 
framework is sufficiently broad to capture the experience of various user types (e.g., AYAs and 
providers); however; a separate list of example questions were developed for AYA and provider guided 
tour participants. This typology and example questions can be found in Appendix E.  
Procedure. During guided tours with providers, I shadowed each for 4 hours, as they completed 
clinical, administrative and other duties, asking them questions about their tasks and thoughts as we 
went.  
During AYA outpatient guided tours, I met AYAs in the lobby of NCCH 15 minutes before their 
appointment time to walk them through the consent form and answer any questions they had before 
giving consent to participate. I then followed AYAs and accompanying family members for the duration 
of their outpatient appointments, asking them questions as they interacted with their environment and 
health care professionals while also taking care not to interject too often. During AYA inpatient guided 
tours, I visited AYAs in their rooms. After receiving their informed consent, I proceeded to spend the 
next one to three hours with them, observing their surroundings and interactions, and asking them 
about their daily tasks and experiences while receiving inpatient care. All AYA participants received a 
$50 Amazon gift card as a modest token of appreciation for their time. 
Guided tours were audio-recorded with consent of participants and anyone accompanying 
them, including providers and hospital staff present for any length of time. To respect the privacy of 
non-consenting individuals, the recording device was only turned on during more private interactions. 
For example, when walking through busy hallways or areas with other patients and families around, the 
recording device would be turned off. I took extensive field notes, capturing conversations with AYA 
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participants as well as conversations amongst AYAs and their treatment staff or other parties present. 
Also documented in field notes were nonverbal cues and features of the physical environment.  
Important to ethnography and contextual inquiry is the researcher’s triangulation across 
multiple data sources.182 Thus, during guided tours, I collected documents (e.g., informational materials 
in patient waiting rooms) and took photographs of physical spaces in NCCH to supplement data from 
field notes and recordings. All photographs and documents were uploaded and amended to field notes.  
Analysis. Immediately following each guided tour, I reviewed recordings from that tour to 
elaborate extensively on field notes. Because these tours often spanned the course of several hours, it 
was not feasible to transcribe each of them. In fact, transcription is not always appropriate for 
ethnographic activities such as observation because key nonverbal information is lost when data is 
extracted solely from transcripts. In ethnography, data collection and analysis are recursive183 and field 
notes are expanded post-data collection through inscription (i.e., retrospectively recording events from 
memory), additional data sources (e.g., photographs), and returning to participants for additional 
information. “The point of field notes is eventually to have written down all the information that you 
think may be relevant to your research”.182 Thus, it is standard practice in ethnography to code field 
notes, rather than transcribing detailed encounters occurring during participant observation.184-186  
Data from guided tours and subsequent semi-structured interviews were analyzed using a 
template analysis approach based on a priori themes (i.e., Maguire’s constructs) but allowing for 
emergent themes (see Section 4.2 for a description of template analysis).148 See the codebook for 
ethnography analyses in Appendix E; the broadly applicable domains and constructs of Maguire’s 
framework allowed me to use the same codebook for both AYA and provider guided tours as well as for 
semi-structured interviews. In ethnography, “solo coding” is not uncommon, as one researcher works 
intimately and recursively with the data.187,188 However, to ensure interpretive convergence, a colleague 
with extensive experience conducting qualitative research and I independently abstracted excerpts from 
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one set of guided tour field notes to calibrate our coding schema. We then met to discuss any 
discrepancies in our coding. Once all discrepancies were resolved, I proceeded to code the remaining 
guided tour field notes and semi-structured interview transcriptions. This double coding of a subset of 
the data, followed by individual coding of the remaining data, represents a commonly-used approach in 
the qualitative literature,189 and a useful means of ensuring codebook quality.190 For each Maguire 
domain, I synthesized user and contextual factors and created a “translation table”191, which translates 
factors into their implications for designing an intervention and its implementation. This translation 
table was reviewed by the design team during our second workshop (described in Section 4.4).  
Interviews  
To ensure AYA NA-SB’s applicability outside of NCCH, I also conducted semi-structured 
interviews with external (i.e., non-NCCH) users to inform future scale-up and sustainability.192 The 
primary objective of these interviews was to review the user and contextual factors identified by NCCH 
users during guided tours, and to identify any areas of divergence or additional factors to consider 
across diverse health systems. Because the goal of these interviews was to identify differences between 
NCCH and other institutions, priming participants with user and contextual information about NCCH was 
considered appropriate. Such information was critical in identifying areas in which AYA NA-SB would 
require flexibility in delivery to accommodate differences across users and contexts.  
Sample. I conducted interviews with users outside of NCCH (n=5), specifically, the key AYA 
program contacts who helped facilitate AYA survey and concept mapping recruitment (described above, 
in Section 4.2). These individuals included program managers, nurses, and patient navigators serving 
primarily AYA patients.  
Interview guide. With input from the design team, I developed a semi-structured interview 
guide based on Maguire’s typology 132 and guided tour findings (Appendix F). Topics addressed included 
AYA program structure, functions, funding and staffing; processes and tools used for identifying AYA 
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patients, assessing and addressing AYAs’ needs, and documenting information about AYAs’ needs; and 
perspectives on AYA NA-SB content and delivery.  
Data collection. I conducted one-hour semi-structured telephone interviews. At the end of each 
interview, I summarized major takeaways for the purposes of member checking. 152 I audio-recorded 
and transcribed interviews verbatim.  
Data analysis. I analyzed interview data alongside data from guided tours, using the template 
analysis approach148 described above, in Section 4.3. I summarized points of variation between NCCH 
and interviewees’ institutions for presentation to the design team during the second workshop. Where 
interviewees discussed tools and other interventions their institution had employed to assess and 
address AYAs’ needs, I summarized this information in an additional table for presentation to the design 
team during the second workshop.  
4.4 Stage 3: Generate Design Solutions   
Overview  
A key UCD principle is the collaboration of a multidisciplinary design team to create intervention 
prototypes.132 At each phase of the project, AYA NA-SB prototypes were presented to the design team 
and, based on their interactions with prototypes, iterative improvements made to AYA NA-SB content 
and delivery. Design team members offered key insights to inform data collection (e.g., review of 
instruments), data analysis (e.g., selection of concept mapping cluster map; prioritization of user and 
contextual requirements), and, ultimately, AYA NA-SB and implementation strategy design. Further, 
design team members proved critical to the recruitment of users for usability testing and ethnographic 
data collection. The design team in this study represents an iterative approach to user engagement, with 
the same group of users reviewing prototypes at multiple time points; this type of iteration may be a key 
moderator in the relationship between stakeholder engagement and improved design.193 
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Sample. At the onset of the project, I convened a design team consisting of academic 
researchers in cancer care delivery and implementation science, individuals with expertise in UCD, and 
prospective AYA NA-SB users. User groups included clinical partners at NCCH, and five AYA 
representatives nominated by clinical partners. These AYAs were primarily individuals who had 
previously expressed interest in research or advocacy activities related to AYA cancer and would thus be 
more likely to consider the ongoing participation that joining the design team would entail.  
Recruitment. To recruit young adult representatives for the design team, clinical partners 
connected young adult representatives to me via email. I provided them with project materials including 
a project summary, a breakdown of their expected role and time commitment, and a brief summary of 
UCD. I then met with each young adult interested in participating to discuss the project and develop 
rapport, followed by meeting with all young adult representatives to build group rapport. I offered 
young adult representatives a one-time $150 incentive for participation. 
Design Team Workshop #1 
Overview. After the survey, cognitive interviews, and concept mapping, I convened the AYA NA-
SB design team for a workshop in which we selected the most interpretable concept mapping cluster 
map and considered eliminating from the CNQ-YP needs that were, relative to others, less important 
and actionable. The elimination, addition, or refinement of CNQ-YP items was further informed by 
usability and usefulness data from the AYA survey and cognitive interviews. Once the design team 
generated a list of high-priority needs grouped by follow-up domains, they collaboratively identified 
services and resources at NCCH which corresponded to each follow-up domain. The goal of the meeting 
was to redesign a PROM for use in AYA NA-SB in which priority needs were grouped based on services 
and/or resources available at NCCH that could address those needs. 
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Sample. Attendees of Design Team Workshop #1 included me (expertise in implementation 
science and UCD), AS (AYA oncologist), LL (AYA program director and social worker), a palliative care 
fellow, and AYA design team representatives (n=3). 
Materials. Design team participants were each given a packet of information including (1) a 
meeting agenda, (2) a project overview, (3) the original CNQ-YP, and (4) usability testing results (see 
Appendix G). Additionally, I developed index cards representing each item up for discussion (i.e., those 
rated as low importance-low actionability during concept mapping, or those for which other salient 
issues were identified during usability testing). On the front of these index cards was the item itself; on 
the back, I included results from usability testing with respect to that item. Specifically, results depicted 
on the index cards included (1) each item’s average importance and actionability ratings from concept 
mapping, (2) each item’s average rating on the AYA survey from one (no need) to five (very high need), 
and (3) select takeaways from cognitive interviews related to that item’s usability or usefulness. I also 
developed index cards representing needs to consider amending to the itemset. I elicited these potential 
additional needs from qualitative data from the AYA survey and cognitive interviews. Attendees were 
also given “cluster comparison worksheets” (Appendix G) which visually depicted, by cluster, the 
differences between various cluster solutions generated from concept mapping data.  
Procedure. Design Team Workshop #1 was held on January 29, 2020 from 12:00pm to 4:00pm. 
Lunch was provided. First, I gave a brief presentation outlining goals for the project, goals for the 
workshop, and a summary of project activities and results to date (i.e., usability testing results). Second, 
we used usability testing results to refine the CNQ-YP itemset, eliminating, revising, and adding items 
based on user feedback. To facilitate this conversation, we discussed each index card in the two decks 
representing items up for discussion and potential additional items, respectively. Points of discussion 
included usability testing results with respect to each item and potential overlap with other items in the 
itemset. After a brief discussion about each item, workshop attendees then voted on that item through 
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open (versus private) voting. Red stickers were used to vote on an item’s elimination; green stickers 
were used to vote to keep an item; yellow stickers were used to vote on a major revision or indecision 
about an item. Votes were then tallied to arrive at a decision about that particular item; where voting 
was split (i.e., greater than two design team members in opposition), we discussed further until the 
design team reached consensus.  
Once changes were made to the itemset, we turned our focus towards grouping items into 
appropriate follow-up domains. First, to inform our discussion, I gave a brief overview of services and 
resources available at NCCH, identified through an environmental scan of NCCH’s website, in-clinic 
brochures, and other relevant documents. We then reviewed various cluster solutions generated from 
concept mapping results. Attendees recorded on their “cluster comparison worksheets” their 
preferences regarding cluster breakdowns. They were also asked to highlight any items which seemed 
out of place in a given cluster. Then, through collaborative discussion, we selected the most 
interpretable cluster map (i.e., the one with the highest face validity). We then moved items between 
clusters, as needed. Finally, we labeled each cluster according to the service/resource/follow-up action 
that needs in that cluster should trigger. Labeling was informed by labels ascribed to clusters by concept 
mapping participants, which are distilled by the CS GlobalMax software during analysis. Labeling was 
also informed by a list of services and resources at NCCH, generated through the aforementioned 
environmental scan.  
Finally, we discussed response options, format, and sequencing of the PROM. This discussion 
was informed by summaries of user feedback on these issues. After a brief discussion of the upcoming 
Design Team Workshop #2 and brainstorming of necessary attendees, we concluded the meeting.  
Analysis. Detailed notes were taken during Design Team Workshop #1 to capture all discussion 
points leading to decisions on AYA NA-SB content; the meeting was also recorded for further elaboration 
on meeting notes. After the workshop, I drafted the revised PROM based on items eliminated or added 
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to the CNQ-YP as well as item revisions discussed. In this draft, needs were grouped by follow-up 
domain. This revised PROM also reflected changes made to item formatting, sequencing, and response 
options. I sent this refined PROM via email to all members of the design team to solicit additional 
feedback on the itemset and its division into follow-up domains.  
Design Team Workshop #2 
Overview. After soliciting user and contextual data through guided tours and interviews, I 
convened the design team for a second workshop during which I presented them the ethnography 
findings in juxtaposition with the PROM content produced during the first design team workshop. This 
juxtaposition allowed design team members to anticipate context modifications and needed 
implementation strategies with respect to the redesigned tool itself. For example, the content of the 
tool might necessitate its administration by providers with certain areas of expertise (e.g., social 
workers); staffing and workflow patterns may need modification to facilitate this administration by 
social workers. Through popular UCD methods, ‘storyboarding’ (i.e., “sequences of images which show 
the relationship between user actions or inputs and system”132), ‘personas’ (i.e., using caricatures of key 
user groups to convey users' needs to the design team), and ‘scenarios of use’ (i.e., using specific 
examples of how users, context, and AYA NA-SB might interact),132 we collaboratively specified who will 
deliver the needs assessment, when, how often, and the materials and procedure that will be used to do 
so. Additionally, we used this workshop to co-design the bridge between identified needs and care 
delivery—in other words, making explicit the referral pathways connecting PROM-identified needs and 
follow-up actions they should trigger. Finally, this workshop was used to plan for AYA NA-SB 
implementation.  
Sample. Attendees of Design Team Workshop #2 included me, AS (AYA oncologist), LL (AYA 
program director and social worker), and the same AYA design team representatives who attended 
Design Team Workshop #1 (n=3). Because designing AYA NA-SB referral pathways was an objective of 
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this meeting, I also included various providers involved in AYA care at NCCH (n=6) including (1) a 
pediatric oncology nurse practitioner, (2) a pediatric palliative care social worker, (3) a nurse navigator, 
(4) a pediatric palliative care physician, (5) a chaplain, and (6) a second AYA social worker. The purpose 
of including these individuals was to capture the perspectives of the range of provider groups that might 
interface with AYA NA-SB in practice and also to build buy-in for future AYA NA-SB implementation at 
NCCH, potentially strengthening referral pathways.  
Materials. I gave design team participants a packet of information including (1) a meeting 
agenda, (2) a project overview, (3) the revised PROM developed through Design Team Workshop #1, 
and (4) ethnography results (see Appendix H). Ethnography results included translation tables from 
provider and AYA guided tours (i.e., user and contextual factors translated into their implications for 
AYA NA-SB delivery), a synopsis of how data from semi-structured interviews with external users 
converged and diverged from ethnography data collected at NCCH, and a table displaying case examples 
of how other institutions were delivering similar interventions (elicited from semi-structured 
interviews). Other materials included a storyboard of AYA NA-SB delivery, personas, and scenarios of use 
(see Appendix H), all of which were generated based on ethnography findings. Four personas were 
crafted to represent four user types: (1) an AYA receiving care in pediatric oncology, (2) an AYA with 
frequent inpatient stays, (3) an AYA receiving maintenance treatment with appointments occurring less 
frequently, and (4) an AYA with a prognosis of less than one year. Scenarios of use reflected various 
appointment types and were presented using a flowchart of patients’ appointments. For example, one 
scenario included labs, treatment, and a clinical appointment; another included just treatment; a third 
included just a clinical appointment.  
Procedure. Design Team Workshop #2 was held on February 26, 2020 from 12:00pm to 4:00pm. 
Lunch was provided. First, I gave a brief presentation outlining goals for the project, goals for the 
workshop, and a summary of project activities and results to date (i.e., Design Team Workshop #1 and 
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ethnography). Second, we revisited the needs assessment revised through Design Team Workshop #1 to 
discuss some outstanding issues related to needs assessment content (e.g., the response scale).  
After discussing the needs assessment, I reviewed the ethnography translation tables, giving the 
design team the opportunity to vet my translation of user and contextual factors into user and 
contextual requirements. I then engaged design team members through storyboarding, scenarios of use, 
and personas to inform the collaborative specification of AYA NA-SB delivery, including who should 
deliver the PROM, through what mode, and when and how often the PROM should be administered. 
These specific dimensions of delivery were derived from the Template for Intervention Description and 
Replication (TIDieR) checklist.194 To facilitate this discussion, I divided AYA NA-SB delivery into six 
segments: (1) AYA receives and completes needs assessment, (2) AYA “turns in” needs assessment, (3) 
data is documented, (4) data is interpreted to identify appropriate services/resources, (5) 
service/resource providers are notified, and (6) services and resources are provided. I then walked 
workshop attendees through each segment, priming them with user and contextual requirements 
relevant to that segment, as well as any other pertinent data. Together, we specified each segment of 
delivery, discussing both a pilot scenario as well as future broader implementation. The selected 
specification options were then vetted in terms of personas and scenarios of use generated from 
ethnographic data. The goal of this vetting process was to ensure that the specification of AYA NA-SB 
delivery was appropriate across the various user types depicted by personas (e.g., pediatric vs. adult 
patient) and across potential scenarios of use (e.g., different appointment types).  
During the second design team workshop, we also discussed the future implementation of AYA 
NA-SB, anticipating barriers and facilitators to implementation and brainstorming strategies to optimize 
AYA NA-SB implementation. This discussion was informed by a list of barriers and facilitators that I 
gleaned from usability testing and ethnographic data. We used PollEverywhere to rank this list of 
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barriers from most to least salient. We then discussed the three barriers ranked as the most salient in 
terms of the mechanisms driving those barriers as well as potential strategies to address them.     
Analysis. I took detailed notes during Design Team Workshop #2 to capture all discussion points 
leading to decisions on AYA NA-SB delivery and implementation; the meeting was also recorded for 
further elaboration on meeting notes. I synthesized and analyzed notes inductively to document the 
results of design team prototyping and generate guidance for AYA NA-SB delivery and implementation.  
 
48 
CHAPTER 5: FINDINGS 
5.1 Design Team Composition 
Young adult representatives included a racially and ethnically diverse group three women and 
two men. They represented different diagnoses and different timepoints in their cancer trajectory, with 
one in active treatment, one in maintenance treatment, and the others in the survivorship phase. In 
addition to their lived experience with cancer, young adult representatives brought various other areas 
of content expertise to the project, including training in instructional design and mental health service 
delivery.  
5.2 AYA Survey 
Participants 
A total of 99 AYAs completed the online survey, with n=70 meeting the eligibility criteria and the 
threshold for response completeness (i.e., made it to the CNQ-YP section of the survey). Although my 
recruitment approaches did not allow for the calculation of a response rate, the broad dissemination of 
the survey link through various channels increases the likelihood that I reached a diverse national 
audience as intended. Based on analytics provided by Twitter, the 5 tweets disseminated by the study 
team received 13,088 views. This does not include views of Tweets disseminated by other stakeholders 
(e.g., Teen Cancer America) through their own social media channels. Key contacts also proved vital to 
recruitment. These AYA providers disseminated the survey link through social media, patient advisory 
boards, email listservs, newsletters, and word-of-mouth. AYA design team representatives also 
disseminated the survey link to their networks (e.g., online cancer support groups and email listservs for 
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AYA programs). Qualtrics analytics indicated that most survey respondents (81%) accessed the survey 
through social media versus 19%, who accessed the survey through another means.  
Survey respondents, summarized in Table 3, were 79% female and 21% male. N=2 respondents 
reported being transgender. Respondents ranged in age from 18 to 30, with a mean age of 24. In terms 
of race/ethnicity, they identified as Non-Hispanic White (70%), Hispanic (14%), Non-Hispanic Asian or 
Pacific Islander (4%), Non-Hispanic American Indian or Alaska Native (3%), Non-Hispanic Black (1%), and 
other/unknown (7%). They represented 18 types of cancer, with Hodgkin Lymphoma (n=14, 21%), 
leukemia (n=11; 16%), and sarcoma (n=9; 13%) being the most common. 1% of respondents were stage 
0 at diagnosis; 34% were stage I/II; 31% were staged III/IV; the rest (32%) reported that they were not 
staged or stage unknown. 27% reported being in active treatment at the time of survey completion but, 
for most respondents (71%), a year or more had passed since their initial cancer diagnosis.  
Survey respondents reported a diversity of living situations:  12% reported living alone, 43% with 
parent(s), 28% with spouse or partner, and 18% with roommates. N=4 respondents reported having 
children. AYAs varied in terms of educational level, with 3% reporting less than high school education, 
38% reporting some college or an associate degree, 22% reporting college graduation, and 24% 
reporting educational training beyond an undergraduate degree. They represented a range of insurance 
sources, both public and private; parents’ insurance, however, was the most commonly reported source 





Table 3. AYA survey summary statistics 
Sex and gender identity  
 
Female 55 (78.6%) 
Male 15 (21.4%) 
Transgender 2 (2.9%) 
Age  
 
Mean (SD) 24.24 (3.96) 
Race   
Hispanic (all races) 10 (14.3%) 
Non-Hispanic American Indian/ Alaska Native 3 (4.3%) 
Non-Hispanic Asian or Pacific Islander 2 (2.9%) 
Non-Hispanic Black 1 (1.4%) 
Non-Hispanic White 49 (70.0%) 
Other 5 (7.1%) 
Cancer type   
Non-Hodgkin lymphoma 5 (7.1%) 
Hodgkin lymphoma  15 (21.4%) 
Leukemia  11 (15.7%) 
Sarcoma 9 (12.9%) 
Cervical 1 (1.4%) 
Other female reproductive 3 (4.3%) 
Male reproductive 1 (1.4%) 
Thyroid 5 (7.1%) 
Brain 5 (7.1%) 
Melanoma 2 (2.9%) 
Colorectal  1 (1.4%) 
Breast  4 (5.7%) 
Other 8 (11.4%) 
Stage at diagnosis   
0 1 (1.4%) 
I/II 24 (34.3%) 
III/IV 22 (31.4%) 
Unknown/ unstaged 23 (32.9%) 
Time since diagnosis   
< 3 months  3 (4.3%) 
3-6 months 9 (12.9%) 
7-12 months 8 (11.4%) 
>12 months 50 (71.4%) 
In active treatment?   
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no 51 (72.9%) 
yes 19 (27.1%) 
Cohabitants 
 
Parent(s) 29 (42.7%) 
Spouse 12 (17.7%) 
Non-spouse partner 7 (10.3%) 
Child/children 4 (5.9%) 
Roommate(s) (not parent, spouse, or child) 12 (17.7%) 
Lives alone  8 (11.8%) 
Education level   
< high school  2 (2.9%) 
Completed high school  9 (13.2%) 
Some college/ vocational training 23 (33.8%) 
Associate degree 3 (4.4%) 
College graduate 15 (22.1%) 
Graduate degree or some post-graduate 
education  
16 (23.5%) 
Insurance source    
Self-pay  4 (5.9%) 
No insurance 3 (4.4%) 
Employer/ school 18 (26.5%) 
Spouse’s employer/ school 2 (2.9%) 
Parent 25 (36.8%) 
Medicare 3 (4.4%) 
Medicaid 8 (11.8%) 
Military/ TRICARE 8 (11.8%) 






Needs. AYA survey respondents reported many and diverse needs on the CNQ-YP section of the 
survey. Figure 5 displays the distribution of the number of needs rated as “high” or “very high”.  Number 
of needs rated as “high” or “very high” ranged from 0 to 54, with an average of 24 needs. Figures 6-10 
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Figure 6. Average rating of needs: treatment environment & care section 
 
Figure 7. Average rating of needs: education section 
 
 




Figure 9. Average rating of needs: feelings & relationships section 
 
 




Evaluation of CNQ-YP. On average, respondents scored CNQ-YP’s acceptability at 3.8 out of 5, 
its appropriateness at 4.1, its feasibility at 4.0, and its actionability at 4.3 (i.e., where 1=strongly 
disagree; 5=strongly agree). Table 4 depicts these mean index scores as well as mean scores for the 
individual items comprising each measure. Figure 11 displays index scores on box and whisker plots.   
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Table 4. Evaluation of CNQ-YP   
Measure Statistics 
Acceptability   
The CNQ-YP meets my approval   4.0 (0.7) 
The CNQ-YP is appealing to me 3.8 (0.9) 
I like the CNQ-YP 3.7 (0.9) 
I welcome the CNQ-YP  3.8 (0.8) 
Index 3.8 (0.7) 
Appropriateness   
The CNQ-YP seems fitting as a needs assessment tool 
for adolescents and young adults with cancer 
3.9 (0.9) 
The CNQ-YP seems like a suitable tool for my doctor to 
administer to me as part of my cancer care 
4.1 (0.6) 
The CNQ-YP seems applicable to adolescent and young 
adult cancer care 
4.2 (0.6) 
The CNQ-YP seems like a good match for adolescents 
and young adults 
4.1 (0.6) 
Index 4.1 (0.6) 
Feasibility   
The CNQ-YP seems like something my doctor could 
administer to all of their patients 
4.0 (0.8) 
The CNQ-YP seems possible for me to complete as 
part of my care 
4.1 (0.6) 
The CNQ-YP seems doable 4.1 (0.6) 
The CNQ-YP seems easy to use  3.9 (0.9) 
Index 4.0 (0.6) 
Actionability   
My doctors would gain a good understanding of my 
needs from reviewing my answers to this survey 
4.2 (0.7) 
I would consider using services/resources offered by 
my doctor if they matched them to the needs I 
identified in this survey 
4.4 (0.6) 









When asked whether they believed that anything was missing from the CNQ-YP, 40% percent of 
respondents reported “yes”, listing a number of gaps with the current itemset. For example, 
respondents wanted more content related to financial needs, sexual health, mental health, social needs, 
physical activity, and in-hospital space and activities specifically for AYAs. A few respondents wanted the 
tool to solicit need for specific specialists such as nutritionists or physical therapists. Several respondents 
wanted additional free-response opportunities to report more specific and individualized information 
about the needs they were experiencing.  
Respondents were also asked whether anything was in the CNQ-YP that should not be. Although 
most (97%) responded “no”, a few noted that the response scales were cumbersome and recommended 










Through bivariate analyses, I assessed the relationship between demographic and patient 
characteristics and number of needs rated as “high” or “very high” (i.e., greater need; see Table 5). In 
terms of cancer type, having breast cancer was associated with having fewer needs. Being uninsured 
was also associated with having greater need. These relationships were statistically significant at the 
=.05 level. Having non-Hodgkin lymphoma and being Black were also associated with having greater 
need but these relationships were only statistically significant at the =.10 level.  
I also examined the relationship between number of needs and ratings of the CNQ-YP’s 
feasibility, acceptability, appropriateness, and actionability (see Table 6). Reporting greater need was 
associated with higher ratings of the CNQ-YP’s actionability; this relationship was statistically significant 
at the =.05 level.  
Table 5. Bivariate relationship between demographic/patient characteristics and number of needs 
reported as “high” or “very high”  
 y=  
# of needs reported as “high” or 
“very high” 
correlation coefficient (standard 
error) reported 





male -2.7778 (5.920) 
Age 0.2186 (0.595) 
 
 
Time since diagnosis 
 
(ref: >12 months)  
                                         <3 months 24.72 (16.20) 
                                         3-6 months -0.85 (6.66) 














(ref: Hodgkin Lymphoma)  
Non-Hodgkin lymphoma 18.78 (10.8)*  
Leukemia  -8.24 (9.04) 
Sarcoma -8.73 (8.17) 
Cervical 18.56 (17.08) 
Other female reproductive  -2.44 (12.67) 
Male reproductive 3.56 (17.08) 
Thyroid -7.69 (9.74) 
Brain -11.19 (9.74) 
Melanoma -6.44 (17.08) 
Colorectal 0.56 (17.08) 
Breast -21.44 (9.74)*** 







0 -20.82 (16.26) 
III/IV 2.74 (5.5) 
Unknown/unstaged 6.32 (5.7) 
Race/ethnicity  
 
(ref: Non-Hispanic White)  
 
Hispanic (all races) 1.03 (6.57) 
Non-Hispanic American Indian/Alaska Native -2.89 (11.5) 
Non-Hispanic Asian or Pacific Islander 19.61 (16.02) 
Non-Hispanic Black  30.61 (16.02)* 




(ref: Parent(s))  
Spouse 3.86 (6.09) 
Non-spouse partner -6.05 (8.12) 
Roommate(s) 1.45 (6.79) 





(ref: Some college/vocational training) 
 
<high school  -7.38 (12.39) 
Completed high school  5.12 (9.23) 
Associate degree -3.88 (10.4) 
College graduate -1.11 (6.17) 







(ref: Parent)  
Self-pay -3.11 (9.79) 
No insurance  27.06 (11.71)*** 
Employer/school 3.02 (5.72) 
Spouse’s employer/school 14.06 (11.71) 
Medicare 13.22 (9.79) 
Medicaid  4.56 (8.68) 
Military/TRICARE 2.56 (9.79) 
*Statistically significant at the =.10 level (p<.10)  
***Statistically significant at the =.05 level (p<.05)  
 
 













                                               Correlation coefficient (standard error) reported         
     
# of needs reported as 









     









Observations 41 40 38 40 
R-squared 0.010 0.005 0.036 0.126 
 ***Statistically significant at the =.05 level (p<.05) 
 
 
5.3 Cognitive Interviews 
Participants  
Cognitive interviews were conducted with n=5 AYAs in treatment or survivorship, including 4 
females and 1 male. Interviewees represented 4 different states including California, Georgia, Michigan, 
and Indiana.  
Table 7 summarizes the usability and usefulness concerns reported by cognitive interview 
participants, and changes made to the CNQ-YP in response to those concerns. All changes made were 
vetted by the design team during the first design team workshop.  
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Table 7. Suggestions for CNQ-YP refinement from cognitive interviews 
Category  Theme Changes made   
Response 
format 
Confusion surrounding “no need” response option 
including both no need, and need already met 
Changed the name of the “no 
need” response option to “no 
need/need met” 
 Item S1 and S2 (“since my cancer diagnosis I have 
enrolled at/had problems enrolling at”) response option 
“TAFE”(i.e., “technical and further education”) not 
understood 
Removed response option 
“TAFE” from S1 and S2 
 For items S1 and S2 (“since my cancer diagnosis I have 
enrolled at/had problems enrolling at”), AYAs wanted a 
response option related to internships  
Added response option for S1 
and S2: “internship (paid or 
unpaid)” 
 In Items S3 and S4 (“since my cancer diagnoses I have 
been employed/ have had problems finding work”) 
response option “part-time/casual”, AYAs didn’t like the 
term “casual” 
Removed the word “casual” so 
response option just reads “part-
time”  
 For Items S3 and S4 (“since my cancer diagnoses I have 
been employed/ have had problems finding work”), AYAs 
wanted a response option for trade 
school/apprenticeship  
Added response option for S3 




Throughout the CNQ-YP the questions are broken up into 
different rows. For example, “I had the following need”, 
“before treatment”, “cancer treatment staff telling me”, 
and “about my diagnosis” are on separate lines. AYAs 
found this confusing.  
All question wording 
consolidated onto one line.  
   
Lookback 
periods 
In general, AYAs found the multiple lookback periods 
(e.g., “before treatment”, “during treatment”, “after 
treatment”, etc.) confusing. Although they emphasized 
that needs do change depending on how far along you 
are in your treatment trajectory, these lookback periods 
were not considered helpful for informing current service 
provision  
All needs items were anchored to 
needs currently being 
experienced (i.e., at the time of 
assessment completion). 
Redundancies stemming from 
the multiple lookback periods 





Item 2 (“cancer treatment staff telling me what might 
happen during treatment”) interpreted the same as Item 
4 (“about the short-term side effects of treatment”) 
Removed Item 2  
 Item 3 (“cancer treatment staff telling me whether I have 
the option to decline treatment”) perceived as less 
relevant/important 
Removed Item 3  
 AYAs did not like Item 6 (“cancer treatment staff telling 
me my chances of a full recovery”) because it is unclear 
what is meant by “full recovery”  
Removed Item 6  
 Section lacks item about sexual health Added item assessing whether 
treatment staff provided 
information about sexual health  
 Item 9 (“cancer treatment staff telling me whether my 
treatment was working”) is too narrow  
Changed item to “how my 
treatment is working”  
 Item 12 (“being able to have time to myself”) perceived 
as unimportant  
Removed Item 12 
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 Item 14 (“cancer treatment staff telling me what I could 
do to stay healthy”) perceived as too vague; interpreted 
as putting the onus on AYAs to prevent secondary 
cancers which may be out of their control 
Changed Item 14 to “cancer 
treatment staff giving me 
information about nutrition and 
exercise”  
 Item 16 (“having cancer treatment staff who listened to 
my concerns”) and Item 24 (“having cancer treatment 
staff who let me talk about my feelings”) perceived as 
redundant 
Collapsed items 16 and 24 into 
“listened to my concerns and let 
me talk about my feelings” 
 Item 19 (“having cancer treatment staff who were 
approachable”) and Item 20 (“having cancer treatment 
staff who were friendly”) perceived as redundant 
Collapsed Items 19 and 20 into 
“having cancer treatment staff 
who were friendly and 
approachable” 
 Item 22 (“having cancer treatment staff who explained 
what they were doing”) does not capture the importance 
of explaining before doing; redundant with Item 23 
(“having cancer treatment staff who spoke to me in a 
way that I could understand”)   
Collapsed Items 22 and 23 into 
“having cancer treatment staff 
who explained what they were 
doing before they did it, in a way 
that I could understand” 
Education 
section 
Items 34-36 had the question stem “I had the following 
needs when studying”. AYAs interpreted this as actively 
studying for a test.  
Changed the question stem for 
Items 34-36 to “I had the 
following needs while enrolled at 
school” 
 Section is missing an item related to financial aid or loan 
repayment  
Added item “being able to get 
guidance about financial aid or 
loan repayment options” 
 
Work section Item 39 (“knowing that managers/co-workers had 
support to help them cope with my situation”) not 
perceived as important 
Removed Item 39 
 Section lacks item about health insurance, which is a 
major need with respect to employment 
Added item “worrying about my 




AYAs did not understand/like Item 43 “finding 
information that was specifically designed for me”  




Item 45 (“feeling frustrated”) not perceived as important 
relative to other psychosocial concerns 
Removed Item 45  
 Item 45 (“feeling anxious or nervous”) doesn’t fully 
capture the feeling of fear which is pervasive during 
treatment  
Changed item 45 to “feeling 
anxious or scared” 
 Section lacking item about depression Added item “feeling depressed”  
 Item 48 (“worrying about my cancer returning”) does not 
capture pervasive fear surrounding secondary cancers 
Changed Item 48 to “worrying 
about my cancer returning or 
secondary cancers” 
 Item 50 (“worrying about having cancer treatment”) too 
vague  
Removed Item 50  
 Section only includes items assessing changes in 
relationship with partner and siblings; not inclusive of all 
the important relationships that may be affected by 
cancer  
Added items assessing changes in 
relationship with parent/s and 




Item 63 (“coping with my parent/s being overprotective”) 
not relevant for many AYAs 
Changed Item 63 to “coping with 
my parent/s and/or partner 
being overprotective”  
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 Section has item about physical side effects of treatment 
(Item 66) but none about the emotional side effects of 
treatment  
Added item “managing 
emotional side effects of 
treatment”  
 Item 67 (“feeling tired”) does not capture fatigue, which 
AYAs felt was more severe than tiredness 
Changed Item 67 to “feeling 
tired/fatigued”  
 AYAs did not understand or like Item 70 (“managing to 
travel to social event”) 




In general, cognitive interview participants liked the CNQ-YP’s 5-option response scale, 
displayed in Table 8, and did not have trouble distinguishing among the response options. One said, “the 
five options is always kind of what is done on surveys so I think it’s not intimidating.” One noted that the 
survey, at its current length, would be less burdensome with fewer response options. Several AYAs 
noted that assigning number values (e.g., 0-4) to each of the response options would make the response 
format even clearer. One AYA talked about how this would mimic other questions asked by their 
physicians (e.g., what is your pain level?). When asked if they felt the response option table should be 
displayed on every page of the survey, most responded that it was sufficient just to include it at the 
beginning of the assessment. One noted that, if the survey was administered electronically, it might be 
helpful to have an information box, so that hovering over the response options would make the 
response option key appear.  
Interviewees reported some confusion surrounding the “No Need” response option, which 
groups needs that were met with needs that were not experienced. Most recommended splitting the 
response option into two, or relabeling it to improve clarity (e.g., “No Need/Needs Met”). One noted 
that, “for what this tool is trying to be, it’s fine to lump them” but the language should be adjusted to 
clarify. Otherwise, they felt that the response options would be misinterpreted, and respondents would 




Table 8. CNQ-YP response format 
No Need  All my needs were met for this issue or this was not a problem 
for me. 
Low Need  I needed a low amount of help with this problem but was not 
able to get it. 
Moderate Need  I needed a moderate amount of help with this problem but was 
not able to get it. 
High Need   I needed a high amount of help with this problem but was not 
able to get it. 
Very High Need I needed a very high amount of help with this problem but was 




In the original CNQ-YP, items are broken up into different rows based on common roots. For 
example, in Item 1, “I had the following needs…”, “before treatment”, “cancer treatment staff telling 
me”, and “about my diagnosis” are on separate lines (see Table 9). AYAs found this confusing, and 
several noted that they would have preferred the questions to be kept intact and presented on the 
same row (e.g., “cancer treatment staff telling me about my diagnosis”).  
Table 9. CNQ-YP question format 
I had the following needs… 
BEFORE TREATMENT 









1 about my diagnosis ○ ○ ○ ○ ○ 
 
 
Lookback periods  
The CNQ-YP features several different lookback periods which generated confusion among some 
interviewees. They recommended streamlining the transitions among lookback periods or making the 
lookback period instructions more visually detectable (e.g., by highlighting or centering the text). Some 
AYAs emphasized that their needs have changed a lot as they moved through their treatment trajectory, 
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denoting the importance of assessing needs longitudinally. Ultimately, though, after I reiterated the 
intent of the tool (i.e., to facilitate service and resource provision to meet needs in real time), 
interviewees felt that these lookback periods were unnecessary. For this reason, we opted to anchor all 
items to current needs (i.e., needs present at the time of assessment completion), or needs present 
within a shorter lookback period. This issue would be discussed in detail during the first design team 
workshop (see Section 5.5).  
“Treatment Environment and Care” section  
In general, AYAs liked the items related to information provision. One said, “there’s a lot of 
things they don’t talk to you about and you kind of find out on your own… it’s a lot.” One wanted to 
revise the question root “cancer treatment staff telling me” to “cancer treatment staff talking to me 
about”, to reflect a more bidirectional discussion. 
AYAs noted instances in which items in this section were ambiguous. For example, in reference 
to Item 6 (“cancer treatment staff telling me my chances of a full recovery”), one AYA said the term, “full 
recovery,” was ambiguous. They said, “a full recovery could mean no side effects; a full recovery could 
mean no evidence of disease.” Another said, “I don’t think you fully ever recover from something like 
cancer.” When asked about framing this question around “prognosis” instead, one said that was a 
“jargon-y term”, often conflated with “diagnosis”. Another AYA recommended using the language “my 
chances of having a normal life after cancer”. One AYA wanted Item 29 (“being able to have pleasant 
surroundings”) to be more granular, for example, by asking about the availability of entertainment (e.g., 
books, movies, videogames, etc.). In some cases, AYAs noted an item’s ambiguity, but still thought the 
question was important. For example, for Item 11 (“cancer treatment staff telling me the way I felt was 
normal”), several AYAs talked about how this could be referring to physical or emotional concerns. “It’s 
a little bit confusing if it is referring to side effects, or the emotional side of treatment, or both.” 
However, they still thought it was an important question to ask.  
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For other items, AYAs seemed to interpret them in a way that was redundant with other items 
in the assessment. For example, Item 2 (“cancer treatment staff telling me what might happen during 
treatment”) was interpreted by most as asking about side effects, making it repetitive with Items 4 and 
5, which ask about short-term and long-term side effects. There was much discussion about Items 18 
(“having cancer treatment staff who were respectful”), 19 (“having cancer treatment staff who were 
approachable”), and 20 (“having cancer treatment staff who were friendly”). In general, AYAs felt these 
items were different, and important, but most noted that they could be combined into one or two 
questions. Other items that they felt could be combined included Item 22 (“cancer treatment staff who 
explained what they were doing it”) and Item 23 (“cancer treatment staff who explained what they were 
doing”). Additionally, they felt Item 16 (“cancer treatment staff who listened to my concerns”) and Item 
23 (“cancer treatment staff who let me talk about my feelings”) were similar and could be collapsed.  
AYAs also pointed to questions that were too narrow in scope. For example, in reference to Item 
9 (“cancer treatment staff telling me whether my treatment was working”), one interviewee said, “I 
think I wanted more of a qualitive assessment of how my treatment was working.” Just being told 
whether or not treatment was working was insufficient. For Item 30 (“being able to have good food” at 
the cancer treatment center), several AYAs suggested that this item ask more specifically about nausea-
friendly food or availability of food that meets dietary restrictions (e.g., cultural dietary restrictions). 
One AYA recommended revising Item 7 (“what would happen when treatment finished”) so that it asks 
more specifically about whether one has the resources they need to transition from treatment to post-
treatment. For Item 15 (“what to do if I noticed a particular side-effect”), one AYA thought the term, 
“side-effect” was too narrow; they recommended rewording it to “what to do if I noticed anything out of 
the ordinary”. One AYA said that Item 27 (“cancer treatment staff talked to me in private, without my 
family”) was too narrow because it only referenced family, and did not discuss privacy from others (e.g., 
partners and friends) who may be present.  
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AYAs also flagged select items as less important or applicable. For example, although one 
interviewee liked Item 12 (“being able to have time to myself”), most perceived it as unimportant 
relative to other items. “As a cancer patient, you have a lot of time to yourself.” For them, feeling 
isolated was a bigger problem; one AYA said a better question would ask about “being able to spend 
time with other people.” They did, however, note that this item may be more relevant during inpatient 
stays. Additionally, Item 3 (“whether I had the option to decline treatment”) was described as “a little 
weird”. Describing this item, one AYA said, “I don’t think it really comes up.”  
Finally, AYAs pointed to information missing from this section. Several AYAs noted that this 
section was lacking information about sexual health. “It talks a lot about fertility, which is important, but 
it doesn’t talk at all about sexual health”. They also noted that there was nothing in this section about 
nutrition.  
“Education” section  
AYAs felt that the response options for Items S1 (“since my cancer diagnosis, I have had 
problems enrolling at”) and S2 (“since my cancer diagnosis, I have attended”) were comprehensive. All 
AYAs agreed that the response option “TAFE” (i.e., “technical and further education”) should be 
eliminated, as it is not applicable in the United States. For S1 (“since my cancer diagnosis, I have had 
problems enrolling at”), one AYA questioned what kind of problems the assessment was referring to. 
They suggested the item mention specific problems such as accessing accommodations/disability 
services, finding school difficult, or being too immunocompromised to attend.  
For the question root of Items 34-36 (“when studying”), AYAs did not like the term “when 
studying”. “For me studying is studying, like, when I’m studying for a test.” They recommended revising 
it to “when I’m enrolled at school”. One AYA said that Item 34 (“being able to attend classes”) was too 
vague. In reference to Item 35 (“being able to get extensions/special considerations”), one AYA noted 
that this item may be particularly important for “normal-passing” AYAs, who may have more trouble 
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getting accommodations. “They take your needs more seriously if you’re bald,” she said. Looking at Item 
36 (“being able to get guidance about study options or future career paths”), one AYA wanted a 
standalone item asking about guidance on future career paths, since they felt this was important 
enough to warrant its own item.  
In terms of missing content in this section, one AYA recommended a question about being able 
to receive medication at school as needed. One AYA noted that getting doctors’ notes for school was a 
major hassle, so an item assessing whether doctors provided the needed paperwork to have school 
absences excused could be important. This AYA also recommended an item related to navigating 
financial aid or loan deferment. Another AYA recommended being more specific about information on 
disability options available.  
“Work” section 
For Items S3 (“since my cancer diagnosis, I have had problems finding work”) and S4 (“since my 
cancer diagnosis, I have been employed”), several AYAs wanted a response option for paid or unpaid 
internships. They did not like the term “casual” work, a response option to Item S4 in the original CNQ-
YP.  
For Item S3 (“since my cancer diagnosis, I have had problems finding work”), one AYA asked, 
“what are they asking for when they are talking about problems?” One AYA wanted “if needed” added 
at the end of Item 38 (“how to ask managers/co-workers for support”). One AYA questioned Item 39 
(“knowing that managers/coworkers had support to help them cope with my situation”) as currently 
written. “Where I was working, they don’t really sit down and talk to you about things that are 
happening.” However, this AYA’s employer did provide resources; thus, they recommended hinging the 
question more on the provision of resources rather than support. Another AYA said about this item, “I 
guess that would be dependent on how many people worked there, how close you were, what the 
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culture was like.” Based on previous job experiences, they said “I don’t think that would be an important 
question to include,” although in their current tighter-knit job, they said the item may be more relevant.  
Several AYAs mentioned the need for an item related to health insurance, since this is a major 
consideration associated with employment for AYAs with cancer. “For me, [health insurance coverage] 
has been an important part of me taking certain jobs and I know that I closely monitor my benefits.” One 
AYA mentioned adding an item addressing the issue of “how I would tell my employer, or do I have to tell 
my employer?” 
“Information and Activities” section 
AYAs unanimously disliked Item 43 (“finding information that was specifically designed for me”). 
One said, “this question gives me no information”. Another asked if the item was asking about 
information specifically designed “for me in general? or for my diagnosis?” Others did not understand 
what type of information the item was referring to.  
When asked about overlap between Items 40 (“being able to spend time with people my own 
age”) and 41 (“being able to talk to people my age who had been through a similar experience”), AYAs 
said these items should be kept separate because they are sufficiently different and both important. For 
Item 42 (“being able to have leisure spaces and activities”), one AYA recommended revising “leisure 
spaces and activities”, to “a safe place to hang out”. For Item 44 (“finding information that described 
relaxation techniques”), a couple of AYAs mentioned the need for parenthetical examples (e.g., 
meditation, yoga, etc.).  
In this section, AYAs noted the need for items assessing the availability of information about 
therapy and other psychosocial support for anxiety, depression, post-traumatic stress disorder, 
isolation, etc. One AYA said, “the number one thing I wanted to find was a community of people and that 
took me five years to find it by just typing random google searches… I thought I was alone.” 
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“Feelings and Relationships” section 
Several AYAs noted that the questions in this section didn’t make sense with the question root “I 
had the following needs”. Similarly, the response scale was not considered as applicable to items in this 
section. AYAs suggested a response scale that does not center around need-level for these items. For 
example, one recommended changing the response scale for Items 45-51 to “always, often, sometimes, 
never”.  
One AYA wanted Item 46 (“feeling anxious or nervous”) revised to “feeling anxious or scared”, 
because the fear of disease spread or recurrence is so ubiquitous. For Items 45 and 46, several AYAs 
noted that other mental health concerns beyond frustration, anxiety, and nervousness should be 
captured here, including depression and post-traumatic stress disorder.  
For Item 48 (“worrying about my cancer spreading”), one AYA noted that, because of her 
specific cancer diagnosis, she did not have concerns about her cancer returning; she did, however, worry 
about secondary cancers and recommended adding “or secondary cancers” to this item. AYAs felt that 
Item 50 (“worrying about having cancer treatment”) was ambiguous. Although some liked Item 52 
(“finding inner strength”), one noted that this question “triggers that kind of combative language, like, 
oh the fight against cancer, I think that simplifies cancer treatment in a way that’s unhelpful”. One AYA 
recommended changing Item 53 (“being able to accept my diagnosis”) to “being able to accept and cope 
with my diagnosis”.  
Several AYAs wanted Item S5 and Items 55-58 to capture additional relationships. In addition to 
relationships with partners and siblings, they wanted items assessing relationships with 
parents/guardians. “Parental relationships are the other thing that changes a ton for AYAs”. Several 
AYAs also wanted changes in relationships with friends to be captured in this section. “I think that’s a big 
part of it, too… People’s friend circles get a lot smaller”. One noted that Item 56 (“coping with changes in 
my relationships with my sibling/s”) should also be inclusive of stepsiblings. They also questioned why 
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Item 57 (“knowing how to ask my sibling/s for support”) and 58 (“knowing how to give support to my 
sibling/s”) were only asked with respect to siblings, and not with respect to relationships with partners. 
One AYA noted that their partner was their primary caregiver and thus, these questions would be 
important to ask with respect to that relationship. Another AYA noted that, although they did not 
currently have a partner, the question about changes in relationships with partners (Item 55) would still 
be important to them. “Even single people without siblings struggle with navigating relationships during 
and after cancer treatment, things like, hooking up with a wig and a port.” Thus, they recommended 
removing the skip pattern which only makes this item applicable to those who answered in Item S5 that 
they have a partner.  
“Daily Life” section 
For Items 60 (“coping with changes in my physical ability”) and 61 (“coping with changes in my 
appearance”), one AYA wanted parenthetical examples of these changes. For example, Item 61 might 
list examples such as weight loss and hair loss.  One AYA wanted to revise Item 63 (“coping with my 
parent/s being overprotective”) to “coping with my parents and/or partner being overprotective”. For 
Item 67 (“managing feeling tired”), several AYAs mentioned that it would be helpful to use the word 
“fatigue” in this item, noting that “everybody can be tired, but fatigue is a whole ‘nother level.” For Item 
69 (“being able to take part in social activities”), one AYA recommended expanding this item to ask, not 
just if they were able to take part in social activities, but also whether they were able to enjoy them. 
AYAs were confused about Item 70 (“being able to travel to social events”). One wondered whether the 
item was talking about “being able to drive myself there? You can always take Uber somewhere.”  
5.4 Concept Mapping 
Participants 
A total of 26 AYA program providers/staff, summarized in Table 10, participated in the concept 
mapping exercises, exceeding the recommended sample size for concept mapping (>15).142 Concept 
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mapping participants were from 13 different states including California, Illinois, North Carolina, Texas 
and Utah. They represented several different institution types including hospital-based cancer programs 
(n=15) and community cancer centers (n=3). Many of their programs were housed within pediatric 
cancer programs (n=14), teaching hospital cancer programs (n=13), and National Cancer Institute-
designated comprehensive cancer centers (n=19). Most (92%) reported that their cancer care program 
provides care specifically to adolescents and young adults. Within their institutions, seven respondents 
were social workers; three were oncologists; three were oncology nurse navigators; one was a nurse 
practitioner; one was a patient navigator; one was a health educator. Most (62%) reported being in 
these roles for less than five years; 19% reported being in these roles for between five and 10 years; the 
remainder (19%) reported being in these roles for greater than 10 years.  
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Indiana  1 
Michigan 1 
Missouri  1 
New York 1 
North Carolina 2 
Ohio 2 




Cancer Program Type   
NCI-designated comprehensive cancer 
center 
19 
Teaching hospital cancer program 13 
Veterans Affairs cancer program  0 
Pediatric cancer program 14 
Community cancer center 3 
Hospital-based cancer program 15 
Private oncology practice 0 
Freestanding cancer center program 
 
1 
Role    
Oncologist 3 
Physician (non-oncology) 1 
Physician assistant  0 
Nurse practitioner 1 
Oncology nurse navigator 3 
Nurse 1 
Child life specialist 0 
Dietician 0 
Patient navigator 1 
Social worker 7 
Health educator  1 
Other  8 
Years in role  
Less than 5 16 
Between 5 and 10 5 
Between 10 and 20 2 
Greater than 20 3 







Participants sorted and rated a set of 62 AYA needs (Appendix D). The point map in Figure 12 
displays the relationship and proximity of needs to one another. Each point on the map represents one 
AYA need. Those closer in proximity to each other were sorted together more often by concept mapping 
participants than those farther apart. The stress value for this point map was 0.2474, demonstrating 
goodness of fit. The lower the stress value, the better the fit between the map and the input matrix. In a 
review of 38 concept mapping studies, stress values ranged from 0.155 to 0.352, with an average of 
0.285.142 CS GlobalMax produced many different cluster solutions, ranging from two to 61 follow-up 
domain clusters. Based on my own review of all cluster solutions, I presented 5 different cluster 
solutions to the design team during our first workshop with 8, 10, 12, 14, and 16 clusters. The design 
team walked through the differences between each cluster solution and then collaboratively selected 
the one with the highest face validity (i.e., in which needs were best grouped according to service or 




Figure 12. Concept mapping point map 
 
Rating 
Overall, the mean ratings for needs were relatively high for both importance (4.42) and 
actionability (4.11) (i.e., 1=low importance/actionability; 5=high importance/actionability). Table X 
summarizes the average rating of each need’s importance and actionability. Figure 13 displays the 
average importance and actionability ratings among concept mapping participants. In this graph, the 
overall mean ratings for importance and actionability across all needs form the four quadrants; each 
need falls with respect to its overall mean rating for importance and actionability. Needs regarded as 
most important and actionable included “cancer treatment staff telling me about my diagnosis,” “cancer 
treatment staff telling me about the short-term side effects of treatment”, and “cancer treatment staff 
telling me what to do if I noticed a particular side effect”. Conversely, needs regarded as least important 
and actionable included “being able to have a choice of appointment times,” “being able to have the 
same cancer treatment staff throughout treatment,” and “being able to have good food”. Some needs 
were rated high on the importance scale, but low on the actionability scale, including “coping with not 
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being able to do the same things as other people my age,” “coping with changes in my appearance,” and 
“managing feeling tired/fatigued.” Other needs were rated high on the actionability scale and low on 
the importance scale such as “finding information that described relaxation techniques (e.g., yoga, 
meditation)”.  
Table 11. Concept mapping participants’ average rating of each need’s importance and actionability 




1 Cancer treatment staff telling me about my diagnosis 5 5 
2 Cancer treatment staff telling me about the short-term side effects of 
treatment 
4.92 5 
3 Cancer treatment staff telling me about the long-term side effects of 
treatment 
4.84 4.8333 
4 Cancer treatment staff telling me what will happen when treatment 
finishes 
4.6 4.6667 
5 Cancer treatment staff telling me whether I will be able to have children 4.84 4.5 
6 Cancer treatment staff telling me about how my treatment is working 4.92 4.7391 
7 Cancer treatment staff telling me my test results as soon as possible 4.44 4.4783 
8 Cancer treatment staff telling me the way I feel is normal 4.36 4.5833 
9 Cancer treatment staff giving me information about sexual health 4.52 4.5417 
10 Cancer treatment staff giving me information about nutrition and 
exercise. 
4.32 4.625 
11 Cancer treatment staff telling me what to do if I noticed a particular side 
effect 
4.92 4.9167 
12 Having cancer treatment staff who listened to my concerns and let me 
talk about my feelings 
4.68 4.5 
13 Having cancer treatment staff who treated me as an individual 4.72 4.5833 
14 Having cancer treatment staff who were respectable 4.6 4.4167 
15 Having cancer treatment staff who were approachable and friendly 4.44 4.375 
16 Having cancer treatment staff who could have a laugh with me 3.88 4.0435 
17 Having cancer treatment staff who explained what they are doing in a 
way I could understand 
4.72 4.4583 
18 Having cancer treatment staff who let me ask questions 4.8333 4.7083 
19 Having cancer treatment staff who let me make decisions about my 
treatment 
4.8 4.5833 
20 Having cancer treatment staff who talked to me in private, without my 
family 
4.4 4.2917 
21 Being able to have privacy 4.36 3.9583 
22 Being able to have pleasant surroundings 3.8 3.25 
23 Being able to have good food 3.6 3.2083 
24 Being able to have a choice of cancer care specialists 4.12 3.0833 
25 Being able to have the same cancer treatment staff throughout 
treatment 
3.64 3.125 
26 Being able to have a choice of times for appointments 3.56 3.0833 
27 Being able to attend classes (if enrolled in school) 4.08 3.4583 
28 Being able to get extensions/special consideration (if enrolled in school) 4.28 3.6667 
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29 Knowing how much work I would miss 4.24 3.4348 
30 Being able to get guidance about study options or future career paths 3.84 3.9583 
31 Being able to get guidance about financial aid or loan repayment 
options  
4.24 4.2083 
32 Knowing how to ask managers/coworkers for support 3.92 3.9167 
33 Worrying about my health insurance coverage 4.72 4.1739 
34 Being able to spend time with people my own age 4.6 4.25 
35 Being able to talk to people my own age who had been through a 
similar experience 
4.56 4.4583 
36 Being able to have leisure spaces and activities 3.8 3.5833 
37 Finding information that described relaxation techniques (e.g., yoga, 
meditation) 
3.88 4.5833 
38 Feeling anxious or scared 4.5417 4.3043 
39 Feeling depressed 4.75 4.3478 
40 Worrying about my cancer spreading 4.3333 3.913 
41 Worrying about my cancer returning or secondary cancers 4.25 4 
42 Worrying about whether my cancer treatment has worked 4.4167 3.9565 
43 Worrying about how my family is coping 4.2917 4.0435 
44 Finding inner strength 4.44 3.9167 
45 Being able to accept my diagnosis 4.36 3.75 
46 Being able to be independent 4.2 3.4583 
47 Coping with changes in my relationship to my partner 4.6 3.9583 
48 Coping with changes in my relationship to my sibling/s 4.25 3.9583 
49 Coping with changes in my relationship to my parent/s 4.5 3.9583 
50 Coping with changes in my relationship to my friend/s 4.4583 3.9167 
51 Being able to make plans or think about the future 4.5 3.9583 
52 Coping with changes in my physical ability 4.625 3.875 
53 Coping with changes in my appearance 4.4583 3.75 
54 Coping with not being able to do the same things as other people my 
age 
4.4583 3.625 
55 Coping with my parent/s and/or partner being overprotective 3.9167 3.7917 
56 Managing pain 4.88 4.5417 
57 Managing my medications 4.92 4.5 
58 Managing physical side effects of treatment 4.8 4.3333 
59 Managing emotional side effects of treatment 4.8 4.25 
60 Managing feeling tired/fatigued 4.52 3.75 
61 Managing loss of mobility 4.48 3.9167 










5.5 Design Team Workshop #1 
During the first workshop, the AYA NA-SB design team collaboratively refined the CNQ-YP 
itemset, selected the most interpretable cluster map and labeled each cluster according to the service or 
resource it corresponded to, and made decisions about the needs assessment’s response options, 
format, and sequencing.  
Itemset refinement 
Table 12 displays the items under consideration for elimination during Design Team Workshop 
#1, as well as design team member decisions about their elimination. Based on design team voting, 15 
items were removed from the CNQ-YP itemset. For example, the design team voted to eliminate items 
assessing whether patients perceived their treatment staff as “approachable” or “friendly” based on 
concept mapping participants’ low ratings of these items’ actionability in terms of service or resource 
provision. Design team members also voted to eliminate other items because they were already 
captured by other items. For example, “coping with my parent/s and/or partner being overprotective” 
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was eliminated because it was already captured by broader items about coping with changes in 
relationships with family members and partners. 12 CNQ-YP items were revised; these revisions and the 
rationale for making them are also described in Table 12.  







Being able to have a choice of times for 
appointments 
Eliminate Low importance (a choice of 
appointment times is typically “a given”) 
Being able to have the same cancer 
treatment staff throughout treatment 
Eliminate Low actionability 
Being able to have a choice of cancer care 
specialists 
Eliminate Low actionability 
Knowing how much work I would miss Eliminate  All work-related items into one item 
“Navigating my work life while going 
through cancer treatment” to avoid 
being unnecessarily specific.  
Being able to have leisure spaces and 
activities 
Eliminate Low actionability in terms of leisure 
“spaces”. “Activities” covered by other 
items.  
Knowing how to ask managers/coworkers for 
support 
Revise All work-related items collapsed into one 
item: “Navigating my work life while 
going through cancer treatment” to 
avoid being unnecessarily specific 
Being able to get guidance about study 
options or future career paths 
Revise All school-related items collapsed into 
one item: “Navigating my school life 
while going through cancer treatment” 
to avoid being unnecessarily specific 
Coping with my parent/s and/or partner 
being overprotective 
Eliminate Captured by other items: “Coping with 
changes in my relationships with my 
family members” and “Coping with 
changes in my dating or romantic life”.  
 
Additionally, users said this was an issue 
to solved or navigated and not “coped” 
with.  
Being able to be independent Revise Revised to “Feeling independent” to 
capture psychosocial implications. 
Physical independence captured by 
other items.  
Having cancer treatment staff who treated 
me as an individual 
Revise  Revised to “Having cancer treatment 
staff who respected me as an individual, 
not just a cancer patient” to capture a 









Having cancer treatment staff who talked to 
me in private without my family 
Revise  Revised to “Having cancer treatment 
staff who offered to talk to me in private 
without my family” to leave room for 
patient choice.  
Having cancer treatment staff who could 
have a laugh with me 
Eliminate  Low actionability  
Being able to have pleasant surroundings at 
the cancer treatment center 
Eliminate Low actionability 
Being able to have good food at the cancer 
treatment center 
Eliminate  Low actionability  
Being able to attend classes (while enrolled 
in school) 
Eliminate All school-related items collapsed into 
one item: “Navigating my school life 
while going through cancer treatment” 
to avoid being unnecessarily specific. 
Being able to get extensions/special 
considerations (while enrolled in school) 
Eliminate  All school-related items collapsed into 
one item: “Navigating my school life 
while going through cancer treatment” 
to avoid being unnecessarily specific. 
Worrying about whether my treatment is 
working 
Revise  Revised to “Cancer treatment staff giving 
me honest and timely information about 
the status of my cancer treatment” to 
more broadly capture transparent and 
timely communication during treatment.  
 
Additionally, users noted that whether 
treatment is working is not binary.  
Being able to have privacy at the cancer 
treatment center 
Eliminate  Low actionability  
Finding inner strength* Eliminate  Evokes the “fight against cancer” 
narrative (i.e., “toxic positivity”, which is 
not palatable to many AYAs  
Having cancer treatment staff who were 
respectful* 
Eliminate Low actionability; addressed by other 
items about cancer care team  
Having cancer treatment staff who were 
approachable and friendly* 
Eliminate Low actionability  
Having cancer treatment staff who listened 
to my concerns* 
Revise Revised to “Having cancer treatment 
staff who asked about my concerns 
about treatment” because AYAs often 
don’t broach their concerns with their 
providers (“you don’t know what you 
don’t know”)  
Having cancer treatment staff who let me ask 
questions* 
Revise Revised to “Having cancer treatment 
staff who encouraged me to ask 










Having cancer treatment staff who let me 
make decisions about my treatment* 
Revise Revised to “Having cancer treatment 
staff who engaged me in decision-
making about treatment and respected 
my decisions” to reflect the process, 
rather than the outcome.  
 
Additionally, provider users noted that 
it’s not always possible to relinquish 
total control of decision-making.  
Finding information that described relaxation 
techniques* 
Revise Revised to “Finding information on 
alternative therapies (herbal treatment, 
acupuncture, massage therapy, 
meditation, etc.)” to make more 
inclusive of other modalities.  
Being able to accept my diagnosis* Revise Revised to “Having what I need to cope 
with my diagnosis” to make more 
actionable.  
Cancer treatment staff telling me whether I 
would be able to have children* 
Revise  Broke this item into multiple items about 
fertility to be more comprehensive and 
less presumptuous regarding AYAs’ 
desire to have children: 
 
“Receiving information and counseling 
about risk for infertility and fertility 
preservation options” 
 
“Receiving information on treating 
infertility and other options for having 
children (i.e., artificial insemination, in 
vitro fertilization, surrogacy, adoption, 
etc.)” 
 
“Receiving information on the genetic 
inheritability of my cancer” 
* These items were raised by design team members during Design Team Workshop #1 as additional 




Table 13 displays the potential additional items I raised for consideration during Design Team 
Workshop #1, as well as design team members’ decisions about whether to include them. Based on 
design team voting, 12 items were added to the itemset including items related to sexual health, 
financial needs, sexual and reproductive health, and health behaviors.  







Sexual health  Add Cancer treatment staff giving me information 
about sexuality and intimacy during cancer 
treatment 
Worrying about health insurance 
coverage  
Add  Worrying about my health insurance (e.g., 
access/eligibility, coverage, cost) 
Physical therapy Don’t add  N/A 
Being able to get guidance about 
financial aid or loan repayment  
Add Getting guidance about scholarships or loan 
repayment options 
Other financial needs Add  Paying my bills 
 
Having childcare during my cancer care 
appointments 
 
Having stable housing  
Transportation  Add  Getting to and from my cancer care 
appointments 
Coping with changes in my 
relationships with friends  
Add Coping with changes in my relationships with 
friends 
If and how to tell my employer I have 
cancer 
Don’t add  All work-related items collapsed into one item: 
Navigating my work life while going through 
cancer treatment 
Sleeping* Add Sleeping well  
Spiritual needs* Add Having spiritual support or faith-based 
resources 
Alcohol and drug use * Add Cancer treatment staff giving me information 
about drug and alcohol use during cancer 
treatment 
 
Having the resources I need to quit smoking 
* These items were raised by design team members during Design Team Workshop #1 as additional 





Cluster map selection and labeling 
Based on my own review of all cluster solutions, I presented 5 different cluster solutions to the 
design team with 8, 10, 12, 14, and 16 clusters. We walked through the differences between each 
cluster solution and then collaboratively selected the one with the highest face validity (i.e., in which 
needs were best grouped according to service or resource that could address them). Ultimately, we 
selected the 8-cluster solution (see Figure 14). Based on design team discussion, several changes were 
made to the cluster map. We broke cluster 4 into two follow-up domains: one related to work and 
education, and another related to finances and logistics. Additionally, we moved a few items between 
clusters such that they fell in a more appropriate follow-up domain. Those changes are summarized in 
Table 14.  









1 Cancer treatment staff telling me about my 
diagnosis 
2 Cancer treatment staff telling me about the short-
term side effects of treatment 
3 Cancer treatment staff telling me about the long-
term side effects of treatment 
4 Cancer treatment staff telling me what will 
happen when treatment finishes 
6 Cancer treatment staff telling me about how my 
treatment is working 
7 Cancer treatment staff telling me my test results 
as soon as possible 
11 Cancer treatment staff telling me what to do if I 
noticed a particular side effect 
2 
  
10 Cancer treatment staff giving me information 
about nutrition and exercise. 
56 Managing pain 
57 Managing my medications 
58 Managing physical side effects of treatment 
60 Managing feeling tired/fatigued 
61 Managing loss of mobility 
3 
  
5 Cancer treatment staff telling me whether I will 
be able to have children 
9 Cancer treatment staff giving me information 
about sexual health 
21 Being able to have privacy 
22 Being able to have pleasant surroundings 
23 Being able to have good food 
4 
  
27 Being able to attend classes (if enrolled in school) 
28 Being able to get extensions/special consideration 
(if enrolled in school) 
29 Knowing how much work I would miss 
30 Being able to get guidance about study options or 
future career paths 
31 Being able to get guidance about financial aid or 
loan repayment options  
32 Knowing how to ask managers/coworkers for 
support 
33 Worrying about my health insurance coverage 
36 Being able to have leisure spaces and activities 
5 
  
13 Having cancer treatment staff who treated me as 
an individual 
14 Having cancer treatment staff who were 
respectable 
15 Having cancer treatment staff who were 
approachable and friendly 
16 Having cancer treatment staff who could have a 
laugh with me 
17 Having cancer treatment staff who explained 
what they are doing in a way I could understand 
18 Having cancer treatment staff who let me ask 
questions 
19 Having cancer treatment staff who let me make 
decisions about my treatment 
20 Having cancer treatment staff who talked to me 
in private, without my family 
24 Being able to have a choice of cancer care 
specialists 
25 Being able to have the same cancer treatment 
staff throughout treatment 




8 Cancer treatment staff telling me the way I feel is 
normal 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
34 Being able to spend time with people my own age 
35 Being able to talk to people my own age who had 
been through a similar experience 
62 Managing to take part in social activities 
7 
  
37 Finding information that described relaxation 
techniques (e.g., yoga, meditation) 
46 Being able to be independent 




38 Feeling anxious or scared 
39 Feeling depressed 
40 Worrying about my cancer spreading 
41 Worrying about my cancer returning or 
secondary cancers 




43 Worrying about how my family is coping 
44 Finding inner strength 
45 Being able to accept my diagnosis 
47 Coping with changes in my relationship to my 
partner 
48 Coping with changes in my relationship to my 
sibling/s 
49 Coping with changes in my relationship to my 
parent/s 
50 Coping with changes in my relationship to my 
friend/s 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things 
as other people my age 
55 Coping with my parent/s and/or partner being 
overprotective 





Table 14. Items moved between clusters  
Item Original 
Cluster 
New Cluster Notes 
10 2 7 Item 10 was moved to a non-
adjacent cluster, which was 
unusual. However, the design team 
felt that Item 10, which addresses 
nutrition and exercise, best fit with 
other items about health behaviors 
and wellness (cluster 7) rather than 
with items about physical health 
(cluster 2) because cluster 2 is 
focused more on needs 
addressable by the primary cancer 
care team.   
12 6 5 Item 12 is positioned on the outer 
edge of cluster 6, directly adjacent 
to cluster 5.  
46 7 8 Item 46 is positioned directly 
adjacent to cluster 8.  
51 7 8 Item 51 is positioned directly 
adjacent to cluster 8. 
 
 
CS GlobalMax© generates labels for clusters based on participants’ labeling. Using these 
labels as a starting point, we collaboratively re-labeled each cluster based on the follow-up action 
(i.e., service or resource) that needs in that cluster should trigger. This resulted in nine follow-up 
domains: (1) Information (cluster 1), (2) Cancer Care Team (clusters 5), (3) Physical Health (cluster 2), 
(4) Emotional Health (cluster 8), (5) Sexual & Reproductive Health (cluster 3), (6) Health Behaviors & 
Wellness (cluster 7), (7) Work & Education (cluster 4), (8) Peer Support & Programming (cluster 6), 
and (9) Finances & Everyday Needs (cluster 4). The nine follow-up domains and items falling within 




Table 15. Refined items by follow-up domain  
Information 




2 Cancer treatment staff telling me about the short-term side effects of treatment 
3 Cancer treatment staff telling me about the long-term side effects of treatment  
4 Cancer treatment staff telling me what will happen when treatment finishes 
5 Cancer treatment staff giving me honest and timely information about the 
status of my cancer treatment   
6 Cancer treatment staff telling me my test results as soon as possible 
7 Cancer treatment staff telling me what to do if I noticed a particular side effect  
Cancer Care Team 






9 Having cancer treatment staff who offered to talk to me in private, without my 
family  
10 Having cancer treatment staff who explained what they are doing in a way I 
could understand 
11 Having cancer treatment staff who encouraged me to ask questions  
12 Having cancer treatment staff who engaged me in decision-making about my 
treatment and respected my decisions  
13 Having cancer treatment staff who asked about my concerns about treatment  
Physical Health 
14 Managing pain   
 
Cluster 2 
15 Managing my medications  
16 Managing physical side effects of treatment 
17 Managing feeling tired/ fatigued 
18 Managing loss of mobility  
Emotional Health 






20 Feeling depressed  
21 Having what I need to cope with my diagnosis  
22 Worrying about my cancer spreading  
23 Worrying about my cancer returning or secondary cancers 
24 Worrying about how my family is coping  
25 Coping with changes in my dating or romantic life 
26 Coping with changes in my relationships with my family members 
27 Coping with changes in my relationships with friends  
28 Feeling independent 
29 Coping with changes in my physical ability  
30 Coping with changes in my appearance 
31 Coping with not being able to do the same things as other people my age 
32 Managing the emotional side effects of treatment  
33 Being able to make plans or think about the future  
Sexual & Reproductive Health 
34 Receiving information and counseling about risk for infertility and fertility 
preservation options  
 
Cluster 3 
35 Receiving information on treating infertility and other options for having 




36 Receiving information on the genetic inheritability of my cancer  
37 Cancer treatment staff giving me information about sexuality and intimacy 
during cancer treatment  
Health Behaviors & Wellness 




39 Sleeping well  
40 Having the resources I need to quit smoking  
41 Cancer treatment staff giving me information about drug and alcohol use during 
cancer treatment  
42 Having spiritual support or faith-based resources  
43 Finding information on alternative therapies (herbal treatment, acupuncture, 
massage therapy, meditation, etc.) 
Work & Education 
44 Navigating my school life while going through cancer treatment Cluster 4 
45 Navigating my work life while going through cancer treatment  
Peer Support & Programming 
46 Being able to spend time with people my own age   
Cluster 6 47 Being able to talk to people my own age who have been through a similar 
experience 
48 Managing to take part in social activities  
Finances & Everyday needs 
49 Paying my bills   
 
Cluster 4 
50 Getting guidance about scholarships or loan repayment options  
51 Worrying about my health insurance (e.g., access/eligibility, coverage, cost) 
52 Getting to and from my cancer care appointments  
53 Having childcare during my cancer care appointments  
54 Having stable housing  
 
 
Response options  
The design team approved the revision of the “no need” response option to “no need/need 
met”, as suggested by cognitive interview participants. The design team also discussed whether to 
use the same response scale throughout the entire instrument. Although users expressed some 
concerns about the applicability of the response scale to all items, the design team saw value in 
remaining consistent throughout the tool, noting that multiple response scales could be 
cumbersome for users. However, we opted to table the discussion about the response scale until the 
design team had had the opportunity to review the revised itemset after the meeting.   
Lookback periods  
The original CNQ-YP features similar items with different lookback periods (e.g., “since my 
diagnosis”, “in the last month”); survey and cognitive interview participants felt these multiple 
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reference periods were confusing and redundant given the tool’s goal of addressing current needs 
through service provision. Thus, the design team opted to anchor all items to current needs, or 
needs within a shorter lookback period (e.g., “in the past month”), and eliminate redundant content 
stemming from the original CNQ-YP’s multiple periods of reference. Several considerations were 
raised during this discussion.  
First, design team members noted that the lookback period may depend upon the frequency 
with which the needs assessment is administered. For example, if the tool were to be administered 
every three months, design team members wondered whether a lookback period of three months 
would be appropriate. They definitely felt that administering the needs assessment every month 
would be too often. In general, providers preferred the idea of tying needs assessment 
administrations to specific time intervals (e.g., administering it every three months), as opposed to 
anchoring administration timing to certain events (e.g., change in treatment or disease status). They 
felt that this would be more seamless from a workflow perspective. We discussed the importance of 
administering the tool at diagnosis, at the end of treatment, and somewhere in between. One 
provider said, “I definitely think those bookends are important, right when treatment starts and 
ends. And definitely in the middle.  But I think it’s so variable what ‘in the middle’ looks like for 
people. It could be years.” 
Design team members also noted that, in determining the lookback period for the needs 
assessment, we should consider how frequently AYAs are coming through NCCH. For an AYA with 
four-week treatment cycles, one month would be the longest they would go without seeing a 
provider. In this sense, design team members felt that a one-month lookback period would be 
appropriate. One AYA said, “If you’re in treatment, a month is going to capture your time in 
treatment. If you’re out of treatment and you haven’t experienced something over the last month, 
it’s probably not a pressing issue… it will capture a full cycle, or close to it.” One provider suggested 




Ultimately, the design team made the tentative decision to use a one-month lookback 
period for all items. We planned to revisit this discussion once decisions about administration timing 
were made.  
Item format  
In the original CNQ-YP, questions are broken up into different rows based on common roots. 
For example, in Item 1, “I had the following needs”, “before treatment”, “cancer treatment staff 
telling me”, and “about my diagnosis” are on separate lines. Based on feedback received during 
cognitive interviews, the design team opted to collapse item wording such that each item was 
displayed on one line of the needs assessment tool. Because we made many revisions to CNQ-YP 
wording and grouping, the original item formatting no longer made sense (i.e., groups of items no 
longer shared the same root).   
Sequencing 
The design team opted to abandon the original CNQ-YP’s sequencing in favor of ordering 
items based on follow-up domains.  
Other discussion 
During the workshop, the question was posed: do we still want to include items assessing 
needs for which NCCH does not have services or resources to address? The decision was made to err 
on the side of inclusion and include items for which services and resources might not be available. 
Although the primary purpose of AYA NA-SB is to respond to needs in real time, clinical design team 
representatives also expressed interest in using the tool for program development (i.e., to inform 
institutional changes). They noted that capturing needs for which services and resources do not exist 
could be helpful in identifying areas where resources need to be built in or community providers 
need to be identified to bolster support available through NCCH.  
Another point of discussion was the potential for tailoring the needs assessment based on 
where respondents are in their disease trajectory. For example, some items may be relevant for 
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AYAs in the earlier phases of treatment than for AYAs transitioning into survivorship. This discussion 
was tabled for a later date.  
AYA NA-SB administration was also discussed in the context of the tool’s length. AYA 
representatives noted that the length of the survey would be “less irritating” and “less intimidating” 
were the assessment to be administered electronically (e.g., through a Smart Phone application). 
This would allow for flexibility in terms of when AYAs could complete the assessment and, 
depending on the platform, could facilitate the easy documentation and use of data on the back 
end.   
5.6 Guided Tours 
I first conducted guided tours with clinical partners at NCCH (i.e., providers; n=2), LL (social 
worker/AYA program director) and AS (oncologist/medical director of AYA program), for a total of 10 
hours across three days. I then conducted guided tours with AYAs (n=8). Guided tours generated 
many insights on the NCCH context, which were critical to informing AYA NA-SB design and 
implementation planning. These user and contextual factors were analyzed based on Maguire et al.’s 
framework of user and contextual factors that influence an intervention’s usability and usefulness in 
practice.132 They are reported below, along with their implications for AYA NA-SB, by domain of the 
Consolidated Framework for Implementation Research (CFIR) including: (1) outer context, (2) inner 
context, (3) individuals, (4) process, and (5) intervention. I applied this framework retrospectively to 
anchor user and contextual factors to AYA NA-SB implementation. The implications of guided tour 
findings, summarized in Table 16, were considered by the design team in designing and planning to 
implement AYA NA-SB (Section 5.8).   
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Table 16. Implications of ethnography findings for AYA NA-SB 
Construct  Summary of user/contextual factors Implications for AYA NA-SB 
Outer context  
Patient characteristics • At NCCH, around 150 individuals 
ages 15-30 are diagnosed each 
year 
 
Location • Many AYAs do not live locally  
• Proximity to hospital is a major 
factor influencing AYAs’ use of 
services and resources 
• Transportation represents 
an important for AYA NA-
SB to address. 
• To the extent possible, AYA 
NA-SB should be flexible to 
the diverse locations of 
AYAs. 
Technology • AYAs are tech-savvy and use a 
broad range of technologies to 
manage their cancer 
• Electronic delivery of AYA 
NA-SB should be 
considered. 
Inner context  
Structure • NCCH’s AYA program is 
relatively new (est. 2015) and 
currently undergoing expansion 
• The expansion of NCCH’s 
AYA program represents 
an opportunity for the 
implementation of AYA 
NA-SB. 
Staffing • LL and AS work closely with non-
AYA-specific providers and staff 
across disease groups from both 
pediatric and adult oncology, 
including oncologists, nurse 
practitioners, physician 
assistants, and other oncology 
providers.   
• NCCH’s model of cancer care 
hinges on the provision of 
multidisciplinary services and 
resources to support patients. 
• AYA NA-SB delivery should 
leverage AYA-specific staff 
where possible 
• AYA NA-SB should facilitate 
the communication and 
sharing of information 
across providers from 
pediatric and adult 
oncology and across 
disease groups. 
• Clear referral pathways 
should be established with 
other providers to 
facilitate the provision of 
services from across 
departments and 
disciplines. 
Leadership • NCCH’s AYA program falls 
partially under the umbrella of 
the Comprehensive Cancer 
Support Program.   





Physical space • NCCH is positioned within a 
sprawling medical campus; 
AYAs’ appointments are held in 
disparate locations across the 
medical campus.  
• AYA NA-SB delivery should 
accommodate the variety 
of locations where AYAs 
have appointments.  
• The centralized layout of 
pediatric oncology may 
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Construct  Summary of user/contextual factors Implications for AYA NA-SB 
• For AYAs receiving care in 
pediatric oncology, registration, 
labs, clinical appointments, and 
infusions occur in one 
centralized location on the first 
floor (the Pediatric Oncology 
Clinic). 
• NCCH is in the process of 




information sharing that 
AYA NA-SB will require. 
• For AYAs receiving infusion 
treatments, the addition of 
an AYA-specific infusion 
space represents an 
opportunity for AYA NA-SB 
service and resource 
provision, as AYAs will be 
concentrated in one 
central location. 
Culture • NCCH has a culture of 
collaboration and improvement 
but provider buy-in is an 
important prerequisite of any 
change initiative.  
• The collaborative, 
improvement-oriented 
culture of NCCH bodes well 
for AYA NA-SB 
implementation. Building 
buy-in among providers 
will be critical to 
implementation.  
Reference materials • AYAs did not find brochures and 
other non-tailored resources 
very helpful.  
• The provision of reference 
materials through AYA NA-
SB should be highly 
tailored to the unique 
needs reported by each 




• LL divides her time among (1) 
administrative tasks, (2) 
research-related tasks, and (3) 
clinical tasks. 
• An additional AYA social worker 
was recently hired to help 
offload some of LL’s clinical 
tasks.  
• The hiring AYA-specific 
social worker represents 
an increase in staffing 
hours that might allocated 
towards AYA NA-SB. 
Oncologist • AS’s time is split between 
research (75%) and clinical 
(25%). Although this is a larger 
research focus than most of his 
colleagues have, most of them 
do have some time carved out 
for nonclinical tasks 
• Oncology providers, 
particularly those doing 
research or other 
nonclinical tasks, may not 




• Social workers have a robust 
knowledge of services and 
resources available at NCCH.  
• Social workers may be 
particularly fit to facilitate 
the care coordination 
required by AYA NA-SB. 
Knowledge and beliefs 
about the intervention 
• LL and AS are accustomed to 
assessing AYAs’ needs as part of 
routine care. 
• LL and AS possess the 
fundamental knowledge 
and skills required to 
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engage in a more 
formalized needs 
assessment process.  
Experience with 
PROMs 
• Providers had some experience 
administering PROMs.  
• Some AYAs have experience 
completing surveys. However, 
all AYAs were amenable to 
completing surveys as part of 
their cancer care. 
• Providers’ experience 
administering PROMs will 
facilitate their ability to 
administer AYA NA-SB.  
• Completing a PROM as 
part of their cancer care is 
acceptable to AYAs  
Process 
AYA Tasks    
Diagnosis • After receiving a cancer 
diagnosis, AYAs are often in 
shock or in high distress, and 
may not know what their 
service needs are yet.   





• AYAs experience appointment 
fatigue during cancer treatment  
• AYAs struggle to balance their 
treatment schedules with 
competing priorities such as 
work, school, and raising 
children.  
• AYA NA-SB should be 
minimally burdensome to 
AYAs.  
• To the extent possible, 
services rendered should 
be embedded in existing 
treatment appointments, 
while patients are already 
in the hospital. 
Outpatient 
appointments 
• During outpatient visits, AYAs’ 
task load can be extensive.  
• Appointments entail some 
combinations of segments 
including transportation, 
parking, registration, labs, 
imaging, treatment, clinical 
• AYA NA-SB should 
accommodate the range of 
appointment types that 
AYAs have.  
• To the extent possible, AYA 
NA-SB should incur no 
additional time burden to 
AYAs’ already long and 
exhausting appointments. 
Inpatient stays • Many AYAs have an inpatient 
stay at some point while they’re 
undergoing treatment 
• AYAs staying inpatient have lot 
of “deadtime” 
• Capturing the needs of 
inpatient AYAs is 
important.  
• There is ample opportunity 
for AYA NA-SB 
administration for AYAs 
staying inpatient.  
End-of-life care • For some AYAs, cancer is more 
than just a temporary hurdle.  
• AYA NA-SB content and 
delivery should be 
sensitive to those whose 
cancer is terminal. 
Caregivers’ tasks • AYAs rely heavily on their loved 
ones to navigate cancer care. 
• AYA NA-SB content should 
reflect the importance of 
changes that these 
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relationships undergo after 
a cancer diagnosis.  
Provider tasks    
Identifying 
AYAs 
• There is currently no systematic 
way for new AYA patients to be 
identified. 
• As such, AYA NA-SB should 
include a process or 
strategies for identifying 
new AYA patients (e.g., 
strengthening referral 




• For non-medical concerns, AYAs 
rely on the AYA social workers 
more than their oncology 
providers. Social workers are 
currently conducting needs 
assessments, although 
informally/conversationally 
• AYA NA-SB should leverage 
social workers’ existing 
workflow and expertise in 






• Providers use EPIC to document 
and communicate about patient 
information. 
• Providers also communicate via 
phone, email, pager and in-
person. 
• AYAs are active users of 
MyChart.  
• If possible, AYA NA-SB 
should interface with EPIC 
in order to capitalize on 
existing systems.  
• AYA NA-SB could also 
leverage existing 
communication channels 
(e.g., EMR messaging, 
pager, phone, etc.) 







• AYAs report a number of 
barriers to service and resource 
use; some of these barriers 
(e.g., service capacity) may not 
be addressable by AYA NA-SB.  
• Flexibility should be built 
into AYA NA-SB service 
provision to address 
downstream barriers to 
service use . For example, 
multiple services might be 
offered for a given need 
such that an AYA can select 
the option that is most 
feasible and appealing to 
them. 
Intervention 
Goals for intervention   
Intervention 
outcomes 
• Providers wanted AYA NA-SB to 
fit seamlessly with existing 
workflows. They hoped it would 
formalize documentation and 
communication channels.  
• AYAs wanted the needs they 
report in AYA NA-SB to be 
followed up on in a timely 
manner.  
• To the extent possible, AYA 






• Needs reported on AYA 
NA-SB should trigger 
 
95 
Construct  Summary of user/contextual factors Implications for AYA NA-SB 
timely referral to 
appropriate services or 




• AYAs reported many and 
diverse needs, but financial 
concerns were the most 
commonly discussed.  
• In addition to capturing 
psychosocial concerns, 
peer support, 
transportation, and side 
effect management, it is 
particularly important that 
AYA NA-SB capture 
financial needs which are 
pervasive among AYAs.   
Timing • Providers and AYAs wanted AYA 
NA-SB to account for the 
dynamic nature of needs as 
AYAs move through treatment.  
• After receiving a cancer 
diagnosis, AYAs are often in 
shock or in high distress, and 
may not know what their 
service needs are yet.   
• AYAs appointments are long and 
exhausting.  
• AYA NA-SB should be 
administered at multiple 
timepoints throughout 
cancer including diagnosis, 
during treatment, at the 
end of treatment, and at 
some interval in 
survivorship.  
• AYA NA-SB should not be 
administered immediately 
upon diagnosis when AYAs 
might not have a grasp of 
what they need yet.  
• In the clinic, AYA NA-SB 
should be administered 
during times when AYAs’ 
wait times so as not to 
lengthen AYAs’ already 
long appointments. 
Format • AYAs did not express a strong 
preference in terms of paper 
versus electronic delivery of 
AYA NA-SB. 
• AYA NA-SB could be 
administered through a 
paper or electronic format.  
Benefits of 
intervention 
• AYAs and providers expressed 
numerous potential benefits of 
AYA NA-SB 
• AYA NA-SB potentially has 
high acceptability among 
prospective users. 
Costs of intervention • Providers expressed some 
potential costs of AYA NA-SB 
including staffing time, 
workflow disruptions, and 
provider buy-in.  
• For AYAs, downstream barriers 
to service and resource exist 
(e.g., strict eligibility 
requirements, service capacity 
and timeliness)  
• Staffing time, workflow 
disruptions, and provider 
buy-in represent potential 
barriers to 
implementation.  
• Additional strategies may 
be needed to address 
downstream barriers to 




Outer context  
Patient characteristics. At NCCH, around 150 individuals ages 15-30 are diagnosed each 
year. About one third of these patients are treated in pediatric oncology and the remainder in adult 
oncology. I conducted guided tours with AYAs (n=8), described in Table 17. AYAs were diverse with 
respect to clinical and demographic characteristics. Three were male and five were female. Four 
identified as non-Hispanic White, two as non-Hispanic Black, one as Asian, and one as Hispanic. They 
ranged in age from 18 to 34, with a mean age of 23. They represented seven different diagnoses 
including non-Hodgkin, Hodgkin, and Burkitt’s Lymphoma, osteosarcoma, liver cancer, testicular 
cancer, and Chronic Myeloid Leukemia. They also represented varying points on their cancer 
trajectory with two diagnosed in the past three months, two diagnosed between three and six 
months ago, one diagnosed between seven and 12 months ago, and three diagnosed more than 12 




Table 17. AYA guided tour participants 






Mean (SD) 23.4 (5.0) 
Race   
Hispanic (all races) 1 
Non-Hispanic Black 2 
Asian 1 
Non-Hispanic White 4 
Cancer type   
Non-Hodgkin Lymphoma 1 
Hodgkin’s Lymphoma 1 
Osteosarcoma  2 
Chronic Myeloid Leukemia 1 
Burkitt’s Lymphoma 1  
Testicular cancer 1 
Liver cancer  1 
Time since diagnosis   
< 3 months  2 
3-6 months 2 
7-12 months 1 





Non-spouse partner 3 
Child/children 1 
Lives alone  1 




Location. Many NCCH patients do not live locally. Several AYA guided tour participants lived 
in other North Carolina cities and had to drive multiple hours for appointments at NCCH. As such, 
AYAs cited location as a barrier to service use. One AYA, who lived several hours from NCCH, 
discussed this issue in terms of her psychosocial needs. “I had a few phone call sessions with [the 
social worker] but it’s not like I live in Chapel Hill so it’s not easy for me to have an appointment with 
her all the time. So, I need to find somebody in my area… but then it’s really hard to find someone in 
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my area that is what I’m looking for without the resources to help me navigate it… I want someone 
who is familiar with young adult cancer patients and that’s not necessarily an easy find.” Relatedly, 
transportation proved another barrier to AYAs’ use of services and resources. One AYA’s wife talked 
about the toll that cancer had taken on her and her husband’s mental health, and how much they 
needed “someone to talk to.” However, she said she would struggle to make it to regular outpatient 
therapy appointments because she did not have a ride. Instead, she wanted access to services 
housed in NCCH so that she could access these services while accompanying her husband to his daily 
radiation appointments.  
I visited with one AYA during an inpatient stay. He and his family lived on the North Carolina 
coast, about a 4-hour drive from NCCH. After each chemotherapy session, he was admitted inpatient 
for observation until the chemotherapy levels in his blood fell to an acceptable level. His parents or 
partner typically dropped him off for inpatient stays. However, his parents were older, so he often 
did the driving. He would have liked to drive himself but said it’s cheaper to be dropped off because 
parking at NCCH costs $10 per day. “When you’re here for a week plus, that adds up.” He was finally 
cleared to be discharged while I was with him. However, he had to wait several hours for his family 
members to drive there from the coast. When asked what kind of needs he had while receiving 
inpatient care, he said that the number one thing that has been on his mind was financial help. He 
could not work because of his treatment regimen and was struggling to shoulder the costs of 
hospital bills, transportation, etc. He had not been connected to a financial navigator but had talked 
to the social worker about different financial assistance options, such as a program that provides gas 
cards for transportation to and from the hospital.  
Another AYA moved back home from Scotland to live near her family, so that they could 
help to support her during treatment. Proximity to the hospital became a driving factor in her life 
decisions, ultimately altering the course of her career. Another AYA made a similar move, quitting 




IMPLICATIONS FOR AYA NA-SB. Given that many AYAs do not live locally, transportation 
represents an important need for AYA NA-SB to address. Additionally, proximity to hospital 
is a major factor influencing AYAs’ use of services and resources. When connecting AYAs to 
services and resources, access should be an important consideration. To the extent possible, 
AYA NA-SB should be flexible to the diverse locations of AYAs, for example, by offering 
external referrals convenient to AYAs’ place of residence or services that can be delivered 
remotely.  
Technology. Unsurprisingly, AYAs were tech-savvy, and used their mobile phones and other 
technologies to seek information and manage other aspects of their illness. Leading into our guided 
tours, several preferred to communicate with me via text versus via email. Most had their mobile 
phones out frequently during guided tours, using them to communicate with friends and family, 
access needed information, or bade time while waiting at various points throughout their 
appointments. The wife of one AYA said that she used her phone to record notes about upcoming 
appointment times and questions she had for the providers. To keep track of his appointment 
schedule, one AYA relied primarily on text and call reminders from NCCH, saying they would call “like 
5 times” before appointments. Interestingly, these automated reminders asked about 
transportation. This AYA noted that they also received emails about upcoming appointments. Prior 
to being diagnosed with cancer, they said they seldom used email. However, they had become much 
more “email-active” because of all the emails they receive related to their cancer care. When asked 
if they opened emailed appointment reminders, several AYA guided tour participants said yes.  
IMPLICATIONS FOR AYA NA-SB. Given that AYAs are tech-savvy and use a broad range of 
technologies to manage their cancer, electronic delivery of AYA NA-SB should be considered. 
For example, AYA NA-SB could be embedded in emailed appointment reminders or delivered 
through a mobile application.  
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Inner context  
Structure. NCCH is a public, National Cancer Institute (NCI)-designated Comprehensive 
Cancer Center located in central North Carolina, in a relatively metropolitan area. NCCH’s AYA 
program was established in 2015 with funding from a local nonprofit organization, the BeLoud 
Sophie Foundation. This funding was initially allocated towards hiring one fulltime employee (a 
social worker/program director) to provide AYA-specific care at NCCH. Since 2015, the program has 
evolved, hiring new AYA-specific staff members and expanding program activities and reach.  
IMPLICATIONS FOR AYA NA-SB. NCCH’s AYA program is relatively new; it is currently 
undergoing expansion, representing an opportunity for the implementation of interventions 
like AYA NA-SB.  
Staffing. NCCH’s AYA program is led by clinical partners and guided tour participants: LL 
(program director, social worker) and AS (program medical director, pediatric oncologist). AS sees 
both pediatric and AYA patients; LL exclusively sees AYA patients. An additional AYA-specific social 
worker was hired recently to help offload some of LL’s clinical duties.  
LL and AS reported working closely with non-AYA-specific providers and staff across disease 
groups from both pediatric and adult oncology, including oncologists, nurse practitioners, physician 
assistants, and other oncology providers.  In adult oncology, there are 15 oncologists. There is a 
psychiatry physician assistant who LL said can visit patients “on the fly”, at her request. There are 
patient navigators who help with logistics like setting up appointments and scans. There are five 
outpatient social workers who can help with financial and other logistics; however, you have to ask 
to see them, and typically would only see them if “something is wrong.” There is one dietician 
serving all of NCCH. There are also a number of fellows available through psycho-oncology. In 
pediatric oncology, there are 13 pediatric oncologists and six fellows who see an average of six to 
eight patients in a given day. There are two outpatient social workers. There are child life specialists 
and teachers. There are also nurse practitioners, common extenders, nurses, nurse navigators, 
volunteers, and research staff. The two AYA social workers and a psychologist “tag team” AYA 
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psychosocial concerns. The psychologist typically takes patients with preexisting mental health 
concerns, but his caseload is not constrained to just AYA patients. 
NCCH’s model of cancer care hinges on the provision of multidisciplinary services and 
resources to support patients. Figure 15 displays the services and resources available to NCCH 
patients. In this figure, NCCH resources are outlined in red; external resources are outlined in black. 
LL has forged relationships across pediatric and adult oncology, and across disease groups. This 
relationship-building has given her the ability to advocate for her patients and “push back against 
the status quo.” LL questioned whether someone without these relationships would be able to do 







Figure 15. Services and resources available to NCCH patients 
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IMPLICATIONS FOR AYA NA-SB.  AYA NA-SB delivery should leverage AYA-specific staff where 
possible as these individuals’ time is already allocated towards providing care to AYAs. AYA 
NA-SB should facilitate the communication and sharing of information across providers from 
pediatric and adult oncology and across disease groups. Clear referral pathways should be 
established with other providers to facilitate the provision of services from across 
departments and disciplines.  
Leadership. LL works under the Division Head of General Adult Psychiatry; her position falls 
within NCCH’s Comprehensive Cancer Support Program. AS works under the Division Chief of 
Pediatric Oncology who works under the Chair of Pediatrics.  
IMPLICATIONS FOR AYA NA-SB. AYA NA-SB should leverage Comprehensive Cancer Support 
Program resources, where applicable, to build leadership buy-in.  
Physical space. NCCH is positioned in University of North Carolina (UNC) Health Care’s Main 
Medical Campus (see Figure 16), adjacent to the Emergency Room and across a courtyard from the 
main hospital, children’s hospital, and women’s hospital. In reference to navigating the sprawling 
medical campus, one AYA said, “it’s big, but once you get the hang of it, it’s not that bad.” To access 
the 315,000 square-foot cancer hospital, patients, some of whom have driven hours to get there, 
pay to park in a deck across the street, and follow a pedestrian skybridge to the hospital’s ground-










NCCH has seven floors. Radiology and Radiation Oncology, Imaging, and a Lab Draw Station, 
are located on two basement floors (Figure 17, 18). The ground-level floor includes a lobby, patient 
admitting, the Patient and Family Resource Center, a conference center, food service, a retail 
pharmacy, and a gift shop (see Figure 19). Mammography and the Pediatric Oncology Clinic are 
located on the first floor (Figure 20). Outpatient Multidisciplinary and Surgical Oncology Clinics are 
located on the second floor (Figure 21). The infusion center for adult oncology is located on the third 
floor (Figure 22). The fourth floor contains 50 inpatient beds (Figure 23). Although patient 
appointments vary, a typical appointment for AYAs currently in treatment in adult oncology included 
checking in at the ground-floor registration desk, going downstairs for labs, going up to the first or 
second floor for a clinic appointment, and then going up to the third floor for an infusion. Patients 
receiving radiation would go directly to the basement level for their radiation appointments. Young 
adults with obstetric-gynecologic cancers, however, receive much of their clinical care in the 
Women’s Hospital. The social worker, LL, noted that physical space becomes a major barrier for 
providing AYA services to these patients. 

























Figure 22. NCCH third floor 
 
 
Figure 23. NCCH fourth floor  
 
 
The Patient and Family Resource Center, located on the ground floor of NCCH, offers 
education, support and comfort services, patient assistance, and referrals to both internal and 
external resources. Its Education Center offers a lending library of books, pamphlets, and audiovisual 
resources to help patients and families learn about their disease. Its image boutique offers a variety 
of head coverings to those going through chemotherapy.  
For AYAs receiving care in pediatric oncology, registration, labs, clinical appointments, and 
infusions occur in one centralized location on the first floor (the Pediatric Oncology Clinic). There is 
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even a procedure space in pediatric oncology where anesthesiology can be brought in. The pediatric 
oncology suite opens to a large waiting room, equipped with an interactive touch board on the floor. 
In the waiting room, there is a registration desk and a play area. The aesthetic is colorful and cheery. 
The waiting room leads back to a physician workspace with desktop computers lining the exterior 
walls and a conference table positioned in the middle. Physicians and other staff bustled around the 
workspace, talking to each other. The oncologist, AS, noted that, in the pediatric clinic, working in 
such close proximity to the other providers facilitates communication among them. Because the 
physical space is so centralized, it allows for more in-passing informal communication. AS said that 
he often asks other providers for advice when he runs into them around the pediatric oncology 
suite. Past the physicians’ workspace, the hallway splits. On the right, there are about 10 exam 
rooms, each with their own animal theme; a nursing station lines the wall opposite of the exam 
rooms. On the left, the hallway leads past a kitchen and playroom into an open-concept infusion 
room. On one side of the infusion room, there is a long nursing station and a couple of small rooms 
reserved for labs and procedures. On the other side, 14 infusion chairs line the windowed walls. The 
pediatric infusion space is bright and colorful, with ample natural light and artwork. Each infusion 
chair has a television. Families, providers and volunteers moved around the communal space, 
engaging in amicable conversation. 
During guided tours, the importance of physical space became apparent. One AYA guided 
tour participant, who had just finished four three-week chemotherapy cycles and begun one month 
of near-daily radiation therapy, spoke to this. When describing the difference between her 
experience with chemotherapy versus radiation, she talked at length about physical space. She was 
receiving care in pediatric oncology; when I accompanied her there for a clinical appointment, it was 
clear that she was comfortable and familiar with the space and the providers there. After her clinical 
appointment, we visited the infusion room, where she greeted and chatted with staff and other 
patients and family members. For example, she stopped to talk to the mother of a child receiving an 
infusion, with whom she shared information about treatment side effects. Later, I accompanied her 
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to her radiation appointment. We took the elevator down to NCCH’s basement floor to enter the 
Radiation Oncology suite. She swiped an ID badge to indicate her arrival and we followed a dimly lit 
hallway to a women’s dressing room. She put her belongings in a locker, donned a hospital gown, 
and met me in the waiting room directly adjacent to the lockers. We were the only occupants of the 
small waiting room. Within 10 minutes, a radiation therapist arrived to take her back. She was gone 
for approximately 10 more minutes, during which she said she was “tied down to the radiation 
machine”, with little to no conversation occurring. She went on to describe her radiation 
appointments as “cold and mechanical” and the radiation oncology suite as “dark and depressing”, a 
stark contrast from the bright and social pediatric infusion space. “I barely say two words to anyone” 
during the radiation appointments, she said. Because of the difference in physical space and 
atmosphere, she said that radiation has been far more demoralizing for her than chemotherapy.  
The adult infusion center has 57 infusion spaces. Some of the spaces are set in an open-
concept layout, separated only by curtains. Others are set in private rooms with sliding glass doors. 
One AYA described the adult infusion center as a “cold factory” that is always “just packed”. After his 
first infusion, him and his wife bought noise-cancelling headphones, because the adult infusion 
center can be very noisy. They said that they were consistently the youngest people in the room “by 
three decades.” In recognition of the importance of physical space, the AYA program at NCCH is in 
the process of designing and implementing an infusion space specifically for AYAs. The social worker, 
LL, noted that this will streamline AYA programming tremendously; by having all AYAs in one 
centralized location, she will be able to connect with and provide services to AYAs more easily. She 
added that the new infusion space will also facilitate peer-to-peer connection.  
The private inpatient rooms at NCCH are spacious, with a bed in the middle of the room, and 
a seating area with two chairs and a table against the window. A modestly sized television is 
mounted to the wall and can be turned to face the bed or the sitting area. Underneath the 
television, there is a desk and computer for nursing staff to use. There is a mini refrigerator in the 
closet and a private bathroom by the door. A large whiteboard hangs on the wall with names of the 
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patients’ care team, lab results, a “to-do” list, precautions, and skin concerns. A field at the bottom 
of the whiteboard says “goals/needs/questions”. For one guided tour participant, this field had his 
methotrexate (chemotherapy) level. He did not recall the space being used to notate any other 
goals, needs, or questions during his frequent inpatient stays.  
IMPLICATIONS FOR AYA NA-SB. Given that AYAs receive care in disparate locations 
throughout UNC’s Medical Campus, AYA NA-SB delivery should accommodate the variety of 
locations where AYAs have appointments. The centralized layout of pediatric oncology may 
facilitate the communication and information sharing that AYA NA-SB will require more so 
than the more scattered layout of adult oncology. For AYAs receiving infusion treatments, 
the addition of an AYA-specific infusion space represents an opportunity for AYA NA-SB 
service and resource provision, as AYAs will be concentrated in one central location.  
Culture.  Providers described the culture in pediatric oncology as highly collaborative. They 
described this collaboration as critical given that “pediatric oncology (and probably oncology in 
general) can generate a lot of tension and stress”. A group-oriented culture, in which providers freely 
solicit each other’s advice, helped to ease some of that tension.  
Providers also said there is a culture of continuous improvement at NCCH. However, the 
extent to which staff buy in to a new initiative or change is contingent upon how dramatically it 
impacts current workflow as well as staff members’ perception of the initiative’s merits. I asked AS 
what it takes to get his leadership and colleagues on board with new research or quality 
improvement initiatives. He provided a recent example of a survivorship initiative he spearheaded. 
First, AS pulled together a stakeholder panel including his supervisor (the Director of Pediatric 
Oncology), a nurse with robust survivorship research experience, and several oncologists with large 
panels of survivors. Together, they reviewed and refined his protocol. Finally, he presented the 
protocol to a larger group including nursing management and all oncologists. The goal of this 
meeting was to solicit input on the protocol but also to build buy-in and provide education on the 
intervention being implemented as part of the initiative. 
 
112 
IMPLICATIONS FOR AYA NA-SB. The collaborative, improvement-oriented culture of NCCH 
will likely support the multidisciplinary cooperation needed for AYA NA-SB implementation 
and delivery. However, building buy-in among providers will be critical to implementation.  
Reference materials. “After-Visit Summaries” are printed and given to families after each 
visit. They include information about medications, possible side effects, and upcoming 
appointments. LL noted that, although she sometimes prints out additional resources for patients 
and families, it is typically not very helpful for them to receive a “pile of non-tailored resources”. 
When asked if she often leaves appointments with paperwork or printed resources one AYA said, 
“not really at all.” Another AYA said, “for the cancer, they gave me a book on the different types of 
treatments and what kind of treatment I was going to have and stuff like that so that was helpful.. 
that’s about it.” One AYA’s wife sought resources in NCCH’s Patient and Family Resource Center. 
Specifically, she leveraged the “wall of brochures” to learn more about young adult cancer, talking to 
children about a parent’s cancer, and what happens after radiation. Brochures are also staged 
throughout NCCH clinic waiting rooms (see Figure 24), although AYA guided tour participants said 
they rarely looked at them. NCCH’s AYA program is in the process of revamping their website and 
using it to house resources for patients and families.   
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IMPLICATIONS FOR AYA NA-SB. Printed resources could be provided with the After-Visit 
Summaries given to AYAs at the end of each appointment. However, the provision of non-
tailored reference materials may not be helpful for AYA; as such, the provision of resources 
through AYA NA-SB should be highly tailored to the unique needs reported by each AYA.   
Individuals  
Program director/social worker. LL, who has been at NCCH for 4 years, divided her time 
among (1) administrative tasks, (2) research-related tasks, and (3) clinical tasks. Her administrative 
and program development tasks included identifying gaps in care and spearheading quality 
improvement projects, advocating for the AYA program at the hospital-level, program branding, and 
hiring new staff. Over the course of this project, LL hired another social worker to help assume some 
of her AYA clinical duties so she could devote more time to advancing program goals. As far as 
clinical tasks, LL shifted between adult and pediatric oncology and between outpatient and inpatient 
patients. LL noted that, while most providers at NCCH have “homes” (i.e., departments, disease 
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groups, or physical locations where all of their work is done), she did not. Because of the scattered 
locations of her patients, LL said she is “always on the move” and rarely at her desk. She added that 
other providers and staff do not always understand this and expect her to be immediately available 
in their physical location. 
IMPLICATIONS FOR AYA NA-SB. The hiring of another AYA-specific social worker represents 
an increase in staffing hours that might allocated towards AYA NA-SB.  
Oncologist. AS’s time is split between research (75%) and clinical (25%). He noted that, 
although this is a larger research focus than most of his colleagues have, most of them do have some 
time carved out for nonclinical tasks (e.g., education, administrative tasks, advocacy). For four weeks 
out the year (in 1-week blocks), AS worked in the inpatient unit. Additionally, for four weeks out of 
the year (in 1-week blocks), AS was on consultation for other providers in the community.   
IMPLICATIONS FOR AYA NA-SB. Oncology providers, particularly those doing research or 
other nonclinical tasks, may not have the time to deliver AYA NA-SB.  
Organizational knowledge. LL and AS both demonstrated extensive knowledge about NCCH. 
LL was knowledgeable about patient flow and the workflow of various provider groups. She had an 
idea of the bigger picture of how those workflows culminate in patient care. AS easily cited 
information about NCCH including the leadership structure, the number of oncologists, fellows, and 
other types of providers employed in pediatric oncology, and the number of AYAs served including 
breakdowns by pediatric versus adult, tumor type, etc.  
Although social workers demonstrated robust knowledge on the psychosocial services and 
resources available at NCCH, this was not always the case for other providers whose focus was more 
constrained to medical concerns. For example, one AYA, who was also a pediatric oncology provider, 
noted that he had never referred patients to NCCH’s Patient and Family Resource Center because he 
was not sure what resources the program offered. “I’ll be honest, I guess I don’t know what exactly is 
down there. And I don’t know how much of it is directed at pediatric support.”  
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IMPLICATIONS FOR AYA NA-SB. Given that they have a robust knowledge of the services and 
resources available at NCCH, social workers may be particularly well-positioned to facilitate 
the care coordination required by AYA NA-SB.  
Knowledge and beliefs about intervention. Providers demonstrated deep knowledge and 
experience with assessing AYAs’ needs informally (i.e., without using a formalized tool). Observing 
AS and LL interact with patients and families, it was clear that they had a high level of comfort and 
skill with engaging with patients about their medical, psychosocial, and practical needs. Both had a 
robust base of knowledge on AYA guidelines, research, and programming. 
IMPLICATIONS FOR AYA NA-SB. LL and AS are accustomed to assessing AYAs’ needs as part 
of routine care. As such, they possess the fundamental knowledge and skills required to 
engage in a more formalized needs assessment process.  
Experience with PROMs. A critical component of AYA NA-SB is the administration of a 
patient-reported outcome measure (PROM); thus, we asked providers and AYAs about their 
experience administering or completing PROMs. Providers demonstrated some experience 
administering PROMs. LL talked about the Distress Thermometer, which is currently being rolled out 
in adult oncology at NCCH. The tool is administered during patients’ first follow-up visit after their 
initial visit. Front desk staff give patients a piece of paper containing the tool upon signing in at the 
registration desk. Someone then enters this information in EPIC, the electronic health record (EHR) 
used by NCCH. Although LL does not administer the Distress Thermometer, she has received some 
referrals through Distress Thermometer screening. A Distress Thermometer score of four to seven 
triggers a referral to the Patient and Family Resource Center; if it’s an AYA, LL will be called. She 
noted, however, that this is not a major source of referrals. The Distress Thermometer has not been 
implemented in pediatric oncology. However, AS reported that he routinely administers the PHQ-9 
and GAD-7, popular depression and anxiety screening tools, to pediatric patients.  
Overall, AYAs had little experience completing surveys or questionnaires, but were 
amenable to the idea of it. One AYA had recently completed a survey as part of another research 
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study she was participating in. A couple of AYAs recalled completing patient satisfaction 
questionnaires after certain visits or procedures. One said, “now the hospital is trying to do a lot of 
surveys…I guess they’re starting to listen people”. When I asked her if she was overburdened by 
surveys, she replied, “it’s not too many surveys, ‘cause before it was a point where it was no 
surveys... I would rather for them to ask me what it is I need and what’s going on versus them not 
asking and just making the assumption of ‘this is what people need’”. She added that surveys are 
critical to her work as a customer service representative. “I don’t mind a survey…to come from a 
place where surveys do matter… it doesn’t bother me”. One AYA said he received mailed and emailed 
surveys, but never completed them.  
One AYA receiving care in the Multidisciplinary Oncology Clinic said that he completes a 
survey assessing his symptoms during every visit with his oncologist or nurse practitioner. The survey 
includes just over 30 items, in which respondents are asked to rate the severity of symptoms/side 
effects from 0 (“best”) to 4 (“worst”) (see Figure 25). The majority of the symptoms addressed in this 
questionnaire are physical; however, there are a couple of items assessing anxiety and depression. 
The survey is administered via paper in the clinic exam room, after the nurse assesses vitals, but 
before the oncology provider comes in. It is attached to a clipboard which the nurse hands to the 
patient and it takes approximately two minutes to complete. When the nurse practitioner arrived in 
the room during our guided tour, she used the completed survey as a reference point for her 
conversation with the AYA, asking him questions about the symptoms he reported. This AYA said he 
was not sure what, if anything, was done with the survey after that (e.g., if the information was 
documented somewhere) and speculated that the survey “may be unique to the Multidisciplinary 
Clinic” because he had not been asked to complete it during appointments with other providers 
(e.g., his clinical pharmacist in the Surgical Oncology Clinic). In general, he did not mind completing 
the survey and said “it wouldn’t be necessarily a hard thing to just slide another survey underneath 
that symptom reporting thing on the same clipboard and just have them fill all of it out all at once... I 
would do that”.  
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IMPLICATIONS FOR AYA NA-SB. Providers had some experience administering PROMs, which 
will facilitate their ability to administer AYA NA-SB. Although some AYAs had experience 
completing surveys as part of their cancer care, many do not. However, all AYAs were 
amenable to it.  
Process  
AYA tasks 
Diagnosis. The lives of AYA guided tour participants were changed dramatically by their 
cancer diagnosis. “It’s hard to handle, hard to live with,” the wife of one guided tour participant said. 
One AYA had had the phrase, “the thing is…”, tattooed in delicate cursive on her left wrist to 
commemorate the date she was diagnosed. “It’s a big life changing event and I feel like it should be 
acknowledged. so, I went and got this tattoo because it’s actually the title of a poem I’ve found 
helpful and comforting these past two years.” Another AYA recalled being completely shocked when 
she was diagnosed, saying that she barely remembers a thing from the weeks after she got the 
news. However, she quickly took on a “let’s do this mentality”, looking ahead to treatment as “just a 
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thing, just a shitty thing.” Another AYA echoed this sentiment, saying “this is just a small portion of 
my life”.  
IMPLICATIONS FOR AYA NA-SB. Because of the shock rendered by a cancer diagnosis, AYA 
NA-SB should not be administered immediately upon diagnosis.  
Treatment schedules. Patients are generally in active treatment for between six months and 
one year, barring no recurrence. Some diagnoses, like osteosarcoma, require lengthy treatment 
schedules. One guided tour participant with osteosarcoma had an 11-week chemotherapy schedule, 
followed by surgery, followed by another round of chemotherapy. For other diagnoses, treatment 
schedules are shorter. For example, one AYA described his treatment schedule as “hard and fast” 
because it would only last 80 days from start to finish. During active treatment, patients are typically 
coming in for appointments between weekly and monthly. Some, however, come in more 
frequently. One AYA guided tour participant, for example, came in everyday Monday through Friday 
for radiation appointments. Others come less frequently. For example, one AYA guided tour 
participant receiving maintenance chemotherapy for Chronic Myeloid Leukemia only came in for 
appointments once every three months.  
After receiving a cancer diagnosis, AYAs found themselves responsible for a range of tasks 
related to managing their treatment and disease including seeking information, managing complex 
appointment schedules, managing medications and side effects, and navigating relationships with 
family and friends, among others. This task load was exhausting for AYAs. One AYA said she was 
“pretty burnt out of the back-and-forth driving, the constant appointments.” Another AYA echoed 
her appointment fatigue: “it’s the same thing every day, and weekends I get off, and then repeat the 
cycle”.  
Treatment side effects represented a major interference in AYAs’ regular role and activities. 
One said, “when I’m done with these 5 days of chemo, I generally am so wiped out that I can’t even 
safely drive a car… I basically can’t do anything around the house... I can’t do anything”. Another 
AYA’s wife talked about navigating the physical effects of cancer while raising a 2-year old son. “It’s 
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just my husband’s worried that he’s gonna be too sick to, like, enjoy things, like his birthday ‘cause 
our son’s birthday is coming up, and Christmas was difficult because he was too sick to drive… it’s 
just hard.” For some AYAs, the physical effects of cancer are more permanent. One 19-year-old AYA 
guided tour participant, an aspiring pediatrician with a love of dance, lost her leg to osteosarcoma. 
More than a year later, she was still adjusting to her prosthetic leg and learning how to do things like 
climb stairs and dance again. Her mother told me, “she has suffered so much… I just thank God that 
she can still walk.” 
AYAs managed their illness in the context of a variety of other obligations including work, school, 
and raising children, among others. The work of being a cancer patient required AYAs to put their 
lives on hold. One AYA talked about how much work she had missed while undergoing treatment for 
Hodgkin’s Lymphoma: “if I didn’t have FMLA, I probably would have been fired by now.” One AYA, 
who couldn’t work, said, “I went from working 60 plus hours a week to nothing. I have nothing to do. 
It’s driving me crazy.” For other AYAs, competing priorities represented a barrier to service use. For 
example, one AYA was working fulltime while undergoing maintenance treatment for Chronic 
Myeloid Leukemia. She routinely exhausted her sick days and vacation days. Although her job was 
relatively accommodating, she did not think she could take off additional time for programming 
beyond regular appointments (e.g., counseling, peer support programs, etc.). Another AYA’s wife 
faced a similar predicament. While her husband was staying inpatient, she would attend weekly 
caregiver support group meetings in NCCH’s Patient and Family Resource Center. She really liked this 
group, however, it was held at an “odd time of day”, so she could only go when her husband was 
staying inpatient at NCCH. She wished that they held the support group at multiple different times 
so she could attend more regularly.  
IMPLICATIONS FOR AYA NA-SB. Service provision through AYA NA-SB should reflect AYAs’ 
appointment fatigue while undergoing treatment and competing priorities such as work, 
school, and raising children. To the extent possible, services rendered should be embedded 
in existing treatment appointments, while patients are already in the hospital.  
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Outpatient appointments. During outpatient visits, AYAs’ task load was extensive. For some, 
these appointments lasted almost all day. One AYA arrived at the hospital for his 6:30am registration 
time and did not leave until after 2:00pm. AYA guided tour participants came to appointments 
equipped with snacks, entertainment, and other supplies; one AYA’s wife said she had learned to 
never show up “emptyhanded”. Appointments entailed some combinations of segments including 
transportation, parking, registration, labs, imaging, treatment, clinical appointments, and scheduling. 
Figure 26 summarizes the flow of patients through their appointments. During each of these 
appointment segments, AYAs faced waiting times that ranged from 5 minutes to more than 2 hours. 
One AYA and his wife found the waiting time during appointments to be “the hardest part of all of 
this”, describing the waiting as “anxiety-provoking”. 
1. Getting there: Although some AYAs were local, others travelled for hours to get to their 
appointments. For some, family or friends would drive and drop them off. Others drove 
themselves to their appointments. One AYA and his wife took the Medicaid Chatham 
Country Transit bus to daily radiation appointments because their car was in disrepair; this 
incurred an extra four hours roundtrip to their already long appointment days.  Another AYA 
and her boyfriend, neither of whom could drive, got rides to the hospital from a free Uber 
service. One AYA said they she typically arrives a few minutes early to appointments because 
she often is not sure, based on her appointment reminders, where exactly she is supposed 
to be. Another AYA said that, although he did not necessarily have control over his 
appointment times, he preferred early appointments because the doctors wouldn’t yet have 
fallen behind and thus, the waiting times would be shorter.  
2. Parking: The hospital parking deck costs $1.50 per hour. AYAs and families paid to park in 
deck and walked across a skybridge to NCCH. There are shuttles running frequently from the 
parking deck to NCCH. For patients receiving frequent treatments, special parking privileges 
may be given. For example, one guided tour participant undergoing daily radiation therapy 
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received a parking permit for a small parking lot adjoining NCCH. Valet parking is also 
available.  
3. Registration: For appointments in Radiation Oncology, Pediatric Oncology or Gynecologic 
Oncology, AYAs go directly to the clinic to register. All other adult oncology patients check in 
on the ground floor. Registration appointments are 30 minutes prior to appointment time 
and may be as early as 6:30am. If AYAs have more than one appointment in a day, they need 
only register before their first appointment. After checking in at the registration desk, where 
AYAs are given a numbered ticket, there may or may not be a short waiting time before they 
are called back to one of the 11 registration stations. “Normally, waiting to register is not 
that bad,” one AYA said. The registration waiting area was particularly busy on the day of 
our guided tour; we waited for 15 minutes. A large screen hanging above the registration 
desk indicates patients’ ticket numbers and designates a station number for them to 
proceed to when their number is called. Once in the registration station cubicle, registration 
center staff scan AYAs’ license and insurance card and provide them with a bracelet that will 
be scanned during subsequent steps of their appointment (e.g., for lab appointments). AYAs 
sign any necessary forms and may pay their copay at this time. If patients are receiving 
treatment on the weekend, they bypass registration and go directly to the location of their 
treatment appointment.  
At registration, adult oncology patients receive a 1-page document (“a patient passport”), 
which they hand off to providers at each segment of their appointment. On the front of this 
form, there is a step-by-step summary of their appointment itinerary. On the back, there is 
information about moving through the hospital visit (see Figure 27).  
4. Labs/Imaging: Many visits include labs, which typically occur prior to clinical appointments. 
Some clinics (e.g., pediatric oncology, bone marrow transplant) have their own designated 
room where labs are done. In these clinics, after checking in at the clinic’s front desk, AYAs 
waited in the clinic waiting room for their name to be called. Once called by a nurse, AYAs 
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went back to the lab room and had their vitals taken and blood drawn, a process that took 
about 5 minutes. Afterwards, they returned to the waiting room to wait for the next 
segment of their appointment. For other disease groups, labs are done in the Lab Drawing 
Station on the 2nd basement level of NCCH. After checking in at the front desk of the Lab 
Drawing Station, AYAs waited in a large waiting room for about 20 minutes before they were 
called back; however, this wait can be as long as an hour and a half, leading one AYA to 
question “what their system is, if they have one.”  Once they were called back, labs took 
approximately 5 to 10 minutes.  
Patients may also have imaging scheduled during their appointments. Imaging 
equipment is scattered throughout UNC’s medical campus. For example, the magnetic 
resonance imaging (MRI) machine is located on the ground floor of the children’s hospital 
and the computerized tomography (CT) machine is located in the basement of the women’s 
hospital. Thus, depending on the scans they are receiving, patients may have to walk all over 
the medical campus to various locations. Scans may also be scheduled in locations outside of 
UNC’s main medical campus. For example, one AYA guided tour participant had a CT 
scheduled at UNC Hospital’s Hillsborough location (about 20 minutes away), before her 
clinical appointment in NCCH. One AYA described her most recent scans, saying that it took 
all day because there was a period of waiting prior to each scan.  
5. Treatment: Visits may include treatment (i.e., infusion or radiation). For radiation 
appointments, AYAs proceeded directly to radiation oncology, located in the basement-floor 
of NCCH. AYAs swiped an ID badge to enter the radiation oncology suite. They put their 
belongings in a locker and changed into a hospital gown in gender-separated dressing 
rooms. They waited in a small waiting room for between 0 and 15 minutes and then were 
taken back by a radiation therapist. Radiation took approximately 10 minutes. Infusions, 
however, can take between 1 and 8 hours and require, at least for adult oncology, more 
waiting time. One AYA said, “I’m there for like 4 hours, killing time”.  In pediatric oncology, 
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infusions occur in the pediatric oncology clinic infusion room. In adult oncology, infusions 
occur in the third-floor adult infusion center. There, AYAs said the wait for an infusion chair 
ranges from 15 minutes to almost 2 hours, although everything moves more quickly on the 
weekends.  
6. Clinic appointment: Many visits included a clinical appointment with an oncologist, nurse 
practitioner, or physician’s assistant. The wait for these appointments can be long, 
particularly in adult oncology, depending on how behind a provider is that day. For example, 
in a guided tour with one AYA, we waited for nearly two hours in the clinic waiting room. 
From the clinic waiting rooms, nurses called AYAs back to assess their vitals and then took 
them into an exam room where they waited for their provider. AYAs may also have to wait 
for a while once in the exam room. Once their provider arrives, visits were mostly focused 
on medical concerns (e.g., physical symptoms and side effects), but sometimes included 
some discussion of psychosocial or other concerns. During this time, AYAs might raise any 
questions or concerns they have. AYAs said that these visits can be as quick as five minutes. 
As one AYA put it, “it’s just a lot of waiting for a little bit of progress.” Another AYA echoed 
this sentiment, describing how her conversations with her provider typically went: “How you 
doing? You doing good? Ok, bye.” 
In addition to their appointments with oncology providers, AYAs may have 
appointments with other providers across UNC’s medical campus. For example, I 
accompanied one AYA to her appointment with an infectious disease doctor who, after a 
transplant, was working with her cancer doctors to manage the various aspects of her 
health. I accompanied another AYA to her appointment with the prosthetics doctor. She had 
lost her leg to osteosarcoma and met with him every six months to adjust her prosthetic leg.  
7. Scheduling. After their clinical appointment is complete, AYAs worked with a Linberger 
scheduler to schedule their next visit(s). At this time, an After Visit Summary was often 
printed and given to AYAs. For adult oncology clinics, scheduling took place at the clinic front 
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desk or check-out stations, on their way out. The pediatric oncology suite had separate 
scheduling cubicles.  









IMPLICATIONS FOR AYA NA-SB. AYA NA-SB should accommodate the range of appointment 
types that AYAs have. Additionally, to the extent possible, AYA NA-SB should incur no 
additional time burden to AYAs’ already long and exhausting appointments.  
Inpatient stays. Many AYAs have at least one inpatient stay during their course of treatment. 
One guided tour participant was required to stay inpatient after every chemotherapy infusion, 
resulting in frequent inpatient stays. Another guided tour participant had spent a total of nearly 12 
months staying inpatient. During inpatient stays, AYAs had a different set of tasks to attend to. 
 
126 
Guided tour participants spoke to the boredom and “killing time” associated with inpatients stays. 
One, for example, spoke about his daily routine during frequent inpatient visits. An early riser, he 
was typically already awake when the nurse arrived to do labs at 6:00am. Then, he laid in bed until 
around 8:00am. At some point during the morning, the doctors on rotation would visit his room. He 
said he rarely saw his primary oncologist while staying inpatient; the inpatient team rotated 
continuously. “They never tell me much,” he said, just whether or not he could be discharged; for 
him, inpatient stays were just a waiting game until the levels of chemotherapy in his blood fall to a 
threshold at which it was safe for him to leave the hospital. He received IV fluids and medications 
throughout the day to flush the chemotherapy from his system. Nurses came in and out throughout 
the day to take his vitals and change out intravenous (IV) bags. He ordered food when hungry but 
said he “struggles to eat in the hospital” even though the food “isn’t that bad.” Chicken noodle soup 
was his “go-to nausea-friendly meal”. “Time gets kind of weird in the hospital”, so he tried to stay 
busy with video games, music, podcasts, adult coloring books. Since his parents and girlfriend did not 
live in town, they usually stayed all day when they did visit. Earlier in his treatment trajectory, they 
visited more often during his inpatient stays. He would leave the room sometimes to go to the 
Family Resources Room on the inpatient floor, which has a computer, board games, books, and 
informational pamphlets for patients and family members. He visited this room more often during 
his last inpatient stay; this time, he had “more or less kept to himself.” He said that he felt “a little 
stir crazy sometimes but [he tries] to just take a deep breath and maintain a positive attitude. The 
doctors wouldn’t keep [him] here if they didn’t have to. This is just a small portion of [his] life, 
something to get through, and hopefully come out healthy on the other side.”   
IMPLICATIONS FOR AYA NA-SB. Many AYAs have an inpatient stay at some point while 
they’re undergoing treatment; thus, capturing the needs of inpatient AYAs is important. 




End-of-life care. For some AYAs, however, cancer represented more than just a temporary 
hurdle. I met with another 22-year old AYA and her boyfriend. In the waiting room, she opened up to 
me about their relationship, a recent falling out with her family, and their plans for the future. They 
were getting on a Greyhound bus the following morning to start a new life together in Oklahoma. 
Although she was still struggling with the decision to leave her family behind, they were both excited 
for the adventure and confident in their ability to support each other through the move and through 
her illness.  Shortly after we were taken back to the exam room, her oncologist came in and sat 
across from her. She said that, initially, they had planned to treat her tumors with chemotherapy 
until they had shrunk enough to operate on. However, although the tumors had indeed shrunk, they 
were still inoperable. The oncologist said, gently but matter-of-factly, that her cancer was incurable. 
She likely had less than a year to live.  
IMPLICATIONS FOR AYA NA-SB. AYA NA-SB content and delivery should be sensitive to those 
whose cancer is terminal.  
Caregivers’ tasks. Guided tours also shed light on the roles and tasks of AYAs’ family 
members and partners. Family members and partners of guided tour participants drove them to 
appointments, helped them process and keep track of information, entertained them during waiting 
times, and offered them moral support. One dad of a guided tour participant waited outside with 
her dog for the entire length of her appointment. The wife of another guided tour participant stayed 
on a pull-out couch with him every night during his inpatient stays. Family members even 
communicated with me prior to guided tours to make arrangements on their loved one’s behalf. One 
AYA warned me that his treatment had affected his vocal cords so he might not be able to 
communicate easily; fortunately, he said, his wife would be there to talk for him. When I 
commented on how much was on her plate, his wife said simply, “I’m his wife.” Another AYA’s wife 
came to all of his appointments equipped with a list of questions for the doctors. One AYA’s mom 
made tamales for her doctors and brought them to nearly every appointment. AYAs’ loved ones 
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regularly took days off work to accompany AYAs to appointments and spoke passionately about the 
care AYAs were receiving.  
IMPLICATIONS FOR AYA NA-SB. AYAs rely heavily on their loved ones to navigate cancer 
care. AYA NA-SB content should reflect the importance of changes that these relationships 
undergo after a cancer diagnosis.  
Providers’ tasks.  
 
Identifying AYA patients. There was no singular or formalized process for LL to identify AYAs 
to visit. For initial referrals for outpatient AYAs, oncologists or other providers would contact LL via 
email, phone, or EPIC message. For inpatient AYAs, a nurse often notified LL through those same 
channels. LL said that her relationship-building across disease groups has been essential to this 
referral process. One pediatric oncology provider said that AYA patients are often referred to LL or 
the psychologist. However, he noted, “I don’t know if it happens automatically for every single one, 
but if there’s a clear need identified, we will often refer them to [LL or the psychologist].”  
When a patient LL had seen before is in the hospital (inpatient or outpatient), they would 
show up in LL’s EPIC screen. She would click on notes from their previous visit, and would check in 
with them if (1) she had not seen them in a while, (2) they or their parents had contacted her, (3) 
their other providers had let her know they may benefit from speaking to her, or (4) just because. 
For example, while I was with her, a nurse practitioner called LL to say that one of the AYA patients 
was looking great, and she should come see her during her outpatient appointment that day. Also 
during my time with her, LL was texting with the mother of a newly-diagnosed AYA who wanted LL 
to come by during a clinical appointment that day and speak with the AYA and her family about 
coping with the diagnosis. 
IMPLICATIONS FOR AYA NA-SB. There is currently no systematic way for new AYA patients to 
be identified. As such, AYA NA-SB should include a process or strategies for identifying new 
AYA patients (e.g., strengthening referral networks to expand reach).  
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Assessing AYAs’ needs. During our guided tour, LL approached AYAs during various segments 
of their appointments to assess their needs. Sometimes, these appointments were made in advance. 
LL said that appointments made with her are typically by families who live locally and have more 
resources. For these appointments, LL usually meets with the families in NCCH’s Patient and Family 
Resource Center. Typically, however, LL would seek out patients during their appointments for 
impromptu visits. She did not think AYAs would come to her because it would be just “one more 
thing”. She saw logistical barriers as the primary thing keeping patients from engaging more 
proactively with her or with other supportive services available at NCCH. AYAs echoed the 
impromptu nature of social workers’ visits. One AYA, describing her relationship with an AYA social 
worker, said, “she pops in here and there. Or she’ll email me and ask if I need anything or if I’m OK, or 
if I’ve found any more programs to help with like paying rent and stuff like that… I don’t schedule 
appointments with her. I guess its one of those things where, if I need something, I’ll just email her 
and ask.” Another AYA said that the AYA social worker would often come by the infusion space for 
“quick, informal check-ins”. Similarly, one AYA and her boyfriend said that the social worker would 
stop by and see them during nearly every appointment. 
When she approached AYAs during our guided tours, I watched LL seamlessly initiate and 
engage them in meaningful conversation. Her demeanor was informal and approachable as she 
asked them what is going on with their treatment, or where they are in the course of things. She 
then asked, in a very organic and conversational manner, a series of questions to assess their needs. 
“How are you feeling?” “Have you been sleeping well?” “How is school going?” “How’s your family 
handling everything?” “How are you handling everything emotionally?” Based on their responses to 
these questions, LL offered services and resources to support them. Some of these services and 
resources were housed in NCCH, while others were external. For example, she followed up with one 
patient about their Make a Wish Foundation submission. She spoke to another AYA about a free 
rock-climbing trip through a nonprofit organization, First Descents. She helped another apply for 
financial assistance from a local nonprofit. After offering services and resources, LL discussed next 
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steps with AYAs. For example, one AYA we saw was nearing the end of his chemotherapy regimen. 
LL discussed this transition with him, telling him about NCCH’s Survivorship Clinic. During these 
conversations with AYAs, LL also checked in with family members to ensure that their needs were 
being met. Watching these interchanges, I was reminded that the goal of AYA NA-SB is to 
systematize these conversations between LL and AYAs.  
During outpatient appointments, AS said he currently engages in an informal needs 
assessment process. For AS, Fridays are clinical days, although he said the clinical work always spills 
over into other days depending on patients’ emergent issues. He has nine patient slots available but 
sees about six patients on an average clinical day. The slots are 45 minutes to an hour in duration 
but, for the patients we saw during our guided tour, appointments were much shorter. On Thursday 
nights, AS said he typically reviews information on patients he is seeing the following day. He 
reviews and prints notes from previous visits, jotting down handwritten notes to remind himself of 
things to address during the upcoming visit. AS thought that this type of preparation work was 
pretty typical of oncologists in his department. On Friday, AS can see in EPIC when a patient has 
arrived, and when they are ready for him. He said he looks in EPIC to see if anything stands out 
about their vitals. He then retrieves their patient folder and goes to find the patient; they may be in 
the waiting room, infusion space, playroom, etc. He leads them to the exam rooms and follows them 
into the room of their choice. During these visits, although he said he largely focuses clinic visits on 
patients’ medical needs (e.g., symptomology, medication management, treatment details, etc.), AS 
also asked about things going on at home (i.e., social concerns), mood, and other psychosocial 
concerns. Particularly during the initial visit after diagnosis, AS says he assesses the patient’s 
situation at home.  
AS reported that, in general, patients don’t tend to ask him about their psychosocial 
concerns. Interestingly, though, AYAs reported feeling like it was their responsibility to initiate 
conversations with their oncology providers about their needs, particularly nonmedical needs. I 
asked one AYA if she recalled being asked about her nonmedical needs. She responded, “not really, I 
 
131 
have had talks with [my oncologist] about that, but that’s been me saying hey, I’d like to talk to 
somebody about this, and she’ll be like, oh OK, I know where those resources are, let me connect 
you.” Another AYA responded to this question: “No… that would be good for them to ask, ‘besides 
this, what else do you need?’… I’m sure if you mention what you need, they’ll figure out how to get it 
to you. They’re not going read your mind.” In reference to asking patients about nonmedical needs, 
one AYA guided tour participant, who was also a pediatric oncology fellow, said, “I think it happens 
both ways though, either we will dig it up by asking or patients will volunteer that they have a 
concern”. He said that he frequently addresses non-medical concerns during patient visits, 
particularly right after diagnosis. “We’ll talk about anything that could potentially have any effect on 
their care… we will talk about psychosocial stuff…if we identify a psychosocial or financial hardship 
need from talking, we have social workers at our disposal.” During guided tours, however, nurse 
practitioners seemed to broach the subject of non-medical concerns more frequently than 
oncologists. For example, a nurse practitioner in the Multidisciplinary Oncology clinic addressed 
topics ranging from side effects, to fertility, to psychosocial concerns with a guided tour participant 
and his wife. Another AYA guided tour participant, who was struggling to keep up with her 
schoolwork due to “chemo brain”, told me that her nurse practitioner, after eliciting the AYA’s 
concerns about school, had helped her to initiate the process of applying for disability support 
services.  
IMPLICATIONS FOR AYA NA-SB. In addressing their non-medical concerns, AYAs rely on the 
AYA social workers more than their oncology providers. Social workers are currently 
conducting needs assessments, although informally/conversationally; AYA NA-SB should 
leverage their existing workflow and expertise in this domain.  
Documenting and communicating AYAs’ needs. Both AS and LL reporting using EPIC to 
document and communicate patient information, including EPIC messaging with other providers. 
They said that all patient information is recorded in EPIC, primarily as provider notes. “Any little bit 
of data that I got from my history and exam, I’ll put in my note. Almost anything that we either 
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gather or intervene on will likely have even a very brief note put into EPIC.” These notes include fields 
for history of illness, social history, and family history. Oncology providers and auxiliary providers 
separately document notes from their visits with patients. For example, social workers and Child Life 
Specialists would record their own unique note for a given patient. To view information, providers 
must open notes one at a time. Based on their timestamp, providers can identify notes recorded 
during the same appointment.  For providers, notes in EPIC seemed to be a major source of 
information. Prior to all patient visits, AS printed out patient information for his own use, with 
handwritten notes about what to address during an upcoming visit. LL also used notes in EPIC to jog 
her memory about patients’ histories and concerns before visiting with them.  
Providers relied on other technologies to communicate patient information. One AYA, who is 
also a pediatric oncology fellow, said that provider communication was “a healthy mix of emails, 
EPIC, and phone.” LL used her laptop and iPhone at work. Since she is rarely at her desk, LL said she 
has all calls and emails forwarded to her iPhone. She does not, however, access EPIC on her iPhone; 
for this, she used her laptop. Providers also called and texted each other to coordinate care. For 
example, during our guided tour, AS texted LL because his patient wanted to see her. He noted that 
LL is very responsive through text. AS used desktop computers and office phones available in the 
physicians’ workspace in the pediatric oncology clinic. He also communicated via pager, which a 
pediatric oncology fellow noted was the fastest way to communicate.  
Additionally, LL and AS echoed that there is frequent in-person communication among NCCH 
providers. AS described several ways through which providers in pediatric oncology communicate. 
First, there is informal consultation among providers (i.e., “input-seeking”) which occurs almost 
daily. The centralized layout of the pediatric oncology clinic facilitates in-person communication, but 
this input-seeking may also occur via phone. For example, during our guided tour, AS called a nurse 
manager after meeting with a patient. He asked the nurse manager to check in on the patient who 
had seemed “a bit down” and whose visit had raised some concerns about his home situation. 
Second, there are “interest groups” for each tumor type in pediatric oncology, composed of two 
 
133 
oncologists and one nurse practitioner. They are available to meet within a day or two of diagnosis, 
or after any change in status, to conduct a more formal review of the patient’s case and achieve 
consensus on treatment plan. Finally, weekly tumor boards are held, rotating in focus between solid 
and liquid tumor. These meetings are attended by surgeons, radiation oncologists, radiologists, 
geneticists, and others. Providers can present a patient’s case and proposed treatment plan for 
input. Patients are only presented to the tumor board if there are questions or complexities 
surrounding the course of treatment.  
Providers also described various ways through which they communicate with patients. LL 
and the other AYA social worker emailed and texted with patients and their families. Although LL 
used to give most or all patients her cellphone number, she has slowed down on that due to her 
limited bandwidth to respond. AYAs said they communicated with their providers through text, 
email, and MyChart messaging. MyChart is an online, mobile-enabled portal through which patients 
can view their health information, manage their appointments, communicate with their providers, 
and request prescription refills. Although one AYA said he did not use MyChart, most said they use it 
regularly to manage their tasks as a patient. One AYA saw a specialist at UNC every three months, 
but her primary oncologist was in Wilmington, where she lived. Because MyChart pulled her 
information from both hospitals into one place, she found the platform extremely useful for 
reviewing lab results and upcoming appointment reminders and keeping track of billing information. 
She also appreciated “handy reminders” offered through MyChart, such as flu shot and other 
preventative care reminders. Another AYA used MyChart to track her appointments, ask her 
provider questions, and refill prescriptions. Another AYA said, “I constantly look at the MyChart 
thing,” and his wife emphasized that they are “very active on MyChart.” One AYA, during our guided 
tour, declined a printed copy of his After-Visit Summary, saying that he would just view it on 
MyChart.  
IMPLICATIONS FOR AYA NA-SB. Providers use EPIC to document and communicate about 
patient information. If possible, AYA NA-SB should interface with EPIC in order to capitalize 
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on existing systems. Providers also communicate via phone, email, pager and in-person; AYA 
NA-SB could also leverage these existing communication channels. AYAs are active users of 
MyChart; as such, AYA NA-SB could interface with MyChart.  
Providing services and resources to meet AYAs’ needs. When needs emerged, AYAs sought 
help in various ways; in general, they reported relying most heavily on social workers. “We have had 
quite a few talks together,” one AYA said about the AYA social worker, who was helping connect him 
with a program that finances Christmas gifts. Because this AYA was unable to work during treatment, 
such resources were critical to him. The social worker was also helping him to expedite the process 
of filing for disability and Medicaid, a process which he had been told can take up to six months to 
complete, at which point he hopes to be cured. Another AYA’s wife benefitted from seeing the AYA 
social worker. She was helping her apply for a program that provides support for car repairs. 
Similarly, a social worker set another AYA up with a program that helped reimburse patients for their 
medical bills.  
In addition to social workers, AYAs sought help from psychologists, psychiatrists, and nurse 
navigators. For example, a social worker connected one AYA’s boyfriend to a psychologist at NCCH, 
so that he would have someone to talk to separately. One AYA said that he texts his nurse navigator 
to ask, “what’s going on with such and such.” He added that the nurse navigator is pretty responsive, 
and usually has an answer for him, although it is not always the answer he wants. 
AYAs also noted that services and resources can be difficult to navigate or may not be 
delivered in a timely manner. One AYA was uninsured prior to being diagnosed. He had a lump on his 
neck for more than two months before going to the doctor. His wife talked about the process of 
applying for Medicaid after he was diagnosed. She was grateful for NCCH social workers who help 
facilitate this process. However, she said: 
It’s just the initial getting a person that is the issue. When we were in inpatient with him, it 
took four days for a person to come up and talk to us and then it took another week and a 
half and we never got information until we came down here one day and he checked in and 
they were like ‘oh you have Medicaid, you’re good to go’. And he doesn’t actually have a 
card, he never got a notification that he got Medicaid, we just know he has it now… it’s just 
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very discouraging. They’re supposed to help but it just seems like it’d be easier if we just did it 
ourselves. 
 
In some cases, clinician demand outstripped supply. For example, one AYA said, “I had a visit 
with one of the psychiatrists here actually this week. I’ve been trying to get in, I think, since I was first 
diagnosed, so it’s taken a long time to get in. They’re very busy.” 
The perceived applicability of services represented another barrier to AYA use of services 
and resources. One AYA said that, soon after diagnosis, she went to NCCH’s Patient and Family 
Resource Center to find AYA-specific resources. They referred her to First Descents, a program that 
organizes trips for young cancer patients.  However, she opted not to go because she believed trip 
attendees would be much younger than she was. Other AYAs echoed such concerns about 
services/resources not being applicable to them or their specific needs. For example, one AYA with a 
relatively rare diagnosis said that, although she was able to find plenty of general information on her 
cancer type, it was difficult to find information that felt tailored to her. One AYA said that she had 
not used certain peer support programs because she was “socially awkward” and “a crier”. Although 
she desired to meet others her age going through a similar experience, she feared that it would be 
uncomfortable for her.  
Eligibility requirements represented another barrier to AYA use of resources. One AYA talked 
at length about the challenges she has faced in finding financial support programs that she qualifies 
for. “I know the thing that I’ve really struggled with that other people probably have is the financial 
benefits. It’s not only hard to find resources but it’s especially hard to find resources that kind of fit 
this really weird category I’m in where it’s like, I have a full time job; I don’t meet most of the 
guidelines; I’m at a weird age where I’m in between a lot of the benefits that are out there; I’m too 
old for a lot of the teen and pediatric stuff but I don’t really meet a lot of the criteria for some of the 
other things that are out there… because I am able to work, I’m on private health insurance through 
my job. And then, on top of that, my diagnosis is pretty rare. There’s not a whole lot of benefits out 
there for [my cancer type].” A similar predicament was echoed by another AYA who, because he had 
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Medicaid insurance, was not eligible the Pharmacy Assistance Program, a NCCH program that 
provides financial support for patients’ prescriptions. Similarly, his wife said, “he was going to apply 
for social security/disability, but we never went through with that because he was able to start 
working part-time again, and he worked part-time, then he can’t get disability.” Eligibility constraints 
beyond financial requirements were reported. For example, one AYA said she did not qualify for a 
financial support program because she was taking oral chemotherapy; eligibility for the program 
required receiving infusion treatments.  
IMPLICATIONS FOR AYA NA-SB. AYAs report a number of barriers to service and resource 
use. Although some of these barriers (e.g., service capacity) may not be addressable by AYA 
NA-SB, flexibility should be built into AYA NA-SB service provision to accommodate for these 
barriers. For example, multiple services might be offered for a given need such that an AYA 
can select the option that is most feasible and appealing to them.  
Intervention  
Goals for intervention.  
Intervention outcomes. Providers articulated the goal of AYA NA-SB as “formalizing 
something that is already being done more informally.” They wanted the intervention to facilitate 
better documentation in the electronic health record (EHR) surrounding patient needs so that 
providers could use that information as a resource. Currently, they said that “things get lost in the 
medical record.” They saw a needs assessment as a way of getting information about the patient to 
everyone on the care team so that everyone would be on the same page, allowing for better patient 
care. LL said that it’s important to “build better communication processes around needs assessment, 
so that needs information is being communicated to people caring for the patient.” Ideally, providers 
wanted AYA NA-SB to fit “seamlessly” into their existing workflow. Were AYA NA-SB to interface with 
EPIC, NCCH’s EHR, it would help to accomplish this seamless integration because provider and 
patient information are “already there.” Then, AYAs’ needs information could be “pulled into a note 
or whatever and transmitted to other providers.” 
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Importantly, AYAs wanted needs data collected through a PROM to actually drive service 
provision. One AYA said that a needs assessment would be a valuable tool as long as “it’s actually 
used to meet my needs.” When asked what would make a needs assessment worthwhile, another 
AYA said, “I guess if the survey allowed us to express what type of needs we needed or express what’s 
really actually going on with us. And then if we actually see results from the survey within a timely 
manner…like,  if I put in the survey that I want to have therapy services and stuff like that and I turn 
the survey back in, I guess within like a month or two, I would expect somebody to reach out to me 
and be like ‘hey we seen that you need this type of services, here are some options that are available 
to you’.” AYA guided tour participants agreed that they would indeed use services and resources 
offered to them based on their responses to a needs assessment tool. 
IMPLICATIONS FOR AYA NA-SB. To the extent possible, AYA NA-SB should leverage and 
strengthen existing provider workflow, communication channels, and documentation 
practices. Needs reported on AYA NA-SB should trigger timely referral to appropriate 
services or other follow-up actions. 
Needs assessment content. In terms of needs assessment content, financial support was the 
most commonly reported need among guided tour participants. One AYA and his wife who were 
relying on food stamps, gas cards, and family support said, “we are just living in debt right now.” 
AYAs also the wanted the tool to capture needs related to transportation (e.g., gas cards, discounted 
Uber/Lyft rates, parking vouchers), therapy, and peer-to-peer connection. One AYA suffering from 
myriad side effects from radiation said he wanted “just help management with the side effects. I 
knew they said I would get a sore throat, but I have an ulcer in my throat, the side of my tongue has 
sores on it, the radiation’s affected my skin, the way you can see there’s just weak spots in my skin. If 
I had a way to get help for the side effects, that’d be peachy”. His wife added, “he had almost no side 
effects when he was doing chemo, so we thought everything was gonna be smooth. And then he’s hit 
this wall. And ‘sorrys’ don’t exactly fix throat ulcers”. AYAs also wanted opportunities built into the 
assessment for them to elaborate on their own unique concerns. To this end, one AYA suggested 
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that standard survey questions should be supplemented with free-response questions. “If you’re 
trying to find resources to help people and stuff like that, the best way to do it would be like asking 
the question and allowing them to respond. That would be good for us ‘cause some of the stuff that 
people are probably asking on the survey is probably not relevant to what’s going on to that 
particular person so you have to give them room to leave a comment so you can get other ideas.” 
IMPLICATIONS FOR AYA NA-SB.  In addition to capturing psychosocial concerns, peer 
support, transportation, and side effect management, it is particularly important that AYA 
NA-SB capture financial needs which are pervasive among AYAs.  AYA NA-SB should also 
include a free-response opportunity for AYAs to list needs outside of those covered by the 
tool.  
Timing. With respect to needs assessment timing, providers and AYAs emphasized the 
importance of folding the assessment into existing patient flow so that it would not add additional 
time to visits. They consistently pointed to the time period during infusion as an ideal opportunity. 
AYAs thought this would be a good time to complete a needs assessment because “you’re just sitting 
there for hours.” One noted more specifically that the best time would be right after the nurse takes 
their vitals, when they were first sitting down in the infusion chairs. AYAs not receiving infusion 
therapies noted other times when a needs assessment could be folded in without incurring 
additional time or burden. One AYA guided tour identified two time points during clinical 
appointments that typically require some waiting time: (1) in the clinic waiting room, after any labs 
are done, but before being called back to the exam room by a nurse, or (2) in the exam room, after 
the nurse takes vitals, before the AYAs oncology provider enters the room. The latter time point was 
echoed by another AYA. “That would be perfect because most of the time, well, all of my 
appointments that I’ve had with the cancer doctor, they have either been 30 minutes to an hour 
behind, so it’d be perfect for that. I haven’t had an appointment with them that I’ve been on time for. 
They’re never really on time.” For inpatient stays, AYAs noted that needs assessment timing wouldn’t 
really matter, since “you’re just sitting around” for much of the day anyway. One AYA, in the context 
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of inpatients stays, said, “cancer patients have an abundance of time.” As one AYA put it, though, “in 
the population you’re capturing, we have very different experiences... I don’t know if there’s 
something we all have in common then, in terms of the place you would pick to [administer AYA NA-
SB]”.  
As far timing in the disease trajectory, one AYA noted that one month after diagnosis would 
be ideal. They said that, initially, you have not yet grasped the gravity of everything but, by the time 
you are one month out, you have “a better idea of what is happening”. This AYA said that their 
needs had been relatively constant throughout the course of treatment; they did not think their 
responses to a needs assessment would be that different right after diagnosis versus in the middle of 
treatment, versus later in treatment. A few AYAs echoed this; one said, “every cycle has been pretty 
much the same.” One AYA, however, talked about the dynamic nature of his needs with respect to 
managing side effects. “[My needs have] changed somewhat, because like right now I can’t really 
eat. I went from being able to eat anything I wanted to everything tastes like cardboard and I can’t 
really open my mouth to eat a lot.” In this light, providers emphasized the need to administer a 
needs assessment at multiple time points. The oncologist, AS, for example, recommended 
administering it once at admission/diagnosis, once around three to fourth months later, and again at 
the end of active treatment. He noted that the needs assessment may also need to be administered 
annually in survivorship. The social worker, LL, agreed with these general intervals, noting that needs 
tend to be distinct at diagnosis, during treatment, and in survivorship. One AYA agreed with these 
general intervals but noted that his treatment schedule was especially short (80 days), so these time 
general time intervals might need to be compressed in his case.  
IMPLICATIONS FOR AYA NA-SB. AYA NA-SB should be administered at multiple timepoints 
throughout cancer treatment to capture the changing needs of AYAs, including diagnosis, 
during treatment, at the end of treatment, and at some interval in survivorship. It should not 
be administered immediately upon diagnosis when AYAs might not have a grasp of what 
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they need yet. In the clinic, AYA NA-SB should be administered during times when AYAs’ wait 
times so as not to lengthen AYAs’ already long appointments.  
Format. In terms of administration, AYAs tended to favor technology but most did not have a 
strong preference. “People our age are so used to tech.” One said that, although he wouldn’t mind 
completing a paper survey, he would probably opt to complete it via iPhone or iPad if that were an 
option. Another said that she might be faster on paper but didn’t have a strong preference as far as 
format. Another AYA said, “I just feel like nobody’s gonna be into paper. Maybe if it was like a paper 
survey where the person was right there and you were able to turn it in at that moment kinda thing, 
but if it came in, like, the mail or something, I would probably never look at it because I don’t read my 
mail”.  One AYA said that, were the survey emailed to him with appointment reminders, he “could 
easily do it.” AYAs said they would prefer to complete the survey independently rather than have a 
clinician present while they complete the assessment. AYAs also wanted the needs assessment to be 
brief. “The most a survey should be, if it’s going to be electronic or paper, it should probably be like 5 
or 10 minutes, just kind of ask straight-to-the-point questions.” 
IMPLICATIONS FOR AYA NA-SB. AYAs did not express a strong preference in terms of paper 
versus electronic delivery of AYA NA-SB. The needs assessment should be brief, allowing 
AYAs to complete it in less than 10 minutes. 
Benefits of intervention. AYAs expressed largely positive attitudes towards the potential 
value of AYA NA-SB. One AYA could not think of any downsides of having to complete a needs 
assessment. They saw “a lot of positives that would come from it and not a lot of negatives.” 
Another said, that “benefits, depending on the resources you get connected to, could be pretty high.”  
Providers also pointed to several important potential benefits of AYA NA-SB. LL said, “you 
don’t know what you don’t know” and saw AYA NA-SB as a means of making sure that nobody’s 
needs were missed. Providers noted that formalizing processes around care coordination could 
ensure that “things aren’t falling through the cracks”. She added that: 
 
141 
‘We have a lot of resources [at NCCH] but they can be difficult to access. You have to open 
the door for them’, something that AYA NA-SB could accomplish. An AYA guided tour 
participant echoed this sentiment. ‘One potential benefit is that, I think I would even include 
myself in this, a lot of patients probably don’t know what resources they even have access to 
and they don’t know to ask. They don’t know what they don’t know. So, something that 
somebody else sees as a potential trigger and offers them something will, I think, help 
connect people to more stuff that they might not have otherwise known existed. Even I 
probably don’t know all the stuff that I would have had access to if I needed anything.’ 
 
LL also noted that formalizing the needs assessment process would allow other providers and staff 
to do it, making it more sustainable than her maintaining sole responsibility for identifying needs 
and coordinating care. Finally, AS and LL agreed that AYA NA-SB could serve as a valuable source of 
patient information for providers.  
IMPLICATIONS FOR AYA NA-SB. AYAs and providers expressed numerous potential benefits 
of AYA NA-SB, suggesting that the intervention has high potential acceptability among 
prospective users.  
Costs of intervention. Potential costs of AYA NA-SB cited by providers included increase in 
staffing hours, disruptions to workflow, and potential duplicativeness with existing processes. As far 
as staffing hours, LL said that administering a needs assessment would not necessarily incur 
additional burden for her; since it’s something she is already doing informally, it would just be “a 
matter of formalizing the process.” LL cited another challenge associated with AYA NA-SB related to 
leadership buy-in. Because it is difficult to measure the financial gains associated with AYA 
programming, she thought it could be difficult to justify additional resources needed to implement 
and sustain AYA NA-SB. An AYA guided tour participant, who is also a pediatric oncology fellow, 
added that provider buy-in could also be a challenge. He noted that provider awareness of the 
intervention was an important first step. “Providers have more and more things to keep track of,” so 
If AYA NA-SB added to provider workflow, this could negatively impact buy-in, particularly if the 
additional burden incurred was not reimbursable. Additionally, providers pointed to patients’ time 
as another potential cost. However, AS noted that AYAs are a “captive audience” during various 
appointment waiting times. “If you fold it into where they currently are, it wouldn’t be super 
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burdensome for them.” AYAs echoed this sentiment; one said, “I mean, as long as the survey is kind 
of happening during your routine of your appointment, and it’s not an additional thing added on, I 
think the costs are pretty low.” Another AYA said, “time doesn’t necessarily seem to be a barrier, 
because there seem to be a lot of gaps in time where you’re just sitting and waiting”. This AYA also 
said, “paperwork burden is always a concern with surveys… as long as it was appropriately efficient, 
short, I don’t think that would be a big deal”. 
One AYA brought up a concern related to the use of services and resources once needs are identified 
through AYA NA-SB: 
There is an element of adding more appointments to our to-do list, even if it’s something 
that’s supposed to be helpful, it’s another thing. I think that’s a potential cost, too, if linking 
people with services means it just adds to their plate in a state where they’re already 
overwhelmed. Sure, I probably should go see a psychiatrist one time through this to talk 
about how it’s going but it’s just another thing. I’m tired of driving here to check in for 
appointments, sitting in waiting rooms. You could end up hooking people up with things that 
just adds stuff to their to-do list, even if it’s helpful. 
 
IMPLICATIONS FOR AYA NA-SB. AYAs and providers expressed some potential costs of AYA 
NA-SB. Staffing time, workflow disruptions, and provider buy-in represent potential barriers 
to implementation. For AYAs, downstream barriers to service and resource exist; additional 
strategies may be needed to address these barriers.  
5.7 Semi-Structured Interviews (Comparison Between NCCH and Other Contexts) 
Semi-structured interviews were conducted with key provider contacts from around the 
country. These individuals (n=5) represented four healthcare systems in California, Ohio, South 
Carolina and one advocacy and consulting organization (i.e., Teen Cancer America). Providers were 
program managers and nurse navigators, dividing their time between clinical and program 
development tasks. Interview results are presented below by CFIR domain (i.e., intervention; outer 
setting; inner setting; individuals; process). The points of contextual divergence between NCCH and 
other cancer programs that interviewees described are summarized in Table 18. These differences 
represent areas in which AYA NA-SB may require flexibility or adaptation to accommodate 
differences across contexts.  
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Outer context  
Patient population. NCCH’s AYA program is housed within the Comprehensive Cancer 
Support Program and serves patients across adult and pediatric oncology. However, other AYA 
programs may be housed within either adult oncology or pediatric oncology. For example, one 
provider reported that her AYA program was “adult-based and does not see pediatrics ‘proper’ [but] 
AYAs ages 15 through 40 are seen within the health system under the direction of the AYA medical 
director.” Another provider, on the other hand, reported that her program “lives under the children’s 
hospital side, but serves patients in both adult and pediatric oncology.” She described adult and 
pediatric oncology as “fiscally separated but physically connected” in her institution. Some AYA 
programs are constrained to pediatric oncology, with little interface with adult oncology. One 
provider said, “we only serve patients at our pediatric site; we will get community referrals from 
adult institutions when an adult-aged patient has a pediatric cancer. They will get often referred for 
care here. We do take care of patients older than 21 with a pediatric illness.” Some AYA programs 
based in pediatric oncology may serve even younger patients. For example, one provider’s program 
included patients as young as 13. “A lot of programs start at 15. We start at 13, just making the 
assumption that a lot of our 12 and 13-year olds are of reproductive capacity, so we kind of just bring 
them into the fold with the AYA programming concept.” Some programs may start out by serving a 
smaller age range, and expand that age range as the program grows. One provider, who consulted 
with AYA programs from around the country, said: 
I think the programs are blooming from both [pediatric and adult oncology] and what we’re 
really trying to do is make sure that they bloom together versus from one side or the other 
because, if you make a peds AYA program without including your adult people or vice versa, 
then getting the buy-in to support your efforts and to work together becomes more 
challenging. 
 
IMPLICATIONS FOR AYA NA-SB. The population reached by AYA NA-SB may vary by 
institution.  
Cosmopolitanism. One provider noted that structures and functions of AYA programs 
depend largely on their external network, or how they are positioned within their larger institutional 
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network. “Are you a hospital within a hospital? Are you a hospital who has a community partner 
hospital? Are you a freestanding children’s hospital? Are you an adult cancer hospital? How are you 
working with people in your area? That also determines a lot. The geography of the institution is part 
of it.”  
IMPLICATIONS FOR AYA NA-SB. The geography of an institution dictates the structure and 
functions of an AYA program. The referral networks established for AYA NA-SB may depend 
on these external relationships. For example, AYA programs with satellite locations may 
need to consider whether AYAs receiving care in these satellite locations will be reached.  
Inner context  
Structure. Institutions varied in their model of AYA care. One provider, who consulted with 
hospitals from around the country considering establishing AYA programs, said, “I think we see 
different things around the country and that they’re definitely are models where the AYA service is a 
consultation service. And then, there are other programs where they really try to have an AYA-based 
program and dedicated staff.” She said that AYA program establishment is often a “phased project”, 
in which the structure and reach of a program expand overtime.  
IMPLICATIONS FOR AYA NA-SB. The development of AYA programs often occurs in a phased 
fashion. In this context, the implementation of AYA NA-SB may also occur in a phased 
fashion (e.g., initially delivered only to a certain disease or age group).  
Staffing. Given staffing and resource constraints faced by many institutions, providers noted 
the potential time and personnel burden associated with delivering NA-SB and following up on 
needs reported as a potential challenge to implementation. AYA-specific staffing varied across 
institutions. “Sometimes they don’t have any dedicated staff members and they’re just kind of 
piecing together with whatever they can have.”  However, speaking to what makes for a successful 
AYA program, one provider said, “I think what we’ve learned is that there has to be some dedicated 
AYA staff. Because it’s really hard to move these programs forward if you don’t have positions where 
time is bought out to really focus on them.” For some programs, AYA-specific staffing evolves over 
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time. “It’s definitely gradual and sometimes it can be that they’re starting with one dedicated staff 
member.” One provider felt that program managers may be the most important staff members of 
AYA programs because “they’re the ones who are really helping to push these programs forward.” 
Program managers were social workers, nurse practitioners, navigators, or registered nurses; they 
were typically supported by program medical directors from either adult or pediatric oncology, or 
both. Other AYA-specific staff included nurses, nurse navigators, Child Life Specialists, and other 
providers. AYA-specific staff were typically supported by shared staffing and resources across adult 
and pediatric oncology (e.g., social work, palliative care, nutrition, counseling, etc.).   
IMPLICATIONS FOR AYA NA-SB. The availability of AYA-specific staff varies by institution. 
Programs without dedicated AYA staff may face additional challenges in implementing AYA 
NA-SB.  
Funding. AYA programs varied in the extent to which their funding came from inside the 
health system. Many programs, like NCCH, relied on foundation or grant funding. Others, however, 
were largely health system-supported with some auxiliary funding from local or national nonprofit 
organizations. Some providers reported that AYA-specific staff positions were initially grant-funded 
but have since transitioned into being internally funded positions.  
IMPLICATIONS FOR AYA NA-SB. Particularly for programs seeking internal funding for AYA 
programming, AYA NA-SB could provide valuable patient-reported data to justify new or 
continued support of AYA programs.  
Physical space. Another difference among AYA programs was the availability of designated 
spaces for AYAs. Some AYA programs, like NCCH, did not currently have dedicated space for AYA-
specific programming. In contrast, other AYA programs had AYA-specific infusion spaces, exam 
rooms, waiting rooms, lounges, or inpatient centers. One provider’s AYA program even had a 
dedicated outpatient AYA clinic 2.5 days per week. Other programs had done the best they could 
with limited space. “In the infusion space, they tried to create an AYA room. It’s been a bit of a 
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disaster. There’s not a big enough physical footprint to make it really functional, but there is an AYA 
room. Granted, only like two patients can be in it at a time.” 
IMPLICATIONS FOR AYA NA-SB. AYA programs with designated spaces for AYAs (e.g., AYA-
specific infusion rooms) could use these spaces for AYA NA-SB administration or service 
provision since they represent central locations where AYAs may be congregated. However, 
privacy is an important consideration.  
Functions. In general, AYA programs were designed to provide age-appropriate care to AYAs 
with cancer. Their specific functions, however, varied. One provider said that her AYA program 
“provides clinical/medical care to AYAs throughout treatment and into survivorship, with a focus on 
providing age appropriate support, services, resources, opportunities for AYA’s and their 
caregivers/team.” The AYA team in this program were involved in treatment team communication 
immediately upon diagnosis, attending interdisciplinary team meetings for new AYA patients. 
Another provider described the functions of her program similarly: 
We work with all of the doctors and all of the nurses; we come in and we do assessments and 
we provide referrals to resources. And I do some level of care coordination for these patients. 
When I say that, I mean I convene a meeting where we run a list of the patients coming 
through the clinic that week and who are currently hospitalized just to make sure 
everybody’s on the same page about what their care needs are and whose doing what. And 
that’s an interdisciplinary meeting where we pull in social workers, clinical therapists, 
nutritionists, physical therapy, and the team nurses and the physician. Not everybody comes 
to every meeting but it’s an opportunity for us to talk through where everybody is in their 
care, if there’s any concerns raised, we address them. 
 
IMPLICATIONS FOR AYA NA-SB. AYA programs are largely functioning as care coordination 
hubs for AYAs but face challenges to coordinating care for this population; as such, there is a 
need for tools like AYA NA-SB to guide these care coordination efforts.  
Implementation climate. Provider buy-in was mentioned by several interviewees as a 
potential barrier to implementation. One provider noted that implementation could be relatively 
seamless at her institution so long as there was sufficient buy-in among members of the AYA team. 
Providers noted several ways in which their programs had worked to increase buy-in from other 
providers. Describing their implementation of distress screening tool, one provider said: 
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We spent a lot of time on process mapping things. We created our process as a psychosocial 
team. And that was awesome. That’s what pulled in buy-in. I think it has done a good job of 
giving our team a sense to get to work together, because we were fairly siloed. That was part 
of what was identified as something that we wanted to work on. So, this is a nice project to 
bring us all to the table. Personally, I can speak to how its changed professional interventions 
and professional relationships in a positive way. As opposed to just the AYA team process 
mapping it for other people. 
 
Now in their second month of implementation, this provider’s team continued to meet 
weekly to iron out implementation issues and tweak their process. Another provider pointed to the 
importance of education in building provider buy-in and changing the culture around AYA care. “I 
think there’s still a lot of education that has to happen. I think that’s part of the phased and growing 
process until people truly understand what you’re doing and how you can add value to the patient 
experience as well as to the work that they’re already doing, rather than often seeing it as a threat in 
some way. That’s going to help, too.” Another provider, echoing this sentiment, said, “this takes time 
because it is about culture change.” Another provider emphasized the importance of involving 
providers beyond just the core AYA team in implementation planning. 
IMPLICATIONS FOR AYA NA-SB. AYA NA-SB implementation will require buy-in from 
providers beyond just the AYA team. Building this buy-in often requires some degree of 
culture change with respect to the perceived value-add of AYA-specific care.  
Leadership engagement. Leadership buy-in was also flagged by providers as a potential 
implementation challenge. One provider emphasized the importance of establishing a clear plan 
prior to proposing the intervention to leadership. “You’re going to get a lot of questions about the 
who and the how. The more you can lay that out and create that plan and show the value of having 
the metrics for their patients, then they’ll be more apt to use it. The more you can map that out for 
them, the more likely they’ll go and implement it and adapt it for their institution.” 
IMPLICATIONS FOR AYA NA-SB. AYA NA-SB implementation will require the articulation of a 
clear plan for implementation and a compelling case for the value of the intervention.  
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Individual characteristics  
Related experience. While AYA care at NCCH was primarily delivered by two AYA social 
workers, other programs had nurses, Child Life Specialists, nurse navigators, or other providers who 
do this work. A common element of those delivering care to AYAs was an expertise on this 
population. At NCCH, AYA social workers did the work of AYA needs assessment and thus, were 
proposed during provider interviews as central to AYA NA-SB delivery. However, for some 
institutions, this would not be the case. One provider said, “in our program, it would be the AYA Life 
specialist to lead this, gather and then update the medical team promptly with results.” For another 
provider’s AYA program, the AYA navigator was doing the work of needs assessment.  
Determining who follows up on needs reported on an assessment was also mentioned as an 
implementation challenge. Providers listed a number of characteristics that this individual should 
have. When asked about the qualifications needed to follow-up on a needs assessment, one 
provider said, “the biggest thing is well-integrated into the team and is aware of who they are 
referring to. Clear referral pathways make it open to more people who could administer it.” 
Assessment expertise was another qualification deemed important for the individual 
delivering AYA NA-SB. “They have to have good enough assessment skills to know when there’s 
discordance between the numbers circled on the distress screen and what the person is talking about. 
To know, that maybe they’re telling me their overall score is 4, but then they’re talking about this box 
in a way that they probably should see clinical therapy. You have to have that level of thought 
flexibility to know when to elevate a concern.”  
Providers also pointed to training in counseling as an important characteristic of the 
individual delivering AYA NA-SB, particularly for the follow-up piece. “A social worker, in my mind, is 
just a perfect fit for that kind of discussion, especially if they have background and training in 
counseling. Because, they might have an opportunity to even do a little bit of a therapeutic discussion 
if there’s something that comes up right then and there, that they’re skilled and trained to handle 
versus maybe an NA, who basically collects the form and puts it in a box and now is waiting for 
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someone to be aware of it. They can kind of deal with it right then and there and maybe close that 
loop, or get things generated right away because they know what to do with it.” Another provider 
said, “what’s helpful is having someone who is skilled in having difficult conversations, or 
uncomfortable conversations and normalizing them.” 
Providers also mentioned rapport with AYAs as an important characteristic of the individual 
delivering AYA NA-SB. One provider talked about the importance of having a trusting relationship in 
place when assessing AYAs’ needs. Another provider noted that AYAs desire consistency in 
psychosocial care and a point-person to take their concerns to. To the extent that AYA NA-SB 
delivery could be consistent, this provider felt that AYAs would be more receptive to the 
intervention and honest in their responses to needs assessment questions. 
IMPLICATIONS FOR AYA NA-SB. The individual who delivers and follows up on AYA NA-SB 
should have established relationships with providers to whom referrals will be made, 
assessment expertise, training in counseling, and rapport with AYAs. Although this may be 
social workers at NCCH, it varies among other institutions (e.g., child life specialists, nurse 
navigators).   
Attitudes towards AYA NA-SB. Overall, providers liked the revised needs assessment which 
resulted from Design Team Workshop #1, but they offered some critiques. One provider found the 
needs assessment “a bit lengthy” and “too academic in verbiage”. They felt that AYAs might lose 
interest and be noncompliant with a long survey, particularly if it was administered at multiple time 
points. This provider also recommended streamlining the response scales, for example, by reducing 
the five response options to three (e.g., low need, moderate need, high need). One provider 
questioned whether the tool’s intent was to identify patient needs or determine whether patient 
needs are being fulfilled. She felt the that the question phrasing, in combination with the response 
scale wording, made the tool’s intent unclear and recommended revising such that the items and 
response scale were more aligned.  
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One provider, who consulted with AYA programs around the country, spoke to broader 
provider receptivity to an intervention like AYA NA-SB.  
There are so many people that if you could just hand them something and say ‘hey, here’s an 
idea we have and we thought might be helpful’, so many of them would just eat that up. 
Because it would give them something to focus on, and a structure, and I think that’s what 
they’re all trying to do and right now everyone is sort of reinventing the wheel in a lot of 
ways. People are so wanting information and ideas to move their program forward. 
 
AYA receptivity was not considered a major challenge, although providers offered a few 
strategies for engaging them in the process. “We just normalize it and are careful with our scripting, 
making sure they understand this is something we ask everyone to complete, and its just so we can 
understand how to take care of you in the way that you’d like to be taken care of.” 
IMPLICATIONS FOR AYA NA-SB. Providers expressed largely positive attitudes towards AYA 
NA-SB, suggesting that they are receptive to its implementation.  
Process 
Identifying AYA patients. Speaking to the challenges of implementing a formalized needs 
assessment process, one provider noted that identifying new AYA patients represents a major 
hurdle. At her institution, like at NCCH, the AYA program relied on referrals from disease group 
providers. As such, not every AYA that came through the door was referred to the AYA program. One 
said, “I’m not seeing every AYA. We probably have 1800 clients active in our system. And there’s one 
nurse navigator.” Referral networks varied across programs. One provider said that social work, 
nurse practitioners, and nurse coordinators represented major sources of referrals for her program. 
For another program, internal referrals came from navigators, registered nurses, social workers, and 
oncology providers. One AYA provider reported that the most common issue leading to an AYA 
program referral were concerns about fertility. The provider noted that fertility issues “get people in 
the door”, allowing her program to then follow up on other AYA needs and offer AYA-specific 
programming accordingly.  Another provider said: 
‘At the pediatric hospital, [reaching AYAs] is much easier for us to do because they have a 
clinic that meets monthly, an AYA clinic, so all the clients are lined up for us; we know that 
they’re game; we get in there. The adult side is very different because everything is disease 
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specific. So, their survivorship clinics are all over the place, and they might have 1 AYA in 
three weeks… they’re not kind of all conjugated together. That becomes much more a 
challenge and we’re still trying to figure that out.’ This provider said that her AYA program 
was having more success generating referrals from satellite locations; ‘it feels like, the social 
workers have a little less of a case load so we’re getting more referrals from that aspect’. 
 
No providers reported a singular way in the EMR to identify new AYA patients. For example, one 
provider said: 
We don’t have official referral within our EMR. It’s a combination of me stalking the patient 
list to make sure that I haven’t missed anyone. But communication is really tight in our team 
so anytime there’s a new patient who comes through the door, there’s an email generated 
that talks about newly diagnosed patient, age, diagnosis, any pertinent information. So 
that’s kind of the trigger point.  
 
This provider’s institution only had 45 new AYA diagnoses per year, making it possible for 
them to reach all AYA patients this way.  
Providers reported different strategies for strengthening referral pathways. One provider’s 
AYA program opted for a phased scale-up approach. Their AYA program started out covering just a 
few disease groups (i.e., leukemia, lymphoma, sarcoma) and has since expanded to include all 
disease groups. She noted that, as program manager, she had spent a lot of time building 
relationships with disease group providers and establishing AYA champions throughout the hospital 
to facilitate AYA referrals. Another provider’s AYA team often sat in on tumor boards in her health 
system: 
We’ll kind of talk about, ‘these are our services. Are there any needs? Has anyone talked 
about fertility yet?’, those types of things. What started happening was they just started 
giving us referrals. I think, initially, it was a really good place to start because they really 
didn’t know what was this program and who are these people. She described taking on an 
advocacy role during these meetings,’ helping physicians do the right thing’. 
 
IMPLICATIONS FOR AYA NA-SB. There is currently no systematic way for new AYA patients to 
be identified. As such, AYA NA-SB should include a process or strategies for identifying new 
AYA patients (e.g., strengthening referral networks to expand reach). 
Assessing AYAs’ needs. Some AYA programs were assessing AYAs’ needs 
informally/conversationally (i.e., without using a standardized tool). This informal needs assessment 
process was sometimes done through a pre-scheduled appointment. Often, though, like at NCCH, 
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AYA providers make impromptu visits to AYAs while they are in the hospital, stopping by to check in 
with them in the clinic, during infusions, during inpatient stays, etc. “We follow them wherever they 
go,” one provider said. Describing her visits with AYA patients, one provider said, “it’s more 
impromptu. We try to touch every patient at least once when they’re inpatient. We’re not in every 
visit all the time, but we do have a high level of touch. I would say one of us sees a patient practically 
every time they’re in clinic”. Another provider said, “it’s very free-flowing”. In making these visits, 
providers emphasized the importance identifying times that did not disrupt or prolong AYAs’ clinical 
appointments.  
Some programs were working towards assessing needs using a standardized tool. For 
example, one provider had developed a needs assessment tool based on National Comprehensive 
Cancer Network (NCCN) guidelines and piloted it with a small sample of 10 AYA patients. Another 
provider said, “when I started, it was much more conversational, and I still think a large part of it is 
conversational, but we are definitely moving towards a more systematic approach.” Her program 
was in the early stages of implementing a needs assessment/distress screening tool:  
The distress thermometer is a paper assessment. We’ll go in and kind of introduce the 
concept and we give them time to fill it out and then we, either myself or [the child life 
specialist], usually me, will sit down and sort of review it with them as a conversation. So, 
sort of like, ‘I see you checked the box about changes in your romantic relationships. Can you 
tell me a little bit more about that?’ Things like that, just to get more depth.  
 
This provider noted that AYAs had been hugely receptive to completing the screening tool. 
Explaining their receptivity, she said, “I think the fact that it’s not something we send home with 
them- it’s something they get that real-time feedback. ‘I fill this paper out. Then his person comes 
and talks to me about it. And then we make a plan. All in the same session’. That’s been helpful for 
them in seeing it’s not just another piece of paper. They put a concern out there and we are acting 
upon it”.  
Another provider’s program had recently implemented a tool for assessing needs:  
We have a care consultation model that is pretty much based on the NCCN distress screening 
tool that [the social worker will] go in and kind of talk to clients about when she first meets 
them, whether it’s in person, or remotely. We give them a paper consultation sheet, and this 
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is front and back, and ask them to fill it out. And then the social worker will wait [in the room 
while AYA completes form] and then sit down and talk about, ‘ok I see that you indicated 
this, what’s going on there’. 
  
This provider described the care consultation model document as a “living document”, 
saying, “it’s not an event, it’s a process”. The social worker would keep going back to a patient to 
work on the document, focusing on the most pressing concerns during any given visit. Another 
provider recommended a similar approach to needs assessment, in which assessment content 
depended on content addressed in previous assessments. In other words, the full range of needs 
would not be assessed during every administration but, rather, a subset of pressing concerns. “I feel 
like it should be more often just maybe not all parts of it- I think depending on what you learn from 
your first or second time.” 
IMPLICATIONS FOR AYA NA-SB. Some providers’ programs were in the early phases of 
implementing a more formalized needs assessment process. Success in their institutions 
suggests that AYA NA-SB is feasible to implement.  
Documenting and communication AYAs’ needs. Another challenge to implementation noted 
was sorting out how the needs assessment would interface with the EHR and working with software 
vendors to make the necessary changes. One provider said, “our system is so back-logged with EMR 
requests, that if we waited, it would probably be a year before they could build it, unfortunately, so 
we’ve just plodded ahead.” 
Across the board, information about AYAs’ needs was documented in notes in the EHR by 
whichever provider had the interaction with the AYA. These EHR notes were routed to other 
providers, or a page sent for pressing concerns. Otherwise, the AYA team followed up with other 
providers about AYAs’ needs via email, phone, or in-person communications. One provider described 
a “multidisciplinary team-based approach to AYA care” in which “needs are addressed in real time”. 
Within this institution, interdisciplinary team meetings were held for new AYA patients to share 
information and coordinate care. Similarly, another provider described a weekly, multidisciplinary 
“AYA psychosocial round” where all current inpatient AYAs and AYAs coming in for outpatient 
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appointments in the upcoming week were discussed. During these meetings, AYAs’ needs and 
appropriate follow-up actions were discussed.  
One provider, whose program was in the process of implementing a distress screener, said 
that screening results and follow-up actions were documented retrospectively in the EHR. “We use 
EPIC. We created dot phrases to make it consistent in terms of, this is a tool that was administered, 
this is the score, these are the concerns, and then this triggered XYZ referrals. And then, if you receive 
a referral, we have a dot phrase there so its auditable as a trail- a closed loop that can be traced 
through the EMR.” Similarly, another provider (and program director) said that their program’s social 
worker would “scan the document into our EMR because it’s not an electronic document at this point 
in time.” At the end of the day, the social worker would send this provider for her review: 
I’ll kind of review it and then we’ll discuss like, is there anything else we think we should add 
in there, is that enough, anyone we should let know? And then she’ll do a nice follow-up with 
their care team if she feels there’s anything that’s necessary. 
 
IMPLICATIONS FOR AYA NA-SB. Providers use the EHR to document and communicate about 
patient information. If possible, AYA NA-SB should interface with the EHR to capitalize on 
existing systems. However, working with software vendors to make the necessary changes 
represents a challenge to implementation.  
Providing services and resources. One provider noted institutional service capacity as a 
potential barrier to implementation. “I think it’s building the infrastructure within your organization 
to support the needs.” Thus, she emphasized the importance of identifying gaps in service capacity 
prior to implementing a needs assessment tool and building up services to fill existing gaps. “And 
that’s one thing we sat down before we launched the tool. We went through all of these and said ‘ok, 
so if they stay yes to financial distress, what do you do with that’. It’s unethical to ask a question that 
you cannot answer or point them to a service.” To this end, One provider described conducting an 




One of the things we built is a Supportive Services Guide, which basically said who are the 
social workers in [pediatric oncology] and on the adult side. What are their names? What 
floors should they cover? What diseases do they manage? How do I contact one if I need 
one? What are the head nurses names in both areas? So, we could do cross-linkage of 
services and get a good feel for what we had on both sides of the organization. And that was 
very helpful and helped us to get acquainted with folks that we may not have even known 
existed. And other things like supportive integrative medicine-  all of those other aspects that 
can really enrich their experience and help them. 
 
IMPLICATIONS FOR AYA NA-SB. Institutional service capacity represents a potential barrier 
to AYA NA-SB implementation. A thorough understanding of existing services and resources 
should be gathered prior to implementation.  
Intervention  
Goals for intervention. 
Timing. One challenge to implementing AYA NA-SB identified by providers was related to 
timing of needs assessment administration. They noted that, given variation among AYAs and the 
unpredictability of clinical workflow, getting the needs assessment to AYAs at the opportune times 
would be really challenging. Furthermore, treatment trajectories vary tremendously, making it 
difficult to time re-assessment.  
Providers emphasized the importance of not administering AYA NA-SB too soon after 
diagnosis. One provider recommended meeting with the patient as soon after diagnosis as possible 
but cautioned, “the problem is trying to get in with that initial discussion when the client and their 
family is just so completely obliterated emotionally by hearing that they have cancer. We have found 
that that has not necessarily been that productive. Like, you’re trying to with them, they can’t barely 
hear you, it’s just very emotional.” One provider recommended a month or two after diagnosis as 
the first administration time point. Another recommended the third visit after diagnosis; she added 
that the assessment should also be administered during the third visit after relapse. Another 
provider felt that, ideally, needs should be assessed within 2 weeks of diagnosis but noted that this 
may not always be logistically feasible.  
In terms of frequency of AYA NA-SB administration, providers suggested administering the 
needs assessment relatively frequently. “The treatment journey changes so frequently and the 
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different factors that come up along the ways. So, I think checking in periodically, we’ll miss less.” 
However, in pinpointing a specific interval for screening needs, providers noted the challenge of 
accommodating different treatment trajectories. “Who knows what the middle of treatment is. For 
someone like a non-Hodgkin’s, the middle of treatment might be two months. For someone else, the 
middle of treatment could be six months.” One provider’s program was aiming for quarterly re-
screening of needs. Another provider, whose institution was in the process of implementing a 
distress screening tool said that they are re-screening based on the level of distress at initial 
screening. For patients whose initial distress screening score was “low”, they were re-screening at 6 
months; those with a “medium” distress score were re-screened at three months; a “high” distress 
score triggered a re-screening at one month. They were keeping track of this timing in an Excel 
spreadsheet, which was feasible in part because of their small patient case load (i.e., 45 AYA 
diagnoses per year). Eventually, they wanted to build these re-screening rules into the EHR so that 
patients due for re-screening would be flagged for easy identification. One provider noted the 
importance of following up on needs reported in a timely manner. “If you wait too long, they have 
forgotten what the reported on the assessment”. 
Providers also discussed administering the tool during the survivorship phase. One 
articulated the importance of assessing needs in survivorship because, after treatment ends, AYAs 
no longer have providers readily available to help them with their needs. “What clients are telling us 
is that, after they ring that bell, the bottom falls out. They don’t know what to do. They’re going back 
to school or they’re going back to work if they’re able, and they’re like, ‘I don’t have the skills for this. 
I’m just starting to process this trauma I went through. I’m a different person’. With very little 
support.” One provider noted that the assessment may require shortening for AYA survivors, as 
many of the items may only be relevant during treatment.  
Providers agreed that AYA NA-SB should be administered during times when patients are 
already waiting in the clinic. One said that this was how she currently determined times to visit with 
patients; she always aimed to meet with them while they were waiting. She noted that clinical flow 
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can change quickly, though, making it challenging to identify these periods of waiting time. More 
specifically, providers agreed with several time points for AYA NA-SB delivery: (1) during infusion, (2) 
in the clinic waiting room, and (3) in the exam room prior to the oncology provider coming in. One 
provider noted, however, that infusion spaces at many institutions may lack privacy. “I have done 
one follow-up in the infusion space for that very reason, of not wanting to hold up their whole 
appointment. It’s just harder because our infusion space has no privacy, and some of the things that 
get raised are private.” Providers emphasized the importance of screening the needs of inpatient 
AYAs, not just those coming in for outpatient appointments. In regard to administering a tool to an 
AYA staying inpatient, providers felt there was ample opportunity, saying, “there’s tons of deadtime 
in the hospital.” 
IMPLICATIONS FOR AYA NA-SB. AYA NA-SB should be administered at multiple timepoints 
throughout cancer treatment to capture the changing needs of AYAs, including diagnosis, 
during treatment, at the end of treatment, and at some interval in survivorship. It should not 
be administered immediately upon diagnosis when AYAs might not have a grasp of what 
they need yet. In the clinic, AYA NA-SB should be administered during times when AYAs’ wait 
times so as not to lengthen AYAs’ already long appointments. 
Format. Overall, providers did not express a strong preference about paper versus electronic 
delivery of AYA NA-SB. One said, “I personally don’t [have a preference]. I think whatever’s going to 
be easiest and helps you get the information you need, as easily as possible.” Another provider said, 
“I think, if it’s not while they’re sitting there, then technology is something to consider. But if there 
just like right there in the space [i.e., clinic], then I don’t know if it really makes a difference.” 
However, one provider, who developed and piloted a needs assessment in-house, reported that 
participants in her pilot study favored paper over electronic assessment completion. They were sent 
a survey link in advance and given the option to complete it electronically either before or during 
their clinical appointment; 9 out of 10, however, opted to complete it on paper, in the clinic. This 
suggests that AYAs may be less amenable to administration outside of the clinic setting. Another 
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provider said, “Some locations may not have option to implement electronically so paper options 
should be available for all institutions if widespread.” One provider described her institution’s 
implementation of a distress screening tool: 
For us, the paper is working. We are still considering this a pilot so that’s why we haven’t 
gone that next step. Personally, I like the paper. It’s a concrete thing I can do with a patient. 
My AYAs aren’t checking their emails. They have a really low rate of saying that they use the 
MyChart access through EPIC to check their chart. So many of us get bombarded with digital 
things all day long, that it’s not really helpful. It would be helpful from a documentation 
standpoint, for sure, because right now we scan that paper back into the EMR, and it lives in 
a different tab of the EMR, where its findable but it’s not integrated like a flow sheet, which 
would be great, because then you could track it really easily side-by-side. There are benefits 
from a documentation and tracking standpoint, but I don’t know what patient response to 
that would be. I think that might be our next phase of things. 
 
IMPLICATIONS FOR AYA NA-SB. Although providers did not express a strong preference for 
AYA NA-SB format, they recommended considering electronic delivery if AYA NA-SB were to 
be delivered outside of the clinic. In the clinic, they noted several advantages of paper.  
Benefits of intervention. Providers saw AYA NA-SB as an opportunity for AYA programs 
around the country. One provider said, “I think its invaluable.” She noted that, even if AYAs didn’t 
have pressing needs at the time of assessment administration, merely completing the survey could 
be hugely informative to them in terms of pointing out resources and services that are available to 
them should needs arise. Another provider echoed this sentiment, describing the benefits of a 
distress screening tool her program was in the process of implementing: 
It’s been incredibly useful as a conversation starter and it’s also been really clarifying for the 
patients as to what they can talk to our team about. It helps them see ‘oh, so like when you 
say you’re here to support the intersectionality between my life as a teenager, or young 
adult, and my cancer, that’s what you mean’. It’s really been really helpful in clarifying that 
for them. And then also, again, giving them permission to talk about things. It sort of like 
normalizes ‘oh, OK, so this body image thing I’ve been dealing with, it’s not so strange that I 
can’t talk to them about it.’ 
 
One provider noted that AYAs may be more inclined to indicate concerns on a needs 
assessment, than to broach these conversations with their providers, unprompted. Another provider 
said that her program’s distress screening tool “helps us to align ourselves with what’s important to 
[AYAs] pretty quickly.” Similarly, another provider said, “I think it has taught us to be thorough. As 
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humans, we all have areas and things we’re more comfortable discussing than others….by 
standardizing the types of questions we’re asking, it legitimizes all of these discussions.” 
An intervention like AYA NA-SB was also seen as a way to make sure no patients fell through 
the cracks. “It’s a good reminder to address those non-urgent needs of the patient, that are still 
needs. It’s a concrete way of making sure that you’re closing the loops with every patient, not just 
your highest needs ones. It’s sometimes easiest for those highest-drama, sickest patients to get a 
disproportionate amount of time at the expense of the care of other people who do have needs, they 
may just not be as vocal about them, or they may not appear as urgent or tragic. So that’s another 
benefit, I think, for the team.” Similarly, another provider reported described the usefulness of a 
standardized tool in identifying issues among patients who seem like they are coping well or have no 
issues. One provider felt that, by identifying issues upfront that may have otherwise been missed, a 
needs assessment could help move from a reactive to a more proactive space. “A lot of time, we 
always feel like we’re running around putting out fires.”  
A needs assessment intervention was also regarded as a means of justifying an AYA-specific 
program to other health system providers and leadership: 
I think there can be a lot of benefit in saying, we are assessing the needs, and these are the 
needs that have been uncovered by our AYA team. These were not questions that other 
members of the health care team are asking. So, if people are like ‘why do we need AYA-
specific care? what’s so unique about that?’, it gives you data. It can give concrete numbers 
data to the psychosocial support work that’s being done. That’s a huge benefit. That’s sort of 
as a justifying your role to administration or whatever. Also, for the actual providers, in real 
time, to see what’s important and to see what’s covered by the AYA team. If I uncover an 
issue and I take that to the doc, then they’re able to do a better job of caring for the patient. 
It’s also that individual patient-level feedback to the provider team that helps describe the 
reason we care about having an AYA team at your site. 
 
One provider felt that AYA NA-SB could offer a uniform approach for assessing needs across AYA 
programs. She felt that this could generate national-level data to advance AYA cancer practice. “The 
need is there. I think everyone is searching for something like this. And everyone’s kind of doing it in 
different ways. So, if we had a universal one that everyone was using, I think that would be fantastic. 
Especially, to show some data on the national level.” 
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IMPLICATIONS FOR AYA NA-SB. Providers expressed numerous potential benefits of AYA NA-
SB, suggesting that the intervention has high acceptability among prospective users. 
Table 18. Contextual differences identified in semi-structured interviews  
Contextual 
feature of 
AYA Program  
UNC Variation 
Structure   Under the umbrella of NCCH’s 
Comprehensive Cancer Support 
Program which is directed by the 
Vice-Chair of General Hospital 
Psychiatry. There is not currently a 
designated space for AYA care. 
However, an AYA infusion space is in 
development.  
• Some AYA programs have 
designated AYA spaces (e.g., 
infusion centers, inpatient centers), 
but some do not.  
• Some AYA programs are housed 
within pediatric oncology; some are 
housed within adult oncology. The 
extent to which there is interface 
between pediatric and adult 
oncology varies.  
Staffing   Medical director; program 
director/social worker; social worker 
 
Patients rely on social workers for 
non-medical needs, saying that their 
oncology providers rarely ask them 
about non-medical concerns. 
•  Core members of the AYA care 
team vary across institutions. As 
such, who assesses and addresses 
AYAs’ needs varies. A common 
element of those who do the work 
of AYA needs assessment is an 
expertise on the AYA population.  
Funding   Foundation + grant funding   •  Some AYA programs are largely 
health system supported, while 
others rely on foundation grants 
and other external funding.  
Functions  Coordinating across disease groups 
and across pediatric and adult 
oncology to provide age appropriate 
services and resources to AYAs  
•  Some AYA programs are modeled 
as consultations services while 
others function more as part of the 
primary treatment team.   
How are new 
AYA patients 
identified? 
AYA social workers rely on referrals 
from disease group providers. 
• In general, AYA programs rely on 
referrals from disease group 
providers. However, the reach of 
programs vary, with some AYA 
programs reaching every AYA 
patient and some only reaching a 







Although sometimes AYA social 
workers schedule appointments with 
AYAs, they often just “pop in” while 
AYAs are in the hospital for 
appointments 
•  AYA programs vary in the extent to 
which AYA visits are scheduled 





AYA needs are assessed 
informally/conversationally by the 
AYA social workers 
• Some AYA programs are working 
towards implementing distress 





AYA Program  
UNC Variation 






Information about patient needs is 
stored as notes in the EHR; each 
provider records their own separate 








Providers communicate about AYAs’ 
needs via phone, text, email, EHR 
messaging, and in-person. 
• Same  
 
 
5.8 Design Team Workshop #2 
In preparation for the second design team workshop, the research team distilled the most 
pertinent implications of ethnography data to create a translation table, which translates user and 
contextual factors into requirements for NA-SB delivery (see Table 19).  
Table 19. Ethnography translation table  
Domain  User/contextual factor identified 
through ethnography  






AYAs desire a tool that is used to 
address their needs in a timely manner  
AYA NA-SB follow-up actions should 
be delivered in a timely manner  
Needs change as AYAs move through 
their treatment trajectory. Time points 
when needs are particularly distinct 
include (1) after diagnosis, (2) end of 
treatment, and (3) somewhere in 
between 
AYA NA-SB should be administered at 
multiple timepoints, including after 
diagnosis, during treatment, and at 
the end of treatment 
AYAs feel overwhelmed immediately 
following diagnosis and may not know 
what they need yet  
AYA NA-SB should not be 










AYAs at NCCH rely heavily on social 
workers to address their nonmedical 
needs  
AYA NA-SB should be delivered by 
those who are currently doing the 
work of AYA needs assessment and 
those who have relationships with 
providers to whom referrals will be 
triggered (i.e., social workers at NCCH)  
oncologists are primarily focused on 
medical concerns during patient visits 
NCCH has two social workers 
dedicated to AYA patient care; AYA 
social workers are already doing the 
work of needs assessment, although 
informally/conversationally; AYA social 
workers have robust knowledge of 
services and resources available to 
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Domain  User/contextual factor identified 
through ethnography  
Requirement for AYA NA-SB delivery 
AYAs and established relationships 
with providers across clinics 
NCCH has nurse navigators for each 
disease group; nurse navigators often 
see patients at the beginning and end 
of their visits 
At other institutions, nurses, nurse 
navigators, child life specialists, and 
others may do the work of needs 
assessment  
Appointments vary among AYAs, 
including some combination of the 
following: (1) labs, (2) imaging, (3) 
treatment, (4) clinical appointment.  
 
Clinical appointments typically occur 
monthly.  
AYA NA-SB delivery should be flexible 
to the various types of appointments 




Monthly clinical appointments may be 
the common thread.  
AYA tasks are very different during 
outpatient visits versus inpatient stays  
AYA NA-SB delivery should 
accommodate both inpatient and 
outpatient AYAs  
Users expressed the importance of not 
extending AYAs’ already long and 
exhausting appointments.  
AYA NA-SB administration should 
occur during appointment waiting 
times 
AYA social workers identify new AYA 
patients through disease group 
referrals; since the referral process is 
not systematic, not all AYAs are 
reached 
A process for identifying new AYA 
patients should be built into AYA NA-









Adult oncology appointments are 
scattered across NCCH  
AYA NA-SB administration should 
account for disparate physical 
locations  
NCCH is building an AYA-specific 
infusion space  
AYA NA-SB could leverage the new 
AYA space for needs assessment 
administration and/or service 
provision; however, privacy should be 
considered  
AYAs prefer technology, but are not 
averse to paper format 
If possible, AYAs should have the 
option to complete AYA NA-SB 
electronically 
AYAs are active users of MyChart   AYA NA-SB could interface with 
MyChart 
Providers use EPIC for patient 
information documentation and 
communication across providers  
If possible, AYA NA-SB should 
interface with EPIC  
 
 
AYA NA-SB should facilitate 
communication and the sharing of 
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Domain  User/contextual factor identified 
through ethnography  




AYA providers collaborate with 
providers across adult and pediatric 
oncology, and across disease groups.  
information across pediatric and adult 
oncology, and across disease groups 
Clear referral pathways should be 
established to facilitate follow-up on 
reported needs 
the extent to which staff buy in to a 
new initiative or change is contingent 
upon how dramatically it impacts 
current workflow as well as staff 
members’ perception of the initiative’s 
merits. 
AYA NA-SB development and 
implementation planning should 
involve key stakeholders who will 
interface with the intervention in 
practice  
NCCH’s AYA program falls within the 
Comprehensive Cancer Support 
Program, which has a catalogue of 
resources for patients and families  
AYA NA-SB should leverage 
Comprehensive Cancer Support 
Program resources where applicable 
Leadership buy-in often hinges on 
measurable impacts  
AYA NA-SB data should be 
documented somewhere to allow for 
the evaluation of its impact, and its 
use to inform program changes  
NCCH’s AYA program is growing and 
expanding in scope  
 
 
During the second workshop, the AYA NA-SB design team reviewed user and contextual 
requirements and collaboratively specified AYA NA-SB delivery (Figure 28). The final AYA NA-SB 
prototype can be found in Appendix I.  
When should AYA NA-SB be delivered?  
Given the diversity in AYAs’ illness and treatment trajectories and the unstandardized 
approach to AYA care at many institutions, it was determined that some degree of clinical judgment 
will be necessary for identifying the appropriate timepoints to administer AYA NA-SB, at least 
initially. In the future, systems can be built to facilitate a more standardized approach to needs 
assessment timing. 
First administration. Based on ethnography data, I proposed that AYA NA-SB should not be 
administered immediately upon diagnosis, because AYAs are overwhelmed and do not yet know 
what they need. During the workshop, one AYA pushed back on this, noting that he had already 
been diagnosed and undergone surgery by the time he met with his oncology provider for the first 
time. Thus, during this first visit, he already had a list of questions and needs. Waiting to administer 
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the needs assessment could result in these initial needs being missed. Fertility concerns were 
mentioned as an example of a particularly time-sensitive need that could be missed in the time 
period immediately after diagnosis. However, providers noted that administering AYA NA-SB during 
the first visit could potentially result in many “false positives”. Furthermore, there may not be the 
workforce capacity to respond to these false positives. Other arguments against administering AYA 
NA-SB during the first visit included concerns about overwhelming AYAs and concerns about fitting 
the assessment into the hectic logistics of the first visit.  
Ultimately, design team workshop attendees determined that AYA NA-SB should be 
administered within one month of diagnosis. However, this would not necessarily be the first contact 
with the AYA team. For example, information about the services the AYA team can provide and 
contact information might be provided to AYAs immediately upon diagnosis, with a heads-up that 
more extensive conversation will follow.  
Frequency. Design team workshop attendees expressed differing views regarding the 
frequency with which AYA NA-SB should be administered. One AYA recommended 1-month intervals 
to get a “continuous snapshot of needs as they develop.” However, another AYA said that completing 
a needs assessment monthly would be “really annoying”. One suggestion was to increase the 
interval as AYAs progress through treatment, extending the space between assessments from, for 
example, one month to three months to six months. Another suggestion was to determine the 
timing of reassessment based on the severity of needs indicated in previous screens. However, for 
these two options, concerns were raised about the feasibility of tracking this. Another 
recommendation was to administer subsets of the needs assessment during reassessments, or allow 
AYAs to update their previous assessment rather than having to complete it again. These options 
were considered more feasible were the assessment to be administered electronically. Another 
suggestion was to tie reassessment to change in clinical status. However, providers expressed 
concerns about being able to identify and track these time points. As such, providers favored 
anchoring frequency to a given time period, rather than something like clinical changes which vary 
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from person to person. To this end, one design team member recommended tying timing to typical 
treatment cycles. For example, many chemotherapy regimens operate on 3-week cycles; he 
suggested administering AYA NA-SB every cycle, or every other cycle. However, given the variation 
among treatment protocols and schedules, this option was passed on.  
Ultimately, design team workshop attendees determined that pilot testing would be used to 
determine the frequency of AYA NA-SB administration. Specifically, pilot testing will include two 
arms. In one arm, AYA NA-SB will be administered monthly; in the second arm, it will be 
administered every three months. Feedback from AYA and provider pilot participants will inform the 
ultimate determination of needs assessment frequency. Since AYAs typically have monthly 
appointments with their oncology provider(s), the design team discussed tying assessment 
administration to those monthly appointments.  
Who should deliver AYA NA-SB? 
AYA NA-SB drop-off and pick-up. We initially discussed the option of having the needs 
assessment offered to AYAs during registration. However, there were concerns about relying on staff 
working at the registration desks to identify eligible patients; providers felt that this would require a 
significant workflow and culture change. The second option we discussed involved AYA social 
workers dropping off the needs assessment with AYAs, giving them 10 minutes to complete it, and 
then coming back for an immediate follow-up discussion. Since social workers know where people 
are in treatment as well as where they are in the clinic, this was considered a viable option. 
However, from a workflow perspective, there were concerns about the feasibility of this approach. 
Not only would timing this interchange during complicated visit schedules be challenging, but it 
would also be time-intensive for AYA social workers. Ultimately, we decided that AYA social worker 
time should be reserved for following up on needs identified in the assessment.  
Tentatively, we determined that nurse navigators might be the best equipped to drop off the 
assessment with AYAs and pick it up once complete. Each disease group has one or more nurse 
navigators who often see patients at the beginning and end of their appointments, providing the 
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perfect opportunity for dropping off and picking up a needs assessment. However, at NCCH, there 
are no nurse navigators in pediatric oncology; thus, a different approach would be needed in the 
pediatric oncology clinic.  
Interpretation of data. Regarding who would interpret needs assessment data and identify 
appropriate services and resources triggered, we discussed several approaches. We determined 
that, so long as referral pathways were explicitly laid out, AYA expertise was not a necessary 
qualification of the individual interpreting AYA NA-SB data. Thus, nurse navigators were identified as 
appropriate arbiters of this task. Nurse navigators are currently doing the work of care coordination 
and are deeply embedded in patients’ care teams; as such, assuming this task would be not be 
hugely disruptive to their workflow.  
Documentation of data. Ultimately, we determined that whoever is interpreting the data 
would document needs identified and referrals made in the EMR. Thus, if a nurse navigator is the 
one triaging services based on needs assessment responses, they would be the one to record this 
information in notes in the EMR. Service and resource providers will also document follow-up 
actions made to address reported needs.  
Service and resource providers. For follow-up domains 1 (information), 2 (cancer care team), 
and 3 (physical health), an AYAs’ oncology providers were identified as the appropriate points of 
contact. Workshop attendees felt that the close proximity of nurse navigators’ workspaces to 
oncology providers’ workspaces would facilitate this communication. For follow-up domains 4 
(emotional health), 6 (health behaviors & wellness), 7 (work & education), and 8 (peer support & 
programming), AYA social workers were identified as the appropriate points of contact. Follow-up 
domain 5 (sexual & reproductive health) was split in terms of point of contact. Concerns related to 
sexuality would be directed to AYA social workers; concerns related to reproductive health would be 
directed to NCCH’s Fertility Preservation Coordinator. For follow-up domain 9 (finances & everyday 
needs), outpatient social workers were identified as the appropriate points of contact.  
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Where should AYA NA-SB be delivered? 
In general, design team workshop attendees felt that the needs assessment should be 
“dropped off” with patients at the beginning of their clinical visit, allowing flexibility for them to 
complete the assessment as they had waiting time. In terms of where this takes place, design team 
members thought that some degree of variation should be tolerated. “It’s going to have to be a 
flexible deployment” to accommodate diversity in AYAs’ treatment and appointment schedules. 
Thus, the design team determined that nurse navigators would drop off and pick up needs 
assessments in the locations consistent with their current workflow, which vary by disease group 
and by patient.  
How should AYA NA-SB be delivered? 
Mode. Many of the workshop attendees liked the idea of offering AYAs the choice to complete 
the needs assessment electronically prior to appointments, for example, through MyChart or a mobile 
application. Workshop attendees also liked the idea of having AYAs complete the needs assessment 
on an iPad, in the clinic. For pilot testing, however, paper was deemed most feasible.  
Documentation of data. Workshop attendees expressed the importance of documenting 
needs assessment data to inform program changes. Eventually, design team workshop attendees 
agreed that the needs assessment should be built as a flowsheet into the EHR, to allow for easy 
tracking and running of reports. However, working with software vendors to build such changes into 
the EHR can take more than six months. Thus, we opted to use pilot testing as an opportunity to 
clearly outline changes that should be made in the EHR.  
For pilot testing, however, we determined that needs assessment data would be uploaded 
by research staff into a separate, secure database. Then, nurse navigators would only be responsible 
for recording as notes in the EHR details about needs identified and follow-up actions taken. This 
decision was based on concerns about nurse navigators having to upload or scan needs assessments 
into the EHR. This task was considered overly burdensome and minimally helpful given that you 
cannot query or run reports on scanned documents in the EHR.  
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Notification of service/resource providers. Workshop attendees determined that the nurse 












During the second design team workshop, we also discussed the future implementation of 
AYA NA-SB, anticipating barriers to implementation and brainstorming strategies to address those 
barriers. Figure 29 displays workshop attendees’ ranking of barriers to AYA NA-SB implementation. 
Table 20 describes the implementation determinants identified by the design team as most salient 
and the strategies deemed appropriate to address them. The first prioritized barrier was establishing 
AYA NA-SB’s interface with the EHR or other documentation method. Incorporating changes into the 
EHR can take upwards of six months. Ultimately, the design team determined that pilot testing 
would be used to establish a detailed blueprint for EHR modifications needed to fully integrate AYA 
NA-SB into the EHR. The second prioritized barrier was related to variation in AYAs’ treatment and 
appointment schedules. The design team worried that this variation would make it difficult to 
determine the appropriate timing and frequency of AYA NA-SB administration. To address this 
barrier, the design team determined that we would take a phased-in approach to implementation, 
for example, starting with one disease group and expanding outwards. The third prioritized barrier 
was related to the capacity of AYA social workers to respond to needs reported. A phased-in 
approach to implementation was also considered an appropriate strategy to ameliorate this 
challenge. Design team members also noted the importance of setting clear expectations with AYAs 
when AYA NA-SB is first introduced, communicating with them when they might expect follow-up to 
occur.  




Table 20. AYA NA-SB implementation 
Barrier Proposed Strategy for Addressing Barrier 
Establishing interface with EMR/ other 
documentation method  
Use pilot testing to establish a blueprint for EMR 
modifications needed  
Variation in AYAs’ treatment and appointment 
schedules  
During pilot testing, include three different arms 
with different intervals of administration: (1) 
every month, (2) every 3 months, and (3) with 
each significant change in clinical status 
Phase-in approach to implementation  
Capacity of AYA social workers to respond to 
needs  
Phase-in approach to implementation  
Set clear expectations about follow-up when AYA 
NA-SB is first introduced   
 
 
Identifying new AYAs. Another implementation issue discussed by the design team was how 
to identify new AYA patients. Currently, there is no systematic process for doing so; the AYA team 
relies on referrals from disease group providers. The design team determined that, in the future, a 
function in the EHR should flag all new AYA patients. In the meantime, however, the design team 
discussed several strategies for strengthening referral pathways (e.g., take a phased-in approach, 
identify point person in each disease group clinic, provider education). Because each disease group 
has their own workflow, mapping out that workflow and identifying relevant contacts in each 
disease group will be an important component of implementation.  
Other discussion  
Item wording. The design team decided to reframe item wording so that items ask about 
help wanted rather than help needed. One AYA said, “just because you have a need doesn’t mean 
you necessarily want help with it.” Another said, “I feel like sometimes it’s hard to reflect and be like, 
‘do I actually need help?’ Versus ‘do I want help’, it’s more accessible”. Providers agreed that this 
shift in wording was more aligned with the goals of AYA NA-SB.  
Because AYA NA-SB is intended to facilitate real-time service provision, the design team also decided 
to frame items in present tense rather than in past tense, deeming a specific lookback period (e.g., 
“in the past month”) unnecessary.   
Response scale. Design team members were opposed to collapsing response options into a 
binary (i.e., yes/no) scale. They argued that some level of gradation is needed to determine the 
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urgency of response, particularly in contexts with staffing and resource constraints. “Understanding 
if there are needs that can be met by somebody who doesn’t have as high level of knowledge as, for 
instance, a core AYA team might have, could be helpful on the implementation side.” Additionally, 
they were concerned that a binary response option would result in a lot of false positives, with 
needs being flagged where help is not wanted. However, they agree that the five-response scale was 
too cumbersome and advocated for its consolidation into three response options.  
One AYA member of the design team advocated for a “not sure” or “I don’t know” response 
option saying, “I don’t think we always know what we’re going to need. We don’t always know what 
questions to ask”. Design team members also advocated for free response opportunities for AYAs to 
indicate needs not covered by the needs assessment.  
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CHAPTER 6: DISCUSSION 
6.1 Discussion of Results  
AYA NA-SB 
By ensuring AYA NA-SB directly responded to features of users (i.e., AYAs, providers) and 
context (i.e., NCCH), we designed AYA NA-SB for implementation and minimized the need for post-
hoc implementation strategies to address misalignment that may have otherwise existed. 
Furthermore, we designed AYA NA-SB for scale-up; by engaging users from other AYA cancer 
programs across the country to identify points of contextual variation for which AYA NA-SB would 
require flexibility in delivery, we ensured that the tool we created was not overly tailored to one 
unique context.  
Our UCD process culminated in AYA NA-SB, a PROM-based care coordination intervention 
for AYAs with cancer, and guidance for its delivery and implementation (see Appendix I). The PROM 
component of the intervention is a 57-item needs assessment, divided into 9 follow-up domains. The 
PROM will be administered for the first time within one month of diagnosis by disease group nurse 
navigators at the beginning AYAs’ visits. Subsequent administrations will occur at 1-month or 3-
month intervals, depending on feedback received during pilot testing. During pilot testing, needs 
assessments will be administered on paper; in the future, iPads or other electronic formats will be 
used. Needs assessments will be collected by nurse navigators at the end of AYAs’ visits. Nurse 
navigators will then triage needs reported, notifying service and resource providers through EHR 
messaging or pager, using the referral pathways outlined.  They will record, as notes in the EHR, 
needs reported and follow-up actions and referrals made; service and resource providers will also 
document services and resources provided in their own separate EHR notes. During pilot testing, 
needs assessment data will be uploaded to a secure electronic database. Eventually, a flowsheet will 
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be built into the EHR to consolidate and streamline documentation. A phased-in approach to 
implementation will be taken, starting with one disease group and expanding outwards.  
UCD and implementation science 
To date, efforts to improve healthcare quality have focused on implementing EBPs as 
originally designed.195 A potential consequence of this emphasis on EBPs has been resistance to 
considering the implications of EBP design for implementation in practice. Implementation scientists 
often must facilitate the implementation of EBPs with features that clash with the diverse contexts 
to which they are scaled up. In response, implementation scientists turn to implementation 
strategies that can place undue burden on stakeholders in practice. In fact, the National Institutes of 
Health (NIH) defines implementation science as ““the scientific study of the use of strategies to 
adopt and integrate evidence-based health interventions into clinical and community settings”.196 In 
this study, we proposed that the pitfalls associated with ill-fitting EBPs and cumbersome 
implementation strategies may be avoided by placing equal emphasis on EBPs, the contexts in which 
they are to be implemented, and implementation strategies used. Just as embroidering requires 
compatible thread, fabric, and needle, implementation may be optimized by harmonizing EBP, 
context, and implementation strategies. Using UCD to attend equally to features of EBPs, context, 
and implementation strategies has the potential to limit the challenges associated with exceedingly 
complex EBPs and cumbersome implementation strategies that burden stakeholders.  
As demonstrated by this study, UCD can help implementation scientists to operationalize the 
field’s commitment to stakeholder engagement. For example, establishing a design team upfront 
ensured that users remained central throughout AYA NA-SB development and implementation 
planning. Design team members offered key insights to inform data collection (e.g., review of data 
collection instruments), data analysis (e.g., selection of concept mapping cluster map; prioritization 
of user and contextual requirements), and, ultimately, AYA NA-SB design (e.g., specification of AYA 
NA-SB content and delivery). Further, design team members proved critical to the recruitment of 
users for usability testing and ethnographic data collection efforts. UCD also offers methods for 
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translating stakeholder feedback into design decisions. For example, the use of personas and 
scenarios of use during our second workshop, allowed our design team to translate ethnographic 
data into AYA NA-SB design features, in a way that group discussion without such engagement 
methods might not have facilitated. Finally, UCD demands an active and iterative approach to 
stakeholder engagement, often with the same group of users reviewing prototypes at multiple time 
points; this type of iteration may be a key moderator in the relationship between stakeholder 
engagement and improved EBP design.193 This study demonstrates the feasibility of embedding 
extensive and iterative user engagement in EBP design. In terms of engaging AYAs specifically, this 
study offers key insights such as the broad willingness of AYAs to contribute to this kind of research 
and the viability of social media as a recruitment strategy for this population. The use of social media 
to recruit AYAs in this study builds on existing literature describing the high rates of social media 
usage among this population for seeking cancer-related information, and interaction with peers and 
providers.197 
Usability testing of PROMs 
In this study, usability testing elicited user concerns about the CNQ-YP’s usability and 
usefulness that may have stymied its uptake in real-world cancer care practice. Our user groups 
identified many key usability and usefulness concerns, allowing our design team to produce design 
solutions which directly addressed user needs and preferences. For example, through concept 
mapping, AYA providers pinpointed needs assessed by the CNQ-YP which, as originally written, could 
not be addressed with available services or resources (e.g., “having cancer treatment staff who could 
have a laugh with me”); assessing these needs for which services or resources were not available 
would have produced additional burden for users, without improving care. Through the survey and 
cognitive interviews, AYAs identified important, actionable missing content (e.g., AYA sexual health), 
and other areas in which the CNQ-YP’s content, length, wording, and response format were 
unacceptable. Of key importance to this study was considering PROM usefulness, or actionability in 
terms of service provision. Extant PROM literature suggests a limited consideration of usefulness in 
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PROM research and implementation.82,104 However, the mere assessment of needs is not enough to 
influence patient outcomes if patient information is not subsequently used. As such, we prioritized 
usefulness in AYA NA-SB development, forging an explicit connection between PROM information 
and service delivery and outlining care processes required to deliver appropriate follow-up actions 
to AYAs. Concept mapping provided valuable source data to help the design team in forging this 
connection between needs and services in a systematic way. The use of ‘cluster comparison 
worksheets’ during the first workshop allowed design team members to easily digest concept 
mapping data, which can be difficult for stakeholders to interpret without a visual aid, and select a 
cluster solution which best grouped needs based on services or resources they should trigger.  
Ultimately, by identifying and addressing usability and usefulness concerns upfront, we developed a 
tool that is perceived as more feasible, acceptable, and appropriate to those who will use it in 
practice.     
Ethnography to understand context   
Because intervention characteristics like usability and usefulness cannot be considered in a 
vacuum, I leveraged UCD methods to describe both AYA NA-SB’s specific implementation context 
(i.e., NCCH) as well as the broader context to which it may be scaled up in the future (i.e., other AYA 
cancer care programs in the United States). To explore context, UCD offers frameworks, such as 
Maguire’s context-of-use framework used in this case example, as well as questionnaires (e.g., 
System Usability Scale 134), and a menu of methods (e.g., ethnography, diary keeping, user surveys, 
etc.) 132 which are compatible with those used by implementation scientists in the assessment of 
barriers to and facilitators of implementation. Although there may be some overlap in UCD and 
implementation science methods, UCD tends to go a step further than traditional 
barriers/facilitators assessment by embedding users more deeply in the process. In this study, I used 
ethnography, an underused method in health services research,172 to obtain a detailed 
understanding of users and context. Guided tours, for example, elicited rich details about users and 
context. However, it is important to note that the immersive experience of guided tours was, at 
 
177 
times, difficult. During these tours, I found myself present for deeply sensitive and emotionally 
charged conversations. For example, I witnessed an oncologist delivery a terminal prognosis to an 
unsuspecting 22-year-old AYA. I quickly removed myself from the room to offer the AYA and her 
loved one some privacy. Still, though, I felt that I had intruded on a profoundly private moment. The 
interchange weighed on me heavily. As researchers, we may not be accustomed to navigating some 
of the difficult conversations that cancer care providers come up against daily. Taking an 
ethnographic approach can bring us face-to-face with the hardships and tragedies faced by the 
populations we study. In this sense, ethnography demands sensitivity, compassion, and a willingness 
to connect with others on a deeply human level.  
For the ethnographic portion of this study, I leveraged Maguire’s framework for contextual 
inquiry, which helped us to consider the array of user and contextual factors which might impact 
AYA NA-SB’s usability or usefulness in practice. To make my summary of ethnography results more 
digestible to an implementation science audience, I embedded constructs from Maguire’s 
framework into CFIR domains. In some cases, incongruence between the two frameworks made this 
integration challenging. For example, while Maguire’s framework delves deeply into patient 
characteristics through many constructs, CFIR lumps these concepts into one construct in its “outer 
setting” domain. Ultimately, though, this combined use of frameworks allowed us to anchor our rich 
account of users and context to its implications for AYA NA-SB implementation. Additionally, I went 
further than traditional barriers/facilitators assessments by engaging users in analysis to co-create 
an understanding of context. Our multidisciplinary design team reviewed ethnography findings to 
ensure that the user interpretation of context remained central, as opposed to relying solely on the 
researcher’s interpretation of contextual data. UCD also provides methods for translating user and 
contextual factors into user and contextual requirements—i.e., usability and usefulness 
determinants. 132 Translating contextual factors into contextual requirements using UCD 
requirements engineering approaches (e.g., the translation tables, ‘personas’, and ‘scenarios-of-use’ 
used in this case example) could help implementation scientists prioritize implementation 
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determinants by focusing attention on the subset of contextual factors that influence EBP usability 
and usefulness.122 In this study, the ethnography provided valuable source data for workshop 
materials, helping us to leverage the expertise of the design team to identify these usability 
determinants and prioritize contextual features to target with EBP redesign, context preparation, or 
implementation strategies. During the second design team workshop, I presented several alternative 
scenarios of use, or simple descriptions of plausible user interactions with AYA NA-SB, to inform the 
specification of AYA NA-B delivery (i.e., who should administer the needs assessment; when; where; 
how; how often). These scenarios provide user- and task-oriented information about the context in 
which an EBP has to operate,198 and also offer concrete examples for design team members to react 
to. For example, scenarios helped our design team walk through different patient visit types (e.g., 
just infusion versus infusion + clinical visit) to ensure that design decisions about staffing and timing 
for PROM administration suited the range of potential AYA appointments. Likewise, presenting 
multiple personas, or hypothetical archetypes of actual users, to the design team helped them to 
envision the range of users that AYA NA-SB design features should support. For example, based on 
ethnography data pointing to key differences between patients receiving care in pediatric versus 
adult oncology, I developed personas to represent these user differences. Presenting these 
personas- complete with fake names and images- to the design team, allowed us to consider both 
user groups in AYA NA-SB design, ultimately ensuring that the tool met the needs of users receiving 
care in both pediatric and adult oncology.  
Implementation strategies  
Where EBP and context diverge, we can use UCD to tailor strategies which make EBP and 
context more amenable to each other. Through the UCD process employed in this case example, we 
were able to anticipate areas where AYA NA-SB provision may clash with user or contextual 
requirements, some of which could not be addressed by tweaking EBP design or preparing context. 
For example, AYA NA-SB – a tool that spans across multiple domains of care – will require the 
cooperation of multiple departments and disciplines at NCCH; although engaging users in its 
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development likely generated some buy-in, additional implementation strategies targeting cross-
department buy-in will likely be required (e.g., provider education; identifying AYA champions within 
each department). As we move towards implementing AYA NA-SB, such remaining gaps in EBP-
context fit will inform the selection of implementation strategies to promote its uptake at NCCH. For 
example, in preparations for a pilot study, the design team might refer back to user and contextual 
requirements and collaboratively select implementation strategies to address outstanding areas of 
EBP-context misfit. Moreover, this project’s use of UCD to enhance the usability and usefulness of 
AYA NA-SB likely reduced the number of post hoc implementation strategies needed to embed the 
tool in routine care; minimizing the brute force necessary to implement AYA NA-SB will minimize the 
burden placed on implementing organizations and providers. Leveraging UCD to identify user and 
contextual requirements and tailor implementation strategies accordingly addresses an articulated 
need in the field 123,199 and complements approaches for selecting and tailoring strategies that have 
recently been proposed in the implementation science literature (e.g., concept mapping, conjoint 
analysis, intervention mapping). 122 Future work will assess the extent to which UCD minimizes the 
need for complex implementation strategies or, when needed, aids in the selection or design of 
strategies that are contextually appropriate and minimally burdensome to users. We applied a UCD 
approach towards designing a needs assessment; future work will also assess the merits of UCD for 
refining and implementing more complex, multicomponent interventions.  
AYA needs  
This study illuminated the arduous work of being an AYA with cancer. Upon receiving a 
cancer diagnosis, AYAs found themselves responsible for juggling extensive appointment schedules 
and navigating complex health care systems, all while managing myriad symptoms and side effects. 
Moreover, they managed their cancer treatment in the context of busy lives including work or school 
demands, raising children, and navigating changing relationships with family members, partners, and 
friends. In doing all of this, AYAs were exhausted. It was apparent that any intervention for this 
population should be folded into the work they are currently doing, rather than adding more to their 
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already overflowing task loads. Guided tours also shed light on the role of partners and family 
members in AYAs’ cancer care, something that has been documented in previous qualitative 
studies.200 AYAs’ loved ones tracked their appointment schedules, accompanied AYAs to their 
appointments, and offered unyielding moral support. They were knowledgeable about AYAs’ 
diagnoses and treatment plans and relentlessly advocated on AYAs’ behalves. Loved ones paused 
their normal routines to support AYAs, missing work and forgoing other obligations to help AYAs 
manage the physical and emotional demands of cancer treatment.  
Echoing extant literature on AYA needs,1-5 AYAs in this study reported many diverse needs 
during and after cancer treatment. Based on survey results, Black AYAs may experience even more 
needs than their White counterparts, a disparity documented in existing literature.1 Additionally, 
uninsured AYAs may experience greater need. This is problematic given that greater than 25% of 
AYAs are uninsured for some period of time in the 35 months after diagnosis.201 Such disparities 
should be considered in developing and implementing interventions for AYAs with cancer. Certain 
cancer types may also increase the concentration of needs experienced by AYAs. In the AYA survey, 
non-Hodgkin lymphoma was associated with a higher burden of unmet of needs, while breast cancer 
was associated with having fewer unmet needs. Interestingly, in the survey, reporting greater need 
was associated with higher ratings of the CNQ-YP’s actionability; this suggests that AYAs with high 
needs may be even more amenable to service and resource provision through AYA NA-SB.  
Although AYA guided tour participants were pleased with their oncology providers’ handing 
of their medical needs, they desired more discussion of non-medical needs during these visits. This 
parallels a study by Pannier et al. which found that the most frequently requested resource by AYAs 
was the provision of information on non-medical concerns.180  Guided tour participants felt like it 
was on them to initiate conversations with their providers about non-medical needs, something they 
did not always have the awareness or capacity to do. AYA NA-SB has the potential to initiate 
important conversations about non-medical needs, by alerting providers to the individual needs of 
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each AYA and triggering conversations about the full range of needs that AYAs experience during 
treatment.  
During guided tours, financial needs were a major topic of conversation, echoing existing 
accounts of the unique financial burden faced by AYAs with cancer.202 The financial hardships 
incurred by a cancer diagnosis extended beyond just medical bills. While undergoing treatment, 
AYAs struggled to shoulder the costs of transportation to and from appointments, parking at NCCH, 
and childcare. For those unable to work, the financial ramifications of cancer extended across all 
domains of life. However, those who could work often found themselves ineligible for financial 
assistance programs, placing them in a grey area where they could not afford their medical and 
living expenses but did not qualify for financial support resources. Importantly, the economic burden 
of cancer endures even after treatment ends and may disproportionately impact AYAs. One study 
found that, compared to older adult survivors of cancer, AYA survivors had excess annual medical 
expenditures of $3,170 per person and excess annual productivity losses of $2,250 per person.203 
This suggests the importance of continuing to monitor financial needs during survivorship. 
Interestingly, the CNQ-YP in its original form, does not address financial needs. By engaging users to 
review and refine the PROM, we identified such important gaps in content. The result is a PROM that 
more comprehensively captures important need such as financial burden.   
AYA services and resources  
NCCH is a comprehensive cancer center housed in a large academic medical center. As such, 
there is a high volume of services and resources available to NCCH patients. An environmental scan 
revealed a holistic suite of available services ranging from psychosocial care, to physical and 
occupational therapy, to fertility counseling, to financial navigation and assistance, among others. 
Available services and resources were particularly robust in pediatric oncology, where tutors, child 
life specialists, and other ancillary professionals were readily available to patients. In smaller, rural, 
or more resource-constrained hospitals, there may not be services and resources available to 
address the full scope of needs captured in the AYA NA-SB PROM. Such settings may consider pairing 
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the AYA NA-SB down to address the subset of needs that are actionable at their institution. Ideally, 
though, AYA NA-SB could be used in these settings to identify areas for program development, or 
areas in which partnerships or referral networks should be forged with local organizations to fill in 
gaps in service and resource capacity.  
Of note, five out of the nine follow-up domains in AYA NA-SB trigger follow-up by AYA social 
workers or other clinicians with AYA expertise. The role of these clinicians includes a secondary 
triaging of AYAs’ needs. For example, at NCCH, PROM items related to issues navigating work and 
school will trigger an AYA social worker visit. This AYA social worker will then explore the AYAs’ 
reported needs in more depth and connect them to appropriate services and resources (e.g., 
scholarship programs, loan repayment assistance, tutors). For smaller hospitals that do not have 
AYA-dedicated staff, filling this secondary triaging role may prove difficult. The extent to which social 
workers without AYA expertise can fill this role remains to be seen.  
Despite the high volume of services and resources at NCCH, which undoubtedly exceeds that 
of smaller, more resource-constrained hospitals, AYAs’ use of services was confined to only a small 
subset of what is available. A key barrier to AYAs’ use of services and resources was awareness. “You 
don’t know what you don’t know.” However, even once connected to services and resources, AYAs 
reported many barriers to using them including competing priorities, appointment fatigue, strict 
eligibility requirements, service capacity and timeliness, and concerns about the applicability of 
services and resources to their own unique needs. Previous studies have pointed to other 
downstream barriers to AYAs’ use of services and resources, such as living in a rural area or living a 
longer distance from the hospital.204 Although AYA NA-SB addresses key barriers to connecting AYAs 
to services and resources, it does not address many of these downstream barriers to service and 
resource use. Additional strategies may be required to remove outstanding barriers to AYAs’ use of 
services and resources.  
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AYA programs  
Cancer care is, by nature, complex, requiring coordination across multiple disciplines and 
departments within complex cancer care organizations. The complexity of care coordination is 
further heightened for AYAs, who span across disease groups and often occupy a “no-man’s land” 
between pediatric and adult oncology. This study illuminated a stark contrast between pediatric and 
adult oncology and pointed to the potential implications of receiving care in one setting versus the 
other. In pediatric oncology, staffing is robust and services and resources are concentrated to one 
physical space, facilitating easy communication among providers and more seamless integration of 
ancillary services into AYAs’ treatment. Because of these differences, designing AYA NA-SB to 
accommodate both pediatric and adult oncology represented a challenge for the design team. 
Ultimately, to account for heterogeneity across clinics, the design team opted for a phased-in 
approach to implementation, starting in one clinic and expanding outwards.   
The AYA program at NCCH is relatively new and still grappling with the question of how to 
coordinate care without a “home” in terms of physical space for AYAs who are receiving care in 
disparate locations across the hospital. The development of a new, AYA-specific infusion space 
represents an exciting development for NCCH’s AYA program. Still though, developing AYA 
programming such that it accommodates existing workflows is no small task. The mere identification 
of new AYA patients is challenging. Furthermore, cancer treatment schedules are varied and 
complex, making it impossible to conceptualize AYAs’ interactions with the healthcare system in any 
singular way. In this context, intervention delivery and implementation pose a major challenge. 
Embedding an intervention within the complex labyrinth of AYA cancer care requires first unraveling 
that labyrinth to identify portions of the fabric amenable to new threads.  
In this study, I leveraged ethnographic contextual inquiry to elucidate the complexities of 
AYA cancer care. This yielded insights on several key leverage points for AYA NA-SB delivery and 
implementation. For example, AYA guided tour participants pointed to several timepoints during 
which their appointments required extended periods of waiting. Embedding AYA NA-SB 
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administration into these waiting times will alleviate some of the burden of PROM completion. 
Building on existing communication channels among patients and providers will minimize the burden 
associated with AYA NA-SB delivery. Leveraging the expertise of providers who are currently doing 
the work of needs assessment, although informally, will minimize workflow interruptions and the 
need for additional staffing. Finally, engaging various provider groups in AYA NA-SB development 
likely increased awareness of and buy-in for AYA NA-SB among those who will interface with the 
intervention in practice.  
AYA-specific cancer care programs have emerged within cancer centers across the country 
to address the challenge of coordinating services to meet the unique needs of AYAs. However, there 
is broad variation in the structure, staffing, and functions of these programs. As such, other AYA 
programs will likely need to tailor AYA NA-SB to their own unique context. To do so, they might 
consider using elements of the UCD process we employed in AYA NA-SB development (e.g., user 
testing, design team collaboration). However, because we tried to design AYA NA-SB to 
accommodate multiple contexts, it is unlikely that other programs will need to engage in an 
extensive UCD process like the one we used.  
Some AYA programs have implemented, or are in the process of implementing, 
interventions to assess the needs of their AYA patients. During semi-structured interviews, providers 
from these programs spoke to the challenges of delivering this kind of intervention. One challenge 
discussed at length was the electronic integration of these tools. Faced with back-logged EHR 
requests and disparate documentation processes across disease groups or departments, AYA 
programs were often using paper assessments paired with patchwork approaches for retrospectively 
documenting AYAs’ needs and follow-up actions taken. Providers spoke to their desire to deploy 
tools electronically and achieve more systematic and traceable documentation systems. This issue of 
electronic integration represents a major organizational barrier to PROM implementation 
demonstrated in the literature;205 addressing this barrier will require changes to existing 
documentation practices as well as collaboration with software vendors to embed the necessary 
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changes into the EHR. PROM technology systems should be easy for providers to use and should 
enable quick access to PROM results for use at point-of-care, if needed.205 In addition to discussing 
challenges to implementation, providers also offered lessons learned and recommended 
implementation strategies. For example, they described the importance of identifying AYA 
champions in each disease group, leveraging existing communication channels, and employing a 
phased-in approach to implementation. Existing PROM literature suggests the importance of 
establishing clinic teams to develop tailored implementation strategies that address the unique 
individual and organizational barriers at a given clinic.205 Both UCD and implementation science offer 
theories, frameworks, and process models that can help guide and evaluate these efforts.  
6.2 Limitations 
Although I tried to engage users from across the country to increase generalizability, much 
of the tool’s development did occur at NCCH, a large academic medical center in a relatively 
metropolitan area. Many non-NCCH users engaged also worked in comprehensive cancer centers 
(e.g., 73% of concept mapping participants). Key contacts, with whom semi-structured interviews 
were conducted, worked primarily in AYA programs; the ability to establish AYA-specific programs 
reflects the availability of institutional resources which many cancer programs do not have. It is 
important to note that the majority of AYAs do not receive care in institutions like NCCH but, rather, 
in smaller community hospitals. As AYA NA-SB undergoes further testing in the future, it will be 
important to ensure that a range of cancer care settings are engaged, such as small or rural 
community-based hospitals which may face bigger limitations than NCCH in terms of resources and 
capacity for implementing an intervention like AYA NA-SB.  
For logistical reasons, AYAs ages 15 through 17 were not included in data collection activities 
for this study. However, I engaged AYAs from both pediatric and adult oncology to capture key 
differences between these two contexts. Future research will explore the acceptability and 
appropriateness of the revised PROM to adolescents.  
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During this study, the design team was unable to finalize certain aspects of AYA NA-SB 
delivery (e.g., frequency of PROM administration). Future pilot testing will inform the specification of 
these elements of delivery. Additionally, although the needs assessment itself underwent iterative 
refinement, the process for delivering AYA NA-SB did not. Although user data informed the design 
team’s specification of AYA NA-SB delivery during the second workshop, future user testing is 
needed to refine this process and solidify the referral pathways triggered by each needs assessment 
follow-up domain.  
6.3 Future Directions  
Future testing of AYA NA-SB will inform its subsequent refinement and scale-up. The first 
step will be to conduct a small feasibility pilot test of AYA NA-SB, with a primary focus on 
implementation outcomes. Other objectives of this pilot study include (1) specifying outstanding 
aspects of AYA NA-SB delivery (e.g., frequency of PROM administration), (2) solidifying the process 
for following up on PROM-identified needs (e.g., determining the timeframe in which follow-up 
should occur and the process for ensuring that needs were followed up on), and (3) making other 
necessary refinements to AYA NA-SB to facilitate its acceptability, feasibility, and appropriateness in 
practice. Psychometric testing will also be conducted to assess the validity and reliability of the 
revised PROM. Should AYA NA-SB prove feasible, acceptable, and appropriate to implement, I will 
conduct broader testing of the intervention across multiple sites, including community-based 
hospitals.   
Just as embroidery requires the alignment of thread, fabric, and needle, EBP implementation 
and sustainment requires harmonizing EBP, context, and implementation strategies. The importance 
of each of these has been acknowledged; however, methods for understanding the dynamic 
interplay among them and optimizing each with respect to the other two are lacking. UCD offers 
methods and approaches for achieving this which warrant consideration by implementation 
scientists. Future research should explore the utility of collaborating with UCD experts or embedding 
UCD approaches in implementation research. In particular, I argue that UCD’s potential for 
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promoting harmonization among EBP, context, and implementation should be tested empirically. To 
the extent that UCD helps facilitate this harmonization, it will advance us towards the overarching 
goal of the field which is to bridge the gap between research and practice. 
6.4 Conclusions  
Implementing change in dynamic healthcare settings is a complex endeavor; understanding 
the nuances of implementation undoubtedly requires a multimodal, multidisciplinary purview. To 
this end, implementation scientists have borrowed knowledge and approaches from systems 
science, 206,207 organizational studies, 208 cultural adaptation, 209 community-based participatory 
research, 210 behavioral psychology, 211 and quality improvement, 212 just to name a few. I argue that 
UCD can join the list of approaches available to implementation scientists. This may first require 
investigation of where UCD and implementation science converge and diverge. Fortunately, efforts 
to this effect are currently underway.213 While points of divergence may represent barriers to 
integration of the two fields, they may also represent important new insights and approaches for 
implementation scientists to consider.  
I leveraged UCD to develop an AYA needs assessment and care coordination intervention 
with high usability and usefulness. The result, AYA NA-SB, has the potential to improve care 
coordination at the individual level by allowing cancer care programs to tailor service delivery and 
resource provision to the individual needs of AYAs they serve. Additionally, AYA NA-SB addresses a 
critical measurement gap. In the past decade, AYA-specific programs have emerged at cancer 
centers across the country to better coordinate cancer care for AYAs,18 but the impact of these 
programs has been largely unstudied to date.24 In large part, the lack of evidence on AYA-specific 
programs is due to a lack of patient-centered metrics.25,26 By eliciting patient-reported data on 
unmet needs at multiple timepoints during AYAs’ treatment, AYA NA-SB will generate such patient-
centered metrics to assess the effectiveness of AYA-specific programs in addressing AYAs’ unmet 
needs as they emerge. Furthermore, AYA NA-SB will yield critical patient-reported data to inform the   
 
188 
structure and functions of AYA-specific cancer programs as they emerge around the country.20,27 In 
sum, by harnessing patient-reported data to facilitate the coordination of care for AYAs, AYA NA-SB 
has the potential to improve processes of care and subsequent outcomes for AYAs, an underserved 





APPENDIX A: CNQ-YP (ORIGINAL) 
The following questions ask about any needs you may have had at any time since your cancer 
diagnosis. 
 
1. Treatment Environment and Care 
I had the following needs… 
BEFORE TREATMENT 









1 about my diagnosis ○ ○ ○ ○ ○ 
2 
what might happen during 
treatment  ○ ○ ○ ○ ○ 
3 
whether I had the option to decline 
treatment ○ ○ ○ ○ ○ 
4 
about the short term side-effects of 
treatment ○ ○ ○ ○ ○ 
5 
about the long term side-effects of 
treatment ○ ○ ○ ○ ○ 
6 my chances of a full recovery ○ ○ ○ ○ ○ 
7 
what would happen when 
treatment finished ○ ○ ○ ○ ○ 
8 
whether I would be able to have 
children ○ ○ ○ ○ ○ 
DURING TREATMENT 









9 whether my treatment was working ○ ○ ○ ○ ○ 
10 my test results as soon as possible ○ ○ ○ ○ ○ 
11 the way I felt was normal ○ ○ ○ ○ ○ 









12 have time to myself ○ ○ ○ ○ ○ 
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I had the following needs… 
AFTER TREATMENT 









13 how to manage my medication ○ ○ ○ ○ ○ 
14 what I could do to stay healthy ○ ○ ○ ○ ○ 
15 
what to do if I noticed a particular 
side-effect ○ ○ ○ ○ ○ 
THROUGHOUT TREATMENT 
Having cancer treatment staff 
who: 









16 listened to my concerns ○ ○ ○ ○ ○ 
17 treated me as an individual ○ ○ ○ ○ ○ 
18 were respectful ○ ○ ○ ○ ○ 
19 were approachable ○ ○ ○ ○ ○ 
20 were friendly ○ ○ ○ ○ ○ 
21 could have a laugh with me ○ ○ ○ ○ ○ 
22 explained what they were doing ○ ○ ○ ○ ○ 
23 
spoke to me in a way that I could 
understand ○ ○ ○ ○ ○ 
24 let me talk about my feelings ○ ○ ○ ○ ○ 
25 let me ask questions ○ ○ ○ ○ ○ 
26 
let me make decisions about my 
treatment ○ ○ ○ ○ ○ 
27 
talked to me in private, without my 





I had the following needs… 
AT THE CANCER TREATMENT CENTRE 









28 privacy  ○ ○ ○ ○ ○ 
29 pleasant surroundings  ○ ○ ○ ○ ○ 
30 good food ○ ○ ○ ○ ○ 
31 a choice of cancer specialists  ○ ○ ○ ○ ○ 
32 
the same cancer treatment staff 
throughout treatment ○ ○ ○ ○ ○ 
33 a choice of times for appointments ○ ○ ○ ○ ○ 
 
Since my cancer diagnosis, I have had problems enrolling at: (please choose as many as apply) 
S1 ○ school 
○ TAFE  
○ university/college 
○ other place of study (please 
write)_____________________________________________ 
○ none of the above 
Since my cancer diagnosis, I have attended: (please choose as many as apply) 
S2 ○ school 
○ TAFE  
○ university/college 
○ other place of study (please 
write)_____________________________________________ 
○ none of the above (go to Question S3) 
I had the following needs… 
WHEN STUDYING 














consideration ○ ○ ○ ○ ○ 
36 
get guidance about study options 
or future career paths ○ ○ ○ ○ ○ 
 
3. Work 
Since my cancer diagnosis, I have had problems finding work: (please choose as many as apply) 
S3 ○ full-time 
○ part-time/casual 
○ unpaid voluntary work 
○ other type of work (please 
write)______________________________________________ 
○ none of the above 
Since my cancer diagnosis, I have been employed: (please choose as many as apply) 
S4 ○ full-time 
○ part-time/casual 
○ unpaid voluntary work 
○ other type of work (please 
write)______________________________________________ 
○ none of the above (go to Question 40) 
I had the following needs… 
WHEN EMPLOYED 









37 how much work I would miss ○ ○ ○ ○ ○ 
38 
how to ask managers/co-workers for 
support ○ ○ ○ ○ ○ 
39 
that  managers/co-workers had 
support to help them cope with my 
situation 




4. Information and Activities 
I had the following needs… 
DURING TREATMENT 










spend time with people my own 
age ○ ○ ○ ○ ○ 
41 
talk to people my age who had been 
through a similar experience ○ ○ ○ ○ ○ 
AT THE CANCER TREATMENT CENTRE 









42 leisure spaces and activities ○ ○ ○ ○ ○ 
SINCE MY CANCER DIAGNOSIS 









43 was specifically designed for me ○ ○ ○ ○ ○ 
44 described relaxation techniques ○ ○ ○ ○ ○ 
 
5. Feelings and Relationships 
I had the following needs… 
IN THE LAST MONTH  









45 frustrated ○ ○ ○ ○ ○ 
46 anxious or nervous ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









The next group of questions ask about any needs you may have had in the last month.  
We realise that your needs may have changed during different stages of your cancer experience. 
Please only tell us about needs you have had in the last month. If you have not had any needs in 
the last month, please select ‘No Need’.  
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47 my cancer spreading ○ ○ ○ ○ ○ 
48 my cancer returning ○ ○ ○ ○ ○ 
49 
whether my cancer treatment has 
worked ○ ○ ○ ○ ○ 
50 having cancer treatment ○ ○ ○ ○ ○ 
51 how my family is coping ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









52 inner strength ○ ○ ○ ○ ○ 
IN THE LAST MONTH 











53 accept my diagnosis ○ ○ ○ ○ ○ 
54 be independent ○ ○ ○ ○ ○ 
 
S5 Do you have:  (please choose as many as apply) 
○ a spouse/partner or boyfriend/girlfriend (please answer Question 55)  
○ sibling/s or step-brothers/sisters (please answer Questions 56-58)  
○ none of the above (go to Question 59) 
 
I had the following needs… 













changes in my relationship with my 
partner ○ ○ ○ ○ ○ 













changes in my relationships with 
my sibling/s ○ ○ ○ ○ ○ 
IN THE LAST MONTH  
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57 ask my sibling/s for support ○ ○ ○ ○ ○ 
58 give support to my sibling/s ○ ○ ○ ○ ○ 
 
6. Daily Life 
I had the following needs… 
IN THE LAST MONTH  










make plans or think about the 
future ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









60 changes in my physical ability ○ ○ ○ ○ ○ 
61 changes in my appearance ○ ○ ○ ○ ○ 
62 
not being able to do the same 
things as other people my age ○ ○ ○ ○ ○ 
63 my parent/s being overprotective ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









64 pain ○ ○ ○ ○ ○ 
65 medication ○ ○ ○ ○ ○ 
66 physical side effects of treatment ○ ○ ○ ○ ○ 
67 feeling tired ○ ○ ○ ○ ○ 
68 loss of mobility ○ ○ ○ ○ ○ 
69 to take part in social activities ○ ○ ○ ○ ○ 
70 to travel to social events ○ ○ ○ ○ ○ 
YOU HAVE NOW COMPLETED THE SURVEY 
THANK YOU FOR YOUR TIME AND HELP  
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APPENDIX B: AYA SURVEY 
Section 1: Demographics 







g) A gender not listed ___________ 
2. How old are you? 
a) Scroll bar 18-30 
3. How long has it been since you were diagnosed with cancer? 
a) Less than 3 months 
b) Between 3 and 6 months 
c) Between 7 and 12 months 
d) Greater than 12 months 
4. Are you currently in active treatment? 
a) Yes 
b) No 
5. Please select the type of cancer you were diagnosed with from the list below. 
a) Non-Hodgkin Lymphoma 




f) Other female reproductive 






m) Other (please indicate): ________ 





7. With which racial/ethnic group do you most identify? 
a) Hispanic (all races) 
b) Non-Hispanic American Indian/ Alaska Native 
c) Non-Hispanic Asian or Pacific Islander  
d) Non-Hispanic Black 
e) Non-Hispanic White 
f) Other/unknown 
8. Who do you live with? Check all that apply.  
a) Parent(s) 
b) Spouse 




e) Roommate(s) (not parent, spouse, or child) 
f) I live alone 
g) Other  
9. What is your education level? 
a) Less than high school diploma 
b) Completed high school 
c) Some college/vocational training 
d) Associate degree 
e) College graduate  
f) Graduate degree or some post-graduate education 
10. What is your insurance source? 
a) Self-pay 
b) No insurance 
c) Employer/school 






Section 2 : CNQ-YP 
We are now going to ask you to complete a survey tool that was developed in Australia to assess the 
needs of young adults with cancer, called the Cancer Needs Questionnaire- Young People (CNQ-
YP).   
 
As you complete the CNQ-YP, imagine that your doctor has asked you to complete this survey either 
during or before an appointment with them, as part of your clinical care. After you have completed 
the CNQ-YP, we will ask you just a few more questions about what you thought about it. 
No Need  All my needs were met for this issue or this was not a problem 
for me. 
Low Need  I needed a low amount of help with this problem but was not 
able to get it. 
Moderate Need  I needed a moderate amount of help with this problem but was 
not able to get it. 
High Need   I needed a high amount of help with this problem but was not 
able to get it. 
Very High Need I needed a very high amount of help with this problem but was 




1. Treatment Environment and Care 
I had the following needs… 
BEFORE TREATMENT 









1 about my diagnosis ○ ○ ○ ○ ○ 
2 what might happen during treatment  ○ ○ ○ ○ ○ 
3 
whether I had the option to decline 
treatment ○ ○ ○ ○ ○ 
4 
about the short term side-effects of 
treatment ○ ○ ○ ○ ○ 
5 
about the long term side-effects of 
treatment ○ ○ ○ ○ ○ 
6 my chances of a full recovery ○ ○ ○ ○ ○ 
7 
what would happen when treatment 
finished ○ ○ ○ ○ ○ 
8 
whether I would be able to have 
children ○ ○ ○ ○ ○ 
DURING TREATMENT 









9 whether my treatment was working ○ ○ ○ ○ ○ 
10 my test results as soon as possible ○ ○ ○ ○ ○ 
11 the way I felt was normal ○ ○ ○ ○ ○ 









12 have time to myself ○ ○ ○ ○ ○ 




I had the following needs… 
AFTER TREATMENT 









13 how to manage my medication ○ ○ ○ ○ ○ 
14 what I could do to stay healthy ○ ○ ○ ○ ○ 
15 
what to do if I noticed a particular 
side-effect ○ ○ ○ ○ ○ 
THROUGHOUT TREATMENT 









16 listened to my concerns ○ ○ ○ ○ ○ 
17 treated me as an individual ○ ○ ○ ○ ○ 
18 were respectful ○ ○ ○ ○ ○ 
19 were approachable ○ ○ ○ ○ ○ 
20 were friendly ○ ○ ○ ○ ○ 
21 could have a laugh with me ○ ○ ○ ○ ○ 
22 explained what they were doing ○ ○ ○ ○ ○ 
23 
spoke to me in a way that I could 
understand ○ ○ ○ ○ ○ 
24 let me talk about my feelings ○ ○ ○ ○ ○ 
25 let me ask questions ○ ○ ○ ○ ○ 
26 
let me make decisions about my 
treatment ○ ○ ○ ○ ○ 
27 
talked to me in private, without my 




I had the following needs… 
AT THE CANCER TREATMENT CENTRE 









28 privacy  ○ ○ ○ ○ ○ 
29 pleasant surroundings  ○ ○ ○ ○ ○ 
30 good food ○ ○ ○ ○ ○ 
31 a choice of cancer specialists  ○ ○ ○ ○ ○ 
32 
the same cancer treatment staff 
throughout treatment ○ ○ ○ ○ ○ 
33 a choice of times for appointments ○ ○ ○ ○ ○ 
 
2. Education 
Since my cancer diagnosis, I have had problems enrolling at: (please choose as many as apply) 
S1 ○ school 
○ TAFE  
○ university/college 
○ other place of study (please write)_____________________________________________ 
○ none of the above 
Since my cancer diagnosis, I have attended: (please choose as many as apply) 
S2 ○ school 
○ TAFE  
○ university/college 
○ other place of study (please write)_____________________________________________ 
○ none of the above (go to Question S3) 
I had the following needs… 
WHEN STUDYING 











34 attend classes ○ ○ ○ ○ ○ 
35 get extensions/special consideration ○ ○ ○ ○ ○ 
36 
get guidance about study options or 
future career paths ○ ○ ○ ○ ○ 
 
3. Work 
Since my cancer diagnosis, I have had problems finding work: (please choose as many as apply) 
S3 ○ full-time 
○ part-time/casual 
○ unpaid voluntary work 
○ other type of work (please write)______________________________________________ 
○ none of the above 
Since my cancer diagnosis, I have been employed: (please choose as many as apply) 
S4 ○ full-time 
○ part-time/casual 
○ unpaid voluntary work 
○ other type of work (please write)______________________________________________ 
○ none of the above (go to Question 40) 
I had the following needs… 
WHEN EMPLOYED 









37 how much work I would miss ○ ○ ○ ○ ○ 
38 
how to ask managers/co-workers for 
support ○ ○ ○ ○ ○ 
39 
that  managers/co-workers had 
support to help them cope with my 
situation 




4. Information and Activities 
I had the following needs… 
DURING TREATMENT 









40 spend time with people my own age ○ ○ ○ ○ ○ 
41 
talk to people my age who had been 
through a similar experience ○ ○ ○ ○ ○ 
AT THE CANCER TREATMENT CENTRE 









42 leisure spaces and activities ○ ○ ○ ○ ○ 
SINCE MY CANCER DIAGNOSIS 









43 was specifically designed for me ○ ○ ○ ○ ○ 
44 described relaxation techniques ○ ○ ○ ○ ○ 
The next group of questions ask about any needs you may have had in the last month.  
We realise that your needs may have changed during different stages of your cancer experience. 
Please only tell us about needs you have had in the last month. If you have not had any needs in the 
last month, please select ‘No Need’.  
 
5. Feelings and Relationships 
I had the following needs… 
IN THE LAST MONTH  









45 frustrated ○ ○ ○ ○ ○ 
46 anxious or nervous ○ ○ ○ ○ ○ 
IN THE LAST MONTH 
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47 my cancer spreading ○ ○ ○ ○ ○ 
48 my cancer returning ○ ○ ○ ○ ○ 
49 
whether my cancer treatment has 
worked ○ ○ ○ ○ ○ 
50 having cancer treatment ○ ○ ○ ○ ○ 
51 how my family is coping ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









52 inner strength ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









53 accept my diagnosis ○ ○ ○ ○ ○ 
54 be independent ○ ○ ○ ○ ○ 
 
S5 Do you have:  (please choose as many as apply) 
○ a spouse/partner or boyfriend/girlfriend (please answer Question 55)  
○ sibling/s or step-brothers/sisters (please answer Questions 56-58)  
○ none of the above (go to Question 59) 
 
I had the following needs… 
IN THE LAST MONTH  
Coping with: 
No     
Need 







changes in my relationship with my 
partner ○ ○ ○ ○ ○ 




No     
Need 







changes in my relationships with my 
sibling/s ○ ○ ○ ○ ○ 
IN THE LAST MONTH  
Knowing how to: 
No     
Need 






57 ask my sibling/s for support ○ ○ ○ ○ ○ 
58 give support to my sibling/s ○ ○ ○ ○ ○ 
 
6. Daily Life 
I had the following needs… 
IN THE LAST MONTH  









59 make plans or think about the future ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









60 changes in my physical ability ○ ○ ○ ○ ○ 
61 changes in my appearance ○ ○ ○ ○ ○ 
62 
not being able to do the same things 
as other people my age ○ ○ ○ ○ ○ 
63 my parent/s being overprotective ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









64 pain ○ ○ ○ ○ ○ 
65 medication ○ ○ ○ ○ ○ 
66 physical side effects of treatment ○ ○ ○ ○ ○ 
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67 feeling tired ○ ○ ○ ○ ○ 
68 loss of mobility ○ ○ ○ ○ ○ 
69 to take part in social activities ○ ○ ○ ○ ○ 
70 to travel to social events ○ ○ ○ ○ ○ 
 
 
Section 3: Usability Testing 
You have completed the CNQ-YP. Now, we will ask you some questions about your experience filling out 
the CNQ-YP.  As you are answering these questions, imagine that your doctor has asked you to complete 













The CNQ-YP meets my 
approval.  o  o  o  o  o  
The CNQ-YP is appealing to 
me.   o  o  o  o  o  
I like the CNQ-YP.  o  o  o  o  o  
I welcome the CNQ-YP.  o  o  o  o  o  
 
 
Display This Question: 
If Acceptability  = The CNQ-YP meets my approval. [ Completely disagree ] 
And Acceptability  = The CNQ-YP meets my approval. [ Disagree ] 
And Acceptability  = The CNQ-YP is appealing to me. [ Completely disagree ] 
And Acceptability  = The CNQ-YP is appealing to me. [ Disagree ] 
And Acceptability  = I like the CNQ-YP. [ Completely disagree ] 
And Acceptability  = I like the CNQ-YP. [ Disagree ] 
And Acceptability  = I welcome the CNQ-YP. [ Completely disagree ] 


















The CNQ-YP seems fitting as 
a needs assessment tool for 
adolescents and young 
adults with cancer.   
o  o  o  o  o  
The CNQ-YP seems like a 
suitable tool for my doctor 
to administer to me as part 
of my cancer care.  
o  o  o  o  o  
The CNQ-YP seems 
applicable to adolescent 
and young adult cancer 
care.  
o  o  o  o  o  
The CNQ-YP seems like a 
good match for adolescents 
and young adults.   o  o  o  o  o  
Display This Question: 
If Appropriateness = The CNQ-YP seems fitting as a needs assessment tool for adolescents and young adults with cancer. [ Completely 
disagree ] 
And Appropriateness = The CNQ-YP seems fitting as a needs assessment tool for adolescents and young adults with cancer. [ Disagree ]  
And Appropriateness = The CNQ-YP seems like a suitable tool for my doctor to administer to me as part of my cancer care. [ Completely 
disagree ] 
And Appropriateness = The CNQ-YP seems like a suitable tool for my doctor to administer to me as part of my cancer care. [ Disagree ] 
And Appropriateness = The CNQ-YP seems applicable to adolescent and young adult cancer care. [ Completely disagree ] 
And Appropriateness = The CNQ-YP seems applicable to adolescent and young adult cancer care. [ Disagree ] 
And Appropriateness = The CNQ-YP seems like a good match for adolescents and young adults. [ Completely disagree ] 
And Appropriateness = The CNQ-YP seems like a good match for adolescents and young adults. [ Disagree ] 















The CNQ-YP seems like 
something my doctor 
could administer to all 
of their patients  
o  o  o  o  o  
The CNQ-YP seems 
possible for me to 
complete as part of my 
care  
o  o  o  o  o  
The CNQ-YP seems 
doable.  o  o  o  o  o  
The CNQ-YP seems easy 
to use.  o  o  o  o  o  
Display This Question: 
If Feasibility  = The CNQ-YP seems like something my doctor could administer to all of their patients [ 
Completely disagree ] 
And Feasibility  = The CNQ-YP seems like something my doctor could administer to all of their patients [ 
Disagree ] 
And Feasibility  = The CNQ-YP seems possible for me to complete as part of my care [ Completely disagree ] 
And Feasibility  = The CNQ-YP seems possible for me to complete as part of my care [ Disagree ] 
And Feasibility  = The CNQ-YP seems doable. [ Completely disagree ] 
And Feasibility  = The CNQ-YP seems doable. [ Disagree ] 
And Feasibility  = The CNQ-YP seems easy to use. [ Completely disagree ] 
And Feasibility  = The CNQ-YP seems easy to use. [ Disagree ] 

















My doctors would gain a good 
understanding of my needs 
from reviewing my answers to 
this survey.  
o  o  o  o  o  
I would consider using 
services/resources offered by 
my doctor if they matched 
them to the needs I identified 
in this survey.  
o  o  o  o  o  
 
Display This Question: 
If Actionability  = My doctors would gain a good understanding of my needs from reviewing my answers to this 
survey. [ Completely diagree ] 
And Actionability  = My doctors would gain a good understanding of my needs from reviewing my answers to 
this survey. [ Disagree ] 
Please explain why your concerns about the CNQ-YP as a picture of your needs at any given time 
 
 
Display This Question: 
If Actionability  = I would consider using services/resources offered by my doctor if they matched them to the 
needs I identified in this survey. [ Completely diagree ] 
And Actionability  = I would consider using services/resources offered by my doctor if they matched them to 
the needs I identified in this survey. [ Disagree ] 
Please explain why you may not consider using services/resources offered to you by your doctor based 
on needs identified in the CNQ-YP 
 
 Are there any important needs which aren't captured in the CNQ-YP? 
o yes (please list them here)  ________________________________________________ 
o No    
 
Is there anything in the CNQ-YP that shouldn't be? 
o yes (please indicate here):  ________________________________________________ 











APPENDIX C: COGNITIVE INTERVIEW GUIDE 
INTRODUCTION 
 
Thanks for agreeing to speak with me. We are developing a user-friendly tool to assess the needs of 
adolescents and young adults with cancer. This tool would be used by your cancer care providers to 
figure out what services and resources they should direct you to.  
 
As a starting point for developing this tool, we are using the Cancer Needs Questionnaire-Young People 
(or CNQ-YP), which you may remember from the online survey you completed a few weeks ago. The 
purpose of today is to have you provide input on the CNQ-YP, and identify areas where it may need 
improvement. We are also interested in getting your thoughts about how this tool might be delivered in 
practice.  
 
This interview might be a little different from others you’ve done. We are less interested in your 
answers to CNQ-YP questions and more interested in learning how usable the CNQ-YP is.  We would like 
to know how you arrive at your answers and find out if any questions or response options are confusing 
or weird to you. There are no right or wrong answers to any of these questions.  
 
For each question, what I would like you to do is read it aloud and then, please tell me what the 
question means in your own words.  Then, please “think aloud” as you formulate your response.  By 
“think aloud” I mean verbalize your thought process as you interpret each question, recall the 
information you need to respond, look through the response options, and decide your response.   
 
When you are done “thinking aloud” I will ask you a series of questions about the CNQ-YP.  Your 
participation is completely voluntary and you may skip any question. Please feel free to criticize this tool 
openly- I will not be offended. Your thoughts and comments about the tool are very important.  This 
interview will last approximately 60 minutes. Do you have any questions for me before we begin? 
 
During the interview, I will be taking notes.  Since it is difficult to write as fast as people talk, I would like 
to audio record this discussion, as well.  If at any time you would like me to stop audio recording, just tell 
me, and I will do so. The tapes will only be heard by the study team working on this project.  Once we 
have used the tapes to make sure that my notes are accurate, the tapes will be destroyed.  
 
Can we begin? 
 
Before I ask you to look at the tool, I would like to ask you a “warm up” question to introduce you to the 
think-aloud process.  I would like for you to visualize the windows in the place you live.  As you count up 
how many windows you have, tell me what you are seeing and thinking about.   
 
Example questions  
1. Please tell me in your own words what this question means. Then proceed to “think aloud” as 
you formulate your response.  
2. Are there any words here that seem ambiguous, or confusing?   
a. Which ones?  
b. How is the word ambiguous or confusing? 
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c. What did you think the word meant? 
3. Do you have the information in your memory to respond to this question?  
a. If yes, “think aloud” as you access this information in your memory? 
b. If no, who would have this information? How easy or difficult would it be to gather it? 
4. Does this seem to you like an important question?  
a. How important would it be to get accurate information for this question? 
5. How did you arrive at your answers? 
a. How easy or difficult is it to identify your most accurate response? 
b. Can you suggest any changes that would make it easier to identify your most accurate 
response? 
6. Is there anything else about this question that you want to mention?  
7. Are the choices of response adequate to capture your lived experience? 
a. If not, what choices would you like to see included?  
8. Is the organization of the questions easy to follow? 
a. If not, how can the questions be best grouped together? 
9. Are there additional questions you might add to this questionnaire to address needs that are not 





APPENDIX D: CONCEPT MAPPING ITEM LIST 
1. Cancer treatment staff telling me about my diagnosis 
2. Cancer treatment staff telling me about the short-term side effects of treatment 
3. Cancer treatment staff telling me about the long-term side effects of treatment 
4. Cancer treatment staff telling me what will happen when treatment finishes 
5. Cancer treatment staff telling me whether I will be able to have children 
6. Cancer treatment staff telling me about how my treatment is working 
7. Cancer treatment staff telling me my test results as soon as possible  
8. Cancer treatment staff telling me the way I feel is normal  
9. Cancer treatment staff giving me information about sexual health  
10. Cancer treatment staff giving me information about nutrition and exercise.  
11. Cancer treatment staff telling me what to do if I noticed a particular side effect 
12. Having cancer treatment staff who listened to my concerns and let me talk about my feelings 
13. Having cancer treatment staff who treated me as an individual 
14. Having cancer treatment staff who were respectable 
15. Having cancer treatment staff who were approachable and friendly 
16. Having cancer treatment staff who could have a laugh with me 
17. Having cancer treatment staff who explained what they are doing in a way I could understand 
18. Having cancer treatment staff who let me ask questions 
19. Having cancer treatment staff who let me make decisions about my treatment 
20. Having cancer treatment staff who talked to me in private, without my family  
21. Being able to have privacy 
22. Being able to have pleasant surroundings 
23. Being able to have good food 
24. Being able to have a choice of cancer care specialists 
25. Being able to have the same cancer treatment staff throughout treatment  
26. Being able to have a choice of times for appointments 
27. Being able to attend classes 
28. Being able to get extensions/special consideration 
29. Being able to get guidance about study options or future career paths 
30. Being able to get guidance about financial aid or loan repayment options  
31. Knowing how much work I would miss 
32. Knowing how to ask managers/coworkers for support  
33. Worrying about my health insurance coverage 
34. Being able to spend time with people my own age 
35. Being able to talk to people my own age who had been through a similar experience 
36. Being able to have leisure spaces and activities 
37. Finding information that described relaxation techniques (e.g., yoga, meditation) 
38. Feeling anxious or scared 
39. Feeling depressed  
40. Worrying about my cancer spreading 
41. Worrying about my cancer returning or secondary cancers 
42. Worrying about whether my cancer treatment has worked 
43. Worrying about how my family is coping 
44. Finding inner strength 
45. Being able to accept my diagnosis  
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46. Being able to be independent 
47. Coping with changes in my relationship to my partner 
48. Coping with changes in my relationship to my sibling/s 
49. Coping with changes in my relationship to my parent/s 
50. Coping with changes in my relationship to my friend/s 
51. Being able to make plans or think about the future 
52. Coping with changes in my physical ability 
53. Coping with changes in my appearance 
54. Coping with not being able to do the same things as other people my age 
55. Coping with my parent/s and/or partner being overprotective 
56. Managing pain 
57. Managing my medications 
58. Managing physical side effects of treatment 
59. Managing emotional side effects of treatment 
60. Managing feeling tired/fatigued 
61. Managing loss of mobility 




APPENDIX E: GUIDED TOURS QUESTION REPOSITORY & CODEBOOK  
Appendix E1. Framework of user and contextual factors in UCD; guided tour question repository   
User group characteristics 
Factors  Example questions 
 
• User type  
• User role  
• Goals for intervention 
• Perceived benefits of intervention 
• Perceived costs of intervention  
• Experience with intervention  
• Related experience  
• Task knowledge  
• Organizational knowledge 
• Training  
• Input device skills 
• Qualifications  
 
Providers/Staff 
• What is your role in caring for AYAs with cancer?  
• What experience do you have with cancer needs 
assessment tools or asking AYAs about their needs?  
• Are you familiar with the services and resources 
available at your institution for AYAs? 
AYAs 
• Have you ever been asked to complete survey that asks 
you about your needs? 
• What do you think the benefits of this intervention would 
be? 
• What do you think the costs of this intervention would 
be?  
User tasks 
Factors Example questions 
 
• Task list 
o Task 1 
o Task 2 
o Etc. 
• For each task: 
o Task characteristics 
o Task goal/output 
o Task steps 
o Task frequency 
o Task duration 
o Task flexibility 
o Task dependencies 
o Task output 
o Risks resulting from error  
o Critical demands 
 
Providers/Staff 
• Walk me through your daily patient care/ administrative 
tasks.  
o What are the goals of each task? 
o How long does each take? 
o How often is each performed? 
• Given your current task load, would you be able to 
administer a needs assessment to all AYAs? 
o When? As part of which task? 
AYAs 
• Walk me what a typical appointment looks like.  
• Would completing a survey be possible during any of 
these tasks? 
Technical and physical environment 





• Reference materials 
• Other equipment 





• Where do you currently record information about needs 
expressed by AYAs? 
o In the electronic health record? 
o Is this information easy to find? 
• What kind of reference materials do you give to 
patients?  
• What kind of referral network does your institution have 
for AYAs? 
AYAs 
• Where do you currently seek information about 
resources and services available for AYAs? 
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• Where do you wait before your appointments? 
• Do you typically open appointment reminders sent by 
email? 
• What kind of resources have you been given during 
appointments? 
Organizational environment 
Factors Example questions 
 
• Structure 
• Group working 
• Work practices 
• Assistance 
• Interruptions 
• Management structure 
• Communications structure 
• Attitudes and culture 
• Computer use policies 
• Organization aims 
• Industrial relations 
• Job design 
• Job functions 
• Hours of work 
• Job flexibility 





• Does your institution support the establishment of 
systems or processes specifically for AYAs? 
• Who is in charge of AYA cancer care? 
• How do you communicate with other providers in your 
institution?  
• What information are you required to enter in patients’ 
chart? 
• Has your institution implemented needs assessments 
for other patient groups? 
o If yes, how has that gone? 
• What barriers do you anticipate to implementing AYA 
NA-SB in your organization? 
o Staffing? 






Appendix E2. Ethnography codebook  
Code  Definition  Example 
USER GROUP CHARACTERISTICS 
User type  Provider; AYA  
User role  For providers: primary job title; role in caring for AYAs 
 
For AYAs: role as patient in managing cancer. Any clinical or personal 
characteristics. Family members’ roles in patient’s management of treatment.  
e.g., medical oncologist; primary role 
is dealing with medical concerns of 
patients, but also broaches 
psychosocial topics sometimes 
Goals for 
intervention  
What does user want a needs assessment & care coordination intervention to 
accomplish? 
e.g., “I want a system in place that 
gets all providers on the same page as 




What does user see as the main benefits of a needs assessment and care 
coordination intervention?  
e.g., communication among 
multidisciplinary providers 
Perceived costs 
of intervention  
What does user see as the costs of a needs assessment and care coordination 
intervention? (includes financial and non-financial burden)  




For providers: What is user currently doing/ what have they done in past in terms 
of assessing AYA needs? 
 
For AYAs: What experience does user have completing questionnaires about their 
cancer needs? 
e.g., “I ask AYAs about their needs but 
not in a formal or standardized way” 
 
e.g., “I’ve never been asked to fill out 
a survey about my needs” 
Related 
experience 
For providers: Other experiences with patient reported outcome measures; or 
with assessing needs for other patient populations  
 
For AYAs: Other experiences completing surveys/standardized questionnaires 
given to them by their medical provider. Experience seeking and receiving 
services.  
e.g., “I have experience using the 
Cancer Distress Screening tool” 
 
e.g., “I had to fill out a questionnaire 
about my medical information during 
my first appointment but that’s all”/ 
“I have met with the child life 
specialist”  
Task knowledge  For providers: Knowledge and skills related to engaging with patients about their 
medical, psychosocial, and practical needs; knowledge about resources and 
services available to meet those needs 
 
e.g., “Because I’ve been here for so 
long, I’m really comfortable talking to 





For AYAs: knowledge and skills related to communicating their needs to 
providers; knowledge about resources and services available to them  
know where to point them to when 
they need something” 
 
e.g., “I’ve been depressed before but 
didn’t know where to find help” 
Organizational 
knowledge  
For providers: knowledge regarding organizational structure, aims, culture, or 
other facets of their organization 
 
For AYAs:  knowledge about hospital 
e.g., ability to easily cite information 
about patient flow, provider 
workflow, organizational efforts 
Training/ 
qualifications  
For providers: educational training or certifications related to PROMs, AYAs, or 
implementation  
 
For AYAs:  educational training related to managing cancer diagnosis   




E.g., “I joined a peer support group 
focused on sharing lessons learned 
about managing cancer” 
Input device 
skills 
For providers: proficiency in any tool currently used or that could be used to 
document or transfer information related to AYA needs 
 
For AYAs:  proficiency in any tool currently used or that could be used to 
document or transfer information related to AYA needs  
e.g., proficiency in EPIC 
 
 
e.g., familiarity with navigating 
MyChart  
USER TASKS 
Task: Piece of work that the user carries out by interacting with the system e.g., “I keep track of all my 




Any characteristics of a task which don’t fall under other codes in “user task” 
domain 
e.g., “it is mentall exhausting for me 








Steps required to complete a task  e.g., “to remember my appointment 
times, I first record them in my paper 
calendar and then set a reminder in 











Length of time a given task requires to complete e.g., “It takes me 20 minutes to drive 
to my appointments” 
Task  
flexibility 
extent that the task can be controlled by the user during implementation. Within 
this attribute a distinction is drawn between: 
• Performance freedom refers to the extent to which there are alternative 
ways to complete the task. 
• Reversibility refers to the possibility for undoing actions and returning to 
a previous state. 
e.g., “I don’t have much of a say in 
when my appointment times will be”  
Task  
dependencies 
Other tasks that must be performed, or milestones that must be reached in order 
for a given task to be completed 
e.g., “I have to let my boss know 





The severity of consequences should a task not be performed, or be performed 
incorrectly 
e.g., “If I miss an appointment, then 
my treatment regimen won’t be as 
effective”  
TECHNICAL & PHYSICAL ENVIRONMENT 
Hardware/ 
Software 
Access to and use of computers, laptops, mobile devices, iPads, other 
technologies  
e.g., “I have the MyChart app on my 
cellphone which I use to review my 
medical information”  
Network  Any networks through which information is shared by AYAs or providers  e.g., “we have email threads in which 
all of a patient’s providers can share 
information and weigh in on a 
patient’s case” 
 
e.g., “I am a member of a Facebook 
group where AYAs with cancer share 
information about treatments and 
side effects they have experienced”  
Reference 
materials  
Where user seeks or acquires information related to cancer care; descriptions of 
the information they seek or use 




Any other equipment used by users to perform their tasks  e.g., “I have a notebook where I 
record any questions about my 





notebook to all my clinical 
appointments so don’t forget to ask 




Any descriptions of the physical space e.g., the waiting room for radiation is 
small and dimly-lit with 8 chairs, a TV, 
and some informational brochures 
hanging on the wall  
Location  Any descriptions of where two places are in relationship to each other e.g., labwork is done in the basement 
and then you have to take the 
elevator up to the 2nd floor for clinical 
appointments  
ORGANIZATIONAL ENVIRONMENT (only pertinent for providers)  
Group working  extent to which the user interacts with other persons while working e.g., social worker and psychiatrist 
sharing patient load  
Work practices Strategies user deploys to complete their work  e.g., “before a patient’s visit, I skim 
through the notes in their medical 
chart to jog my memory on recent 
concerns they have had” 
Assistance the extent to which the user can count on help from other persons in the 
organization 
e.g., “we just hired a second social 
worker to help me with my patient 
case load”  
Interruptions  the degree to which the work of a user is interrupted by other persons in the 
organization 
e.g., “sometimes when I am with a 
patient, I will get a page to attend to 
an urgent situation”  
Management 
structure  
Where user is positioned in the leadership hierarchy  e.g., “my supervisor is X; their 
supervisor is Y” 
Communications 
structure  
Avenues through which work-related communications occur e.g., how one provider communicates 




underlying beliefs, assumptions, values and ways of interacting that contribute to 
the unique social and psychological environment of an organization 
e.g., “there is a general culture of 
innovation at NCCH”  
Computer use 
policies  
Organizational policies surrounding use of computers and other technologies  e.g., “I cannot access my phone 
during patient visits because of 










the intentions of the organization (NCCH) in regard to AYAs, patient-reported 
outcome measures or patient data in general   
e.g., “the hospital has prioritized using 
patient-generated data to drive 
quality improvement projects” 
Industrial 
relations 
Interactions and relationships with external organizations e.g., interactions with EPIC software 
vendor  
Job design and 
functions  
Functions assigned to user’s position e.g., “as a social worker, my job is to 
help coordinate across all the other 
specialists to ensure that an AYA gets 
what they need” 
Hours of work  User’s work schedule  e.g., “I work from 8-5 on Monday-
Friday”  
Job flexibility  the freedom granted to the user in terms of how to implement tasks e.g., “as long as I complete the tasks 
assigned to me, my supervisor doesn’t 





• Monitoring refers to supervision of the user's work by the organization 
• Feedback refers to information provided to the user in relation to their 
work 
e.g., “at the end of each month, I 
receive a report that tells me XYZ 
information about my job 





APPENDIX F: SEMI-STRUCTURED INTERVIEW GUIDE 
At UNC, we are developing a care coordination intervention for AYAs with cancer. This includes a needs assessment which asks about physical, 
psychosocial and practical needs PLUS a set of explicit processes for connecting AYAs to services and resources based on the needs they report.  
I emailed you the most recent iteration of the needs assessment, which may still be tweaked a bit. It includes 56 items across 9 domains. Now 
that we are close to finalizing the tool itself, we have turned our attention towards how it may actually be rolled out in practice. As we iron out 
how this tool will be administered and used to drive service provision, and how the intervention will be implemented, we want to make sure we 
are not developing an intervention that is only applicable to UNC. Today, I want to talk to you about AYA care at your institution. Your input will 
help us to create an intervention that can be used across health care systems.  
Before we begin, we would like to ask your permission to audio record our discussion for the purposes of future analysis. Would it be OK with 
you if I record this interview? The interview will be transcribed; however, your name or any personal identifiers will not be associated with any 
of the notes. The audio recordings will be deleted once the project is complete.  
Do you have any questions before we begin? 
First, I’d like to ask you some questions about AYA care at your institution.  
Contextual feature UNC Your institution 
AYA program structure  Under the umbrella of NCCH’s Comprehensive Cancer 
Support Program which is directed by the Vice-Chair of 
General Hospital Psychiatry. There is not currently a 
designated space for AYA care. However, an AYA 
infusion space is in development.  
 
AYA program staffing  Medical director; program director/social worker; 
social worker  
 
AYA program functions  Coordinating across disease groups and across 
pediatric and adult oncology to provide age 
appropriate services and resources to AYAs  
 
AYA program funding  Primarily BeLoud Sophie Foundation   
How are new AYA patients 
identified? 
AYA social workers rely on referrals from disease group 
providers. 
 
Who is involved in assessing 
AYAs’ needs and coordinating 
their care? 
patients rely on social workers for non-medical needs, 
saying that their oncology providers rarely ask them 






When and where do these 
interactions take place? 
Although sometimes AYA social workers schedule 
appointments with AYAs, they often just “pop in” while 
AYAs are in the hospital for appointments 
 
Are any standardized tools or 
questionnaires used to assess 
needs? 
AYA needs are assessed informally/conversationally by 
the AYA social workers 
 
What does this look like for 
pediatric versus adult oncology? 
i. AYA-specific social workers care for AYAs in both 
adult and pediatric oncology  
ii. In pediatric oncology, staffing is more robust and 
care provision is more centralized, facilitating 
communication among providers. In adult oncology, 
services and resources are more disparately 
located; there are fewer providers per patient. 
Thus, care coordination in adult oncology can be 
more challenging 
 
How do providers document 
AYAs’ needs? 
Information about patient needs is stored as notes in 
the EHR; each provider records their own separate 
note for each interaction with a patient. Providers 
would prefer that a needs assessment interface with 
the EHR so that it remains a one-stop shop for patient 
information 
 
How do providers communicate 
about AYAs’ needs? 
Providers communicate about AYAs’ needs via phone, 
text, email, EHR messaging, and in-person. 
 
 
Now, I’d like to talk to you about how this needs assessment might be administered. I’m going to run through a few things I’ve heard from 
patients and providers at UNC and ask you the extent to which they match up with your experience at your institution.  
Stakeholder preferences for needs assessment administration Your thoughts 
Important time points for administering the needs assessment include 
right after diagnosis, at the end of treatment, and somewhere in 
between. 
 
AYAs want to complete a survey during times when they are already 
waiting. These time points include:  
• After nurse takes them to exam room and assesses vitals; 






• Infusion  
• Inpatient- anytime  
If given the option, many AYAs would prefer to complete a survey 
through technology (e.g., mobile phone, iPad) but are not averse to 
paper. AYAs are active users of MyChart (mobile-enabled patient 
information app), relying on it to track appointments, view test 
results, communicate with providers, and request prescription refills. 
 
Since social workers are already doing the work of needs assessment, 
although informally, it makes sense for social workers to be involved 
in needs assessment administration  
 
 
Now I’d like to ask you your thoughts on implementing this kind of needs assessment and care coordination intervention in your health care 
system.  
How do you see this as an opportunity?  
What are the challenges in your health system that might influence 
the implementation of this intervention? 
 









APPENDIX G: DESIGN TEAM WORKSHOP #1 MATERIALS 








DESIGN TEAM WORKSHOP #1 
January 29, 2019 
12:00-4:00pm EST 







12:00-12:15  Welcome and introductions  
 
12:15-12:45  Lunch (Panera) 
          Project overview & objectives  
Summary of usability testing results  
 
12:45-2:00  Needs list refinement  
 
2:00-2:15  Break 
 
2:15-3:00 Selection of concept mapping cluster solution 
                             Labeling of follow-up domains  
 
3:00-3:30 Response options, format, sequencing  
 











UCD Aim Method Deliverable 
Review and refine prototype  
 
Usability Testing 
• AYA Survey 
• Cognitive interviews with AYAs 
• Concept mapping with providers/staff 
Evidence of the usability and 
usefulness of the CNQ-YP 
Identify user and contextual 
requirements   
Ethnography 
• Guided tours with AYAs and 
providers/staff from NCCH 
• Semi-structured interviews with 
providers/staff from outside of NCCH 
User and contextual requirements for 
AYA NA-SB’s design and 
implementation  
Design prototypes based on 
user and contextual 
requirements 
Design Team Workshops 
• Workshop #1 
• Workshop #2 
AYA NA-SB prototypes and 
anticipated implementation strategies 
needed 
RESULT A usable and useful PROM linked to 




























        External young adults                  External providers         








For each question, please choose the answer that best describes your level of need. There are five 
choices: 
 
No Need/ Need 
Met 
All my needs were met for this issue or this was not a problem 
for me. 
Low Need  I needed a low amount of help with this problem but was not 
able to get it. 
Moderate Need  I needed a moderate amount of help with this problem but was 
not able to get it. 
High Need   I needed a high amount of help with this problem but was not 
able to get it. 
Very High Need I needed a very high amount of help with this problem but was 
not able to get it. 
 
The following questions ask about any needs you may have had at any time since your cancer 
diagnosis. 
 
1. Treatment Environment and Care 
I had the following needs… 
BEFORE TREATMENT 









1 about my diagnosis ○ ○ ○ ○ ○ 
2 what might happen during treatment  ○ ○ ○ ○ ○ 
3 
whether I had the option to decline 
treatment ○ ○ ○ ○ ○ 
4 
about the short-term side-effects of 
treatment ○ ○ ○ ○ ○ 
5 
about the long-term side-effects of 
treatment ○ ○ ○ ○ ○ 
6 my chances of a full recovery ○ ○ ○ ○ ○ 
7 
what will happen when treatment 




whether I would be able to have 
children ○ ○ ○ ○ ○ 
 About sexual health      
DURING TREATMENT 










whether how my treatment was 
working ○ ○ ○ ○ ○ 
10 my test results as soon as possible ○ ○ ○ ○ ○ 
11 the way I felt was normal ○ ○ ○ ○ ○ 









12 have time to myself ○ ○ ○ ○ ○ 
I had the following needs… 
AFTER TREATMENT 









13 how to manage my medication ○ ○ ○ ○ ○ 
14 
what I could do to stay healthy about 
nutrition and physical activity  ○ ○ ○ ○ ○ 
15 
what to do if I noticed a particular 
side-effect ○ ○ ○ ○ ○ 
THROUGHOUT TREATMENT 










listened to my concerns and let me 
talk about my feelings  ○ ○ ○ ○ ○ 
17 treated me as an individual ○ ○ ○ ○ ○ 
18 were respectful ○ ○ ○ ○ ○ 
19 were approachable and friendly  ○ ○ ○ ○ ○ 
20 were friendly ○ ○ ○ ○ ○ 




explained what they were doing 
before they did it in a way I could 
understand 
○ ○ ○ ○ ○ 
23 
spoke to me in a way that I could 
understand ○ ○ ○ ○ ○ 
24 let me talk about my feelings ○ ○ ○ ○ ○ 
25 let me ask questions ○ ○ ○ ○ ○ 
26 
let me make decisions about my 
treatment ○ ○ ○ ○ ○ 
27 
talked to me in private, without my 
family ○ ○ ○ ○ ○ 
I had the following needs… 
 
AT THE CANCER TREATMENT CENTER 









28 privacy  ○ ○ ○ ○ ○ 
29 pleasant surroundings  ○ ○ ○ ○ ○ 
30 good food ○ ○ ○ ○ ○ 
31 a choice of cancer specialists  ○ ○ ○ ○ ○ 
32 
the same cancer treatment staff 
throughout treatment ○ ○ ○ ○ ○ 
33 a choice of times for appointments ○ ○ ○ ○ ○ 
 
2.Education 
Since my cancer diagnosis, I have had problems enrolling at: (please choose as many as apply) 
S1 ○ school 
○ TAFE  
○ university/college 
○ other place of study (please write)_____________________________________________ 
○ none of the above 
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Since my cancer diagnosis, I have attended: (please choose as many as apply) 
S2 ○ school 
○ TAFE  
○ university/college 
○ other place of study (please write)_____________________________________________ 
○ none of the above (go to Question S3) 
I had the following needs… 
WHEN STUDYING WHILE ENROLLED IN SCHOOL  









34 attend classes ○ ○ ○ ○ ○ 
35 get extensions/special consideration ○ ○ ○ ○ ○ 
36 
get guidance about study options or 
future career paths ○ ○ ○ ○ ○ 
 
3. Work 
Since my cancer diagnosis, I have had problems finding work: (please choose as many as apply) 
S3 ○ full-time 
○ part-time/casual 
○ unpaid voluntary work 
○ internship  
○ other type of work (please write)______________________________________________ 
○ none of the above 
Since my cancer diagnosis, I have been employed: (please choose as many as apply) 
S4 ○ full-time 
○ part-time/casual 
○ unpaid voluntary work 
○ internship  
○ other type of work (please write)______________________________________________ 
○ none of the above (go to Question 40) 
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I had the following needs… 
WHEN EMPLOYED 









37 how much work I would miss ○ ○ ○ ○ ○ 
38 
how to ask managers/co-workers for 
support ○ ○ ○ ○ ○ 
39 
that  managers/co-workers had 
support to help them cope with my 
situation 
○ ○ ○ ○ ○ 
 
4. Information and Activities 
I had the following needs… 
DURING TREATMENT 









40 spend time with people my own age ○ ○ ○ ○ ○ 
41 
talk to people my age who had been 
through a similar experience ○ ○ ○ ○ ○ 
AT THE CANCER TREATMENT CENTER 









42 leisure spaces and activities ○ ○ ○ ○ ○ 
SINCE MY CANCER DIAGNOSIS 









43 was specifically designed for me ○ ○ ○ ○ ○ 
44 
described relaxation techniques (e.g., 
yoga, meditation) ○ ○ ○ ○ ○ 
 
The next group of questions ask about any needs you may have had in the last month.  
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We realise that your needs may have changed during different stages of your cancer experience. 
Please only tell us about needs you have had in the last month. If you have not had any needs in the 
last month, please select ‘No Need’.  
 
5. Feelings and Relationships 
I had the following needs… 
IN THE LAST MONTH  









45 frustrated depressed  ○ ○ ○ ○ ○ 
46 anxious or nervous scared ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









47 my cancer spreading ○ ○ ○ ○ ○ 
48 
my cancer returning or secondary 
cancers ○ ○ ○ ○ ○ 
49 
whether my cancer treatment has 
worked ○ ○ ○ ○ ○ 
50 having cancer treatment ○ ○ ○ ○ ○ 
51 how my family is coping ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









52 inner strength ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









53 accept my diagnosis ○ ○ ○ ○ ○ 




S5 Do you have:  (please choose as many as apply) 
○ a spouse/partner or boyfriend/girlfriend (please answer Question 55)  
○ sibling/s or step-brothers/sisters (please answer Questions 56-58)  
○ none of the above (go to Question 59) 
I had the following needs… 
IN THE LAST MONTH  







changes in my relationship with my 
partner dating or romantic life ○ ○ ○ ○ ○ 
IN THE LAST MONTH  







changes in my relationships with my 
sibling/s family members ○ ○ ○ ○ ○ 
IN THE LAST MONTH  






57 ask my sibling/s for support ○ ○ ○ ○ ○ 
58 give support to my sibling/s ○ ○ ○ ○ ○ 
 
6. Daily Life 
I had the following needs… 
IN THE LAST MONTH  









59 make plans or think about the future ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









60 changes in my physical ability ○ ○ ○ ○ ○ 




not being able to do the same things 
as other people my age ○ ○ ○ ○ ○ 
63 
my parent/s or partner being 
overprotective ○ ○ ○ ○ ○ 
IN THE LAST MONTH 









64 pain ○ ○ ○ ○ ○ 
65 My medications ○ ○ ○ ○ ○ 
66 physical side effects of treatment ○ ○ ○ ○ ○ 
67 feeling tired or fatigued ○ ○ ○ ○ ○ 
68 loss of mobility ○ ○ ○ ○ ○ 
69 
to take part in and enjoy social 
activities ○ ○ ○ ○ ○ 





Needs list refinement 
Items up for consideration: 
1. Being able to have a choice of times for appointments 
2. Being able to have the same cancer treatment staff throughout treatment 
3. Being able to have a choice of cancer care specialists 
4. Knowing how much work I would miss 
5. Being able to have leisure spaces and activities 
6. Knowing how to ask managers/coworkers for support 
7. Being able to get guidance about study options or future career paths 
8. Coping with my parent/s and/or partner being overprotective 
9. Being able to be independent 
10. Having cancer treatment staff who treated me as an individual 
11. Having cancer treatment staff who talked to me in private without my family 
12. Having cancer treatment staff who could have a laugh with me 
13. Being able to have pleasant surroundings at the cancer treatment center 
14. Being able to have good food at the cancer treatment center 
15. Being able to have privacy at the cancer treatment center  
16. Being able to attend classes (while enrolled in school) 
17. Being able to get extensions/special considerations (while enrolled in school) 
18. Worrying about whether my treatment has worked  
 
Potential additional items:  
1. Sexual health 
2. Worrying about health insurance coverage  
3. Physical therapy 
4. Being able to get guidance about financial aid or loan repayment options 
5. Other financial needs 
6. Transportation  
7. Coping with changes in my relationships with friends  












AYA Survey Results 
Table A1. AYA survey participants  
Sex and gender identity  
 
Female 55 (78.6%) 
Male 15 (21.4%) 
Transgender 2 (2.9%) 
Age  
 
Mean (SD) 24.24 (3.96) 
Race   
Hispanic (all races) 10 (14.3%) 
Non-Hispanic American Indian/ Alaska Native 3 (4.3%) 
Non-Hispanic Asian or Pacific Islander 2 (2.9%) 
Non-Hispanic Black 1 (1.4%) 
Non-Hispanic White 49 (70.0%) 
Other 5 (7.1%) 
Cancer type   
Non-Hodgkin lymphoma 5 (7.1%) 
Hodgkin lymphoma  15 (21.4%) 
Leukemia  11 (15.7%) 
Sarcoma 9 (12.9%) 
Cervical 1 (1.4%) 
Other female reproductive 3 (4.3%) 
Male reproductive 1 (1.4%) 
Thyroid 5 (7.1%) 
Brain 5 (7.1%) 
Melanoma 2 (2.9%) 
Colorectal  1 (1.4%) 
Breast  4 (5.7%) 
Other 8 (11.4%) 
Stage at diagnosis   
0 1 (1.4%) 
I/II 24 (34.3%) 
III/IV 22 (31.4%) 
Unknown/ unstaged 23 (32.9%) 
Time since diagnosis   
< 3 months  3 (4.3%) 
3-6 months 9 (12.9%) 
7-12 months 8 (11.4%) 
>12 months 50 (71.4%) 
In active treatment?   
no 51 (72.9%) 
yes 19 (27.1%) 
Cohabitants 
 
Parent(s) 29 (42.7%) 
Spouse 12 (17.7%) 
Non-spouse partner 7 (10.3%) 
Child/children 4 (5.9%) 
Roommate(s) (not parent, spouse, or child) 12 (17.7%) 
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Lives alone  8 (11.8%) 
Education level   
< high school  2 (2.9%) 
Completed high school  9 (13.2%) 
Some college/ vocational training 23 (33.8%) 
Associate degree 3 (4.4%) 
College graduate 15 (22.1%) 
Graduate degree or some post-graduate 
education  
16 (23.5%) 
Insurance source    
Self-pay  4 (5.9%) 
No insurance 3 (4.4%) 
Employer/ school 18 (26.5%) 
Spouse’s employer/ school 2 (2.9%) 
Parent 25 (36.8%) 
Medicare 3 (4.4%) 
Medicaid 8 (11.8%) 
Military/ TRICARE 8 (11.8%) 






Figure A1. Number of needs reported as “high” or “very high” by respondent 
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Figure A3. Average rating of needs: treatment environment & care section 
 
Figure A4. Average rating of needs: education section 
 
 





Figure A6. Average rating of needs: feelings & relationships section 
 





Cognitive Interview Results 
 
Table B1. Cognitive interview results 
Category  Theme Changes made   
Response 
format 
Confusion surrounding “no need” response option 
including both no need, and need already met 
Changed the name of the “no 
need” response option to “no 
need/need met” 
 Item S1 and S2 (“since my cancer diagnosis I have 
enrolled at/had problems enrolling at”) response option 
“TAFE” not understood 
Removed response option 
“TAFE” from S1 and S2 
 For items S1 and S2 (“since my cancer diagnosis I have 
enrolled at/had problems enrolling at”), AYAs wanted a 
response option related to internships  
Added response option for S1 
and S2: “internship (paid or 
unpaid)” 
 In Items S3 and S4 (“since my cancer diagnoses I have 
been employed/ have had problems finding work”) 
response option “part-time/casual”, AYAs didn’t like the 
term “casual” 
Removed the word “casual” so 
response option just reads “part-
time”  
 For Items S3 and S4 (“since my cancer diagnoses I have 
been employed/ have had problems finding work”), AYAs 
wanted a response option for trade 
school/apprenticeship  
Added response option for S3 




Throughout the CNQ-YP the questions are broken up into 
different rows. For example, “I had the following need”, 
“before treatment”, “cancer treatment staff telling me”, 
and “about my diagnosis” are on separate lines. AYAs 
found this confusing.  
All question wording 
consolidated onto one line.  
   
Lookback 
periods 
In general, AYAs found the multiple lookback periods 
(e.g., “before treatment”, “during treatment”, “after 
treatment”, etc.) confusing. Although they emphasized 
that needs do change depending on how far along you 
are in your treatment trajectory, these lookback periods 
were not considered helpful for informing current service 
provision  
All needs items were anchored to 
needs currently being 
experienced (i.e., at the time of 
assessment completion). 
Redundancies stemming from 
the multiple lookback periods 





Item 2 (“cancer treatment staff telling me what might 
happen during treatment”) interpreted the same as Item 
4 (“about the short-term side effects of treatment”) 
Removed Item 2  
 Item 3 (“cancer treatment staff telling me whether I have 
the option to decline treatment”) perceived as less 
relevant/important 
Removed Item 3  
 AYAs did not like Item 6 (“cancer treatment staff telling 
me my chances of a full recovery”) because it is unclear 
what is meant by “full recovery”  
Removed Item 6  
 Section lacks item about sexual health Added item assessing whether 
treatment staff provided 
information about sexual health  
 Item 9 (“cancer treatment staff telling me whether my 
treatment was working”) is too narrow  
Changed item to “how my 
treatment is working”  
 Item 12 (“being able to have time to myself”) perceived 
as unimportant  
Removed Item 12 
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 Item 14 (“cancer treatment staff telling me what I could 
do to stay healthy”) perceived as too vague; interpreted 
as putting the onus on AYAs to prevent secondary 
cancers which may be out of their control 
Changed Item 14 to “cancer 
treatment staff giving me 
information about nutrition and 
exercise”  
 Item 16 (“having cancer treatment staff who listened to 
my concerns”) and Item 24 (“ having cancer treatment 
staff who let me talk about my feelings”) perceived as 
redundant 
Collapsed items 16 and 24 into 
“listened to my concerns and let 
me talk about my feelings” 
 Item 19 (“having cancer treatment staff who were 
approachable”) and Item 20 (“having cancer treatment 
staff who were friendly”) perceived as redundant 
Collapsed Items 19 and 20 into 
“having cancer treatment staff 
who were friendly and 
approachable” 
 Item 22 (“having cancer treatment staff who explained 
what they were doing”) does not capture the importance 
of explaining before doing; redundant with Item 23 
(“having cancer treatment staff who spoke to me in a 
way that I could understand”)   
Collapsed Items 22 and 23 into 
“having cancer treatment staff 
who explained what they were 
doing before they did it, in a way 
that I could understand” 
Education 
section 
Items 34-36 had the question stem “I had the following 
needs when studying”. AYAs interpreted this as actively 
studying for a test.  
Changed the question stem for 
Items 34-36 to “I had the 
following needs while enrolled at 
school” 
 Section is missing an item related to financial aid or loan 
repayment  
Added item “being able to get 
guidance about financial aid or 
loan repayment options” 
 
Work section Item 39 (“knowing that managers/co-workers had 
support to help them cope with my situation”) not 
perceived as important 
Removed Item 39 
 Section lacks item about health insurance, which is a 
major need with respect to employment 
Added item “worrying about my 




AYAs did not understand/like Item 43 “finding 
information that was specifically designed for me”  




Item 45 (“feeling frustrated”) not perceived as important 
relative to other psychosocial concerns 
Removed Item 45  
 Item 45 (“feeling anxious or nervous”) doesn’t fully 
capture the feeling of fear which is pervasive during 
treatment  
Changed item 45 to “feeling 
anxious or scared” 
 Section lacking item about depression Added item “feeling depressed”  
 Item 48 (“worrying about my cancer returning”) does not 
capture pervasive fear surrounding secondary cancers 
Changed Item 48 to “worrying 
about my cancer returning or 
secondary cancers” 
 Item 50 (“worrying about having cancer treatment”) too 
vague  
Removed Item 50  
 Section only includes items assessing changes in 
relationship with partner and siblings; not inclusive of all 
the important relationships that may be affected by 
cancer  
Added items assessing changes in 
relationship with parent/s and 




Item 63 (“coping with my parent/s being overprotective”) 
not relevant for many AYAs 
Changed Item 63 to “coping with 
my parent/s and/or partner 
being overprotective”  
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 Section has item about physical side effects of treatment 
(Item 66) but none about the emotional side effects of 
treatment  
Added item “managing 
emotional side effects of 
treatment”  
 Item 67 (“feeling tired”) does not capture fatigue, which 
AYAs felt was more severe than tiredness 
Changed Item 67 to “feeling 
tired/fatigued”  
 AYAs did not understand or like Item 70 (“managing to 
travel to social event”) 





Concept Mapping Results 
 






Indiana  1 
Michigan 1 
Missouri  1 
New York 1 
North Carolina 2 
Ohio 2 




Cancer Program Type   
NCI-designated comprehensive cancer center 19 
Teaching hospital cancer program 13 
Veterans Affairs cancer program  0 
Pediatric cancer program 14 
Community cancer center 3 
Hospital-based cancer program 15 
Private oncology practice 0 
Freestanding cancer center program 
 
1 
Role    
Oncologist 3 
Physician (non-oncology) 1 
Physician assistant  0 
Nurse practitioner 1 
Oncology nurse navigator 3 
Nurse 1 
Child life specialist 0 
Dietician 0 
Patient navigator 1 
Social worker 7 
Health educator  1 
Other  8 
Years in role  
Less than 5 16 
Between 5 and 10 5 
Between 10 and 20 2 
Greater than 20 3 






Table C2. List of needs sorted and rated by concept mapping participants  
# Statement 
1 Cancer treatment staff telling me about my diagnosis 
2 Cancer treatment staff telling me about the short-term side effects of treatment 
3 Cancer treatment staff telling me about the long-term side effects of treatment 
4 Cancer treatment staff telling me what will happen when treatment finishes 
5 Cancer treatment staff telling me whether I will be able to have children 
6 Cancer treatment staff telling me about how my treatment is working 
7 Cancer treatment staff telling me my test results as soon as possible 
8 Cancer treatment staff telling me the way I feel is normal 
9 Cancer treatment staff giving me information about sexual health 
10 Cancer treatment staff giving me information about nutrition and exercise. 
11 Cancer treatment staff telling me what to do if I noticed a particular side effect 
12 Having cancer treatment staff who listened to my concerns and let me talk about my feelings 
13 Having cancer treatment staff who treated me as an individual 
14 Having cancer treatment staff who were respectful 
15 Having cancer treatment staff who were approachable and friendly 
16 Having cancer treatment staff who could have a laugh with me 
17 Having cancer treatment staff who explained what they are doing in a way I could understand 
18 Having cancer treatment staff who let me ask questions 
19 Having cancer treatment staff who let me make decisions about my treatment 
20 Having cancer treatment staff who talked to me in private, without my family 
21 Being able to have privacy 
22 Being able to have pleasant surroundings 
23 Being able to have good food 
24 Being able to have a choice of cancer care specialists 
25 Being able to have the same cancer treatment staff throughout treatment 
26 Being able to have a choice of times for appointments 
27 Being able to attend classes (if enrolled in school) 
28 Being able to get extensions/special consideration (if enrolled in school) 
29 Knowing how much work I would miss 
30 Being able to get guidance about study options or future career paths 
31 Being able to get guidance about financial aid or loan repayment options  
32 Knowing how to ask managers/coworkers for support 
33 Worrying about my health insurance coverage 
34 Being able to spend time with people my own age 
35 Being able to talk to people my own age who had been through a similar experience 
36 Being able to have leisure spaces and activities 
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37 Finding information that described relaxation techniques (e.g., yoga, meditation) 
38 Feeling anxious or scared 
39 Feeling depressed 
40 Worrying about my cancer spreading 
41 Worrying about my cancer returning or secondary cancers 
42 Worrying about whether my cancer treatment has worked 
43 Worrying about how my family is coping 
44 Finding inner strength 
45 Being able to accept my diagnosis 
46 Being able to be independent 
47 Coping with changes in my relationship to my partner 
48 Coping with changes in my relationship to my sibling/s 
49 Coping with changes in my relationship to my parent/s 
50 Coping with changes in my relationship to my friend/s 
51 Being able to make plans or think about the future 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things as other people my age 
55 Coping with my parent/s and/or partner being overprotective 
56 Managing pain 
57 Managing my medications 
58 Managing physical side effects of treatment 
59 Managing emotional side effects of treatment 
60 Managing feeling tired/fatigued 
61 Managing loss of mobility 






Figure C1. Concept mapping point map  
 
*Each point represents a needs item. They are numbered according to Table C2. The closer two points are in proximity, the more often those 














1. treatment plan 
  
1 Cancer treatment staff telling me about my 
diagnosis 
2 Cancer treatment staff telling me about the short-
term side effects of treatment 
3 Cancer treatment staff telling me about the long-
term side effects of treatment 
4 Cancer treatment staff telling me what will 
happen when treatment finishes 
2.  2. My Treatment 
Team 
  
6 Cancer treatment staff telling me about how my 
treatment is working 
7 Cancer treatment staff telling me my test results 
as soon as possible 
11 Cancer treatment staff telling me what to do if I 
noticed a particular side effect 
3.  Autonomy & 
Independence 
  
10 Cancer treatment staff giving me information 
about nutrition and exercise. 
60 Managing feeling tired/fatigued 
61 Managing loss of mobility 
4.  1AYA 
Programming 
  
56 Managing pain 
57 Managing my medications 
58 Managing physical side effects of treatment 




5 Cancer treatment staff telling me whether I will 
be able to have children 
9 Cancer treatment staff giving me information 
about sexual health 
  
6.  Inpatient Nursing 
Staff 
21 Being able to have privacy 
22 Being able to have pleasant surroundings 
23 Being able to have good food 




27 Being able to attend classes (if enrolled in school) 
29 Knowing how much work I would miss 
32 Knowing how to ask managers/coworkers for 
support 
36 Being able to have leisure spaces and activities 
8.  Financial 
  
28 Being able to get extensions/special consideration 
(if enrolled in school) 
30 Being able to get guidance about study options or 
future career paths 
31 Being able to get guidance about financial aid or 
loan repayment options  
33 Worrying about my health insurance coverage 




13 Having cancer treatment staff who treated me as 
an individual 
14 Having cancer treatment staff who were 
respectable 
15 Having cancer treatment staff who were 
approachable and friendly 
16 Having cancer treatment staff who could have a 
laugh with me 
20 Having cancer treatment staff who talked to me 
in private, without my family 
10.  1All oncology 
staff 
  
17 Having cancer treatment staff who explained 





18 Having cancer treatment staff who let me ask 
questions 
19 Having cancer treatment staff who let me make 
decisions about my treatment 
24 Being able to have a choice of cancer care 
specialists 
25 Being able to have the same cancer treatment 
staff throughout treatment 
26 Being able to have a choice of times for 
appointments 
11. Emotional support 
  
8 Cancer treatment staff telling me the way I feel is 
normal 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
12.  1Connectivity 
  
34 Being able to spend time with people my own age 
35 Being able to talk to people my own age who had 
been through a similar experience 
62 Managing to take part in social activities 
13.  unique challenges 
to this population 
  
37 Finding information that described relaxation 
techniques (e.g., yoga, meditation) 
46 Being able to be independent 
51 Being able to make plans or think about the 
future 
14.  Chaplain/Spiritual 
Health team 
  
38 Feeling anxious or scared 
39 Feeling depressed 
43 Worrying about how my family is coping 
44 Finding inner strength 
45 Being able to accept my diagnosis 
15.  Relationships 
  
40 Worrying about my cancer spreading 
41 Worrying about my cancer returning or 
secondary cancers 
47 Coping with changes in my relationship to my 
partner 
48 Coping with changes in my relationship to my 
sibling/s 
49 Coping with changes in my relationship to my 
parent/s 
50 Coping with changes in my relationship to my 
friend/s 
55 Coping with my parent/s and/or partner being 
overprotective 
16.  Psychosocial 
  
42 Worrying about whether my cancer treatment 
has worked 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things 
as other people my age 














1. treatment plan 
  
1 Cancer treatment staff telling me about my diagnosis 
2 Cancer treatment staff telling me about the short-term 
side effects of treatment 
3 Cancer treatment staff telling me about the long-term 
side effects of treatment 
4 Cancer treatment staff telling me what will happen 
when treatment finishes 
2.  2. My 
Treatment Team 
  
6 Cancer treatment staff telling me about how my 
treatment is working 
7 Cancer treatment staff telling me my test results as 
soon as possible 
11 Cancer treatment staff telling me what to do if I 
noticed a particular side effect 




10 Cancer treatment staff giving me information about 
nutrition and exercise. 
56 Managing pain 
57 Managing my medications 
58 Managing physical side effects of treatment 
60 Managing feeling tired/fatigued 
61 Managing loss of mobility 




5 Cancer treatment staff telling me whether I will be able 
to have children 
9 Cancer treatment staff giving me information about 
sexual health 
5.  Inpatient 
Nursing Staff 
  
21 Being able to have privacy 
22 Being able to have pleasant surroundings 
23 Being able to have good food 





27 Being able to attend classes (if enrolled in school) 
29 Knowing how much work I would miss 
32 Knowing how to ask managers/coworkers for support 
36 Being able to have leisure spaces and activities 
7.  Financial 
  
28 Being able to get extensions/special consideration (if 
enrolled in school) 
30 Being able to get guidance about study options or 
future career paths 
31 Being able to get guidance about financial aid or loan 
repayment options  






13 Having cancer treatment staff who treated me as an 
individual 
14 Having cancer treatment staff who were respectable 
15 Having cancer treatment staff who were approachable 
and friendly 
16 Having cancer treatment staff who could have a laugh 
with me 
20 Having cancer treatment staff who talked to me in 
private, without my family 
9.  1All oncology 
staff 
  
17 Having cancer treatment staff who explained what 
they are doing in a way I could understand 
18 Having cancer treatment staff who let me ask questions 
19 Having cancer treatment staff who let me make 
decisions about my treatment 





25 Being able to have the same cancer treatment staff 
throughout treatment 




8 Cancer treatment staff telling me the way I feel is 
normal 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
11.  1Connectivity 
  
34 Being able to spend time with people my own age 
35 Being able to talk to people my own age who had been 
through a similar experience 
62 Managing to take part in social activities 
12.  unique 
challenges to this 
population 
  
37 Finding information that described relaxation 
techniques (e.g., yoga, meditation) 
46 Being able to be independent 
51 Being able to make plans or think about the future 
13.  Family 
Burdens 
  
38 Feeling anxious or scared 
39 Feeling depressed 
40 Worrying about my cancer spreading 
41 Worrying about my cancer returning or secondary 
cancers 
43 Worrying about how my family is coping 
44 Finding inner strength 
45 Being able to accept my diagnosis 
47 Coping with changes in my relationship to my partner 
48 Coping with changes in my relationship to my sibling/s 
49 Coping with changes in my relationship to my parent/s 
50 Coping with changes in my relationship to my friend/s 
55 Coping with my parent/s and/or partner being 
overprotective 
14.  Psychosocial 
  
42 Worrying about whether my cancer treatment has 
worked 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things as 
other people my age 














1.  Treatment 
Information 
  
1 Cancer treatment staff telling me about my diagnosis 
2 Cancer treatment staff telling me about the short-term 
side effects of treatment 
3 Cancer treatment staff telling me about the long-term side 
effects of treatment 
4 Cancer treatment staff telling me what will happen when 
treatment finishes 
6 Cancer treatment staff telling me about how my 
treatment is working 
7 Cancer treatment staff telling me my test results as soon 
as possible 
 
11 Cancer treatment staff telling me what to do if I noticed a 
particular side effect 
2. Physical Side 
Effect Management 
  
10 Cancer treatment staff giving me information about 
nutrition and exercise. 
56 Managing pain 
57 Managing my medications 
58 Managing physical side effects of treatment 
60 Managing feeling tired/fatigued 
61 Managing loss of mobility 




5 Cancer treatment staff telling me whether I will be able to 
have children 
9 Cancer treatment staff giving me information about sexual 
health 
4.  Inpatient 
Nursing Staff 
  
21 Being able to have privacy 
22 Being able to have pleasant surroundings 
23 Being able to have good food 




27 Being able to attend classes (if enrolled in school) 
29 Knowing how much work I would miss 
32 Knowing how to ask managers/coworkers for support 
36 Being able to have leisure spaces and activities 
6.  Financial 
  
28 Being able to get extensions/special consideration (if 
enrolled in school) 
30 Being able to get guidance about study options or future 
career paths 
31 Being able to get guidance about financial aid or loan 
repayment options  
33 Worrying about my health insurance coverage 




13 Having cancer treatment staff who treated me as an 
individual 
14 Having cancer treatment staff who were respectable 
15 Having cancer treatment staff who were approachable and 
friendly 
16 Having cancer treatment staff who could have a laugh 
with me 
20 Having cancer treatment staff who talked to me in private, 
without my family 
8.  1All oncology 
staff 
  
17 Having cancer treatment staff who explained what they 
are doing in a way I could understand 
18 Having cancer treatment staff who let me ask questions 
19 Having cancer treatment staff who let me make decisions 
about my treatment 
24 Being able to have a choice of cancer care specialists 






26 Being able to have a choice of times for appointments 
9.  Emotional 
support 
  
8 Cancer treatment staff telling me the way I feel is normal 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
34 Being able to spend time with people my own age 
35 Being able to talk to people my own age who had been 
through a similar experience 
62 Managing to take part in social activities 
10.  unique 
challenges to this 
population 
  
37 Finding information that described relaxation techniques 
(e.g., yoga, meditation) 
46 Being able to be independent 
51 Being able to make plans or think about the future 
11.  Family Burdens 
  
38 Feeling anxious or scared 
39 Feeling depressed 
40 Worrying about my cancer spreading 
41 Worrying about my cancer returning or secondary cancers 
43 Worrying about how my family is coping 
44 Finding inner strength 
45 Being able to accept my diagnosis 
47 Coping with changes in my relationship to my partner 
48 Coping with changes in my relationship to my sibling/s 
49 Coping with changes in my relationship to my parent/s 
50 Coping with changes in my relationship to my friend/s 
55 Coping with my parent/s and/or partner being 
overprotective 
12.  Psychosocial 
  
42 Worrying about whether my cancer treatment has worked 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things as other 
people my age 
















1.  Treatment 
Information 
  
1 Cancer treatment staff telling me about my diagnosis 
2 Cancer treatment staff telling me about the short-term 
side effects of treatment 
3 Cancer treatment staff telling me about the long-term 
side effects of treatment 
4 Cancer treatment staff telling me what will happen 
when treatment finishes 
6 Cancer treatment staff telling me about how my 
treatment is working 
7 Cancer treatment staff telling me my test results as soon 
as possible 
11 Cancer treatment staff telling me what to do if I noticed 
a particular side effect 
2. Physical Side 
Effect Management 
  
10 Cancer treatment staff giving me information about 
nutrition and exercise. 
56 Managing pain 
57 Managing my medications 
58 Managing physical side effects of treatment 
60 Managing feeling tired/fatigued 
61 Managing loss of mobility 
3.  within the 1st or 
2nd appointment 
  
5 Cancer treatment staff telling me whether I will be able 
to have children 
9 Cancer treatment staff giving me information about 
sexual health 
21 Being able to have privacy 
22 Being able to have pleasant surroundings 
23 Being able to have good food 
  
4.  education/ career 27 Being able to attend classes (if enrolled in school) 
28 Being able to get extensions/special consideration (if 
enrolled in school) 
29 Knowing how much work I would miss 
30 Being able to get guidance about study options or future 
career paths 
31 Being able to get guidance about financial aid or loan 
repayment options  
32 Knowing how to ask managers/coworkers for support 
33 Worrying about my health insurance coverage 
36 Being able to have leisure spaces and activities 




13 Having cancer treatment staff who treated me as an 
individual 
14 Having cancer treatment staff who were respectable 
15 Having cancer treatment staff who were approachable 
and friendly 
16 Having cancer treatment staff who could have a laugh 
with me 
20 Having cancer treatment staff who talked to me in 
private, without my family 
6.  1All oncology 
staff 
  
17 Having cancer treatment staff who explained what they 
are doing in a way I could understand 
18 Having cancer treatment staff who let me ask questions 
19 Having cancer treatment staff who let me make 
decisions about my treatment 
24 Being able to have a choice of cancer care specialists 
25 Being able to have the same cancer treatment staff 
throughout treatment 






7.  Emotional 
support 
8 Cancer treatment staff telling me the way I feel is 
normal 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
34 Being able to spend time with people my own age 
35 Being able to talk to people my own age who had been 
through a similar experience 
62 Managing to take part in social activities 
8.  unique challenges 
to this population 
  
37 Finding information that described relaxation 
techniques (e.g., yoga, meditation) 
46 Being able to be independent 
51 Being able to make plans or think about the future 
9.  Family Burdens 
  
38 Feeling anxious or scared 
39 Feeling depressed 
40 Worrying about my cancer spreading 
41 Worrying about my cancer returning or secondary 
cancers 
43 Worrying about how my family is coping 
44 Finding inner strength 
45 Being able to accept my diagnosis 
47 Coping with changes in my relationship to my partner 
48 Coping with changes in my relationship to my sibling/s 
49 Coping with changes in my relationship to my parent/s 
50 Coping with changes in my relationship to my friend/s 
55 Coping with my parent/s and/or partner being 
overprotective 
10.  Psychosocial 
  
42 Worrying about whether my cancer treatment has 
worked 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things as 
other people my age 














1.  Treatment 
Information 
  
1 Cancer treatment staff telling me about my diagnosis 
2 Cancer treatment staff telling me about the short-
term side effects of treatment 
3 Cancer treatment staff telling me about the long-term 
side effects of treatment 
4 Cancer treatment staff telling me what will happen 
when treatment finishes 
6 Cancer treatment staff telling me about how my 
treatment is working 
7 Cancer treatment staff telling me my test results as 
soon as possible 
11 Cancer treatment staff telling me what to do if I 
noticed a particular side effect 
2. Physical Side Effect 
Management 
  
10 Cancer treatment staff giving me information about 
nutrition and exercise. 
56 Managing pain 
57 Managing my medications 
58 Managing physical side effects of treatment 
60 Managing feeling tired/fatigued 
61 Managing loss of mobility 
3.  within the 1st or 
2nd appointment 
  
5 Cancer treatment staff telling me whether I will be 
able to have children 
9 Cancer treatment staff giving me information about 
sexual health 
21 Being able to have privacy 
22 Being able to have pleasant surroundings 
23 Being able to have good food 
  
4.  Education/career 27 Being able to attend classes (if enrolled in school) 
28 Being able to get extensions/special consideration (if 
enrolled in school) 
29 Knowing how much work I would miss 
30 Being able to get guidance about study options or 
future career paths 
31 Being able to get guidance about financial aid or loan 
repayment options  
32 Knowing how to ask managers/coworkers for support 
33 Worrying about my health insurance coverage 




13 Having cancer treatment staff who treated me as an 
individual 
14 Having cancer treatment staff who were respectable 
15 Having cancer treatment staff who were approachable 
and friendly 
16 Having cancer treatment staff who could have a laugh 
with me 
17 Having cancer treatment staff who explained what 
they are doing in a way I could understand 
18 Having cancer treatment staff who let me ask 
questions 
19 Having cancer treatment staff who let me make 
decisions about my treatment 
20 Having cancer treatment staff who talked to me in 
private, without my family 
24 Being able to have a choice of cancer care specialists 
25 Being able to have the same cancer treatment staff 
throughout treatment 






6.  Emotional support 8 Cancer treatment staff telling me the way I feel is 
normal 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
34 Being able to spend time with people my own age 
35 Being able to talk to people my own age who had 
been through a similar experience 
62 Managing to take part in social activities 
7.  unique challenges 
to this population 
  
37 Finding information that described relaxation 
techniques (e.g., yoga, meditation) 
46 Being able to be independent 
51 Being able to make plans or think about the future 
8.  Emotional 
support/Social Work 
  
38 Feeling anxious or scared 
39 Feeling depressed 
40 Worrying about my cancer spreading 
41 Worrying about my cancer returning or secondary 
cancers 
42 Worrying about whether my cancer treatment has 
worked 
43 Worrying about how my family is coping 
44 Finding inner strength 
45 Being able to accept my diagnosis 
47 Coping with changes in my relationship to my partner 
48 Coping with changes in my relationship to my 
sibling/s 
49 Coping with changes in my relationship to my 
parent/s 
50 Coping with changes in my relationship to my 
friend/s 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things as 
other people my age 
55 Coping with my parent/s and/or partner being 
overprotective 




































       
1 Cancer treatment staff telling me about my diagnosis 1 Cancer treatment staff telling me about my 
diagnosis 
2 Cancer treatment staff telling me about the short-term side 
effects of treatment 
2 Cancer treatment staff telling me about the 
short-term side effects of treatment 
3 Cancer treatment staff telling me about the long-term side 
effects of treatment 
3 Cancer treatment staff telling me about the 
long-term side effects of treatment 
4 Cancer treatment staff telling me what will happen when 
treatment finishes 
4 Cancer treatment staff telling me what will 
happen when treatment finishes 
6 Cancer treatment staff telling me about how my treatment is 
working 
 
7 Cancer treatment staff telling me my test results as soon as 
possible 
6 Cancer treatment staff telling me about how my 
treatment is working 
11 Cancer treatment staff telling me what to do if I noticed a 
particular side effect 
7 Cancer treatment staff telling me my test results 
as soon as possible 
11 Cancer treatment staff telling me what to do if I 










































     
 
 
10 Cancer treatment staff giving me information about nutrition 
and exercise. 
10 Cancer treatment staff giving me information 
about nutrition and exercise. 
60 Managing feeling tired/fatigued 
56 Managing pain 61 Managing loss of mobility 
57 Managing my medications  
58 Managing physical side effects of treatment 56 Managing pain 
60 Managing feeling tired/fatigued 57 Managing my medications 






































Same as 12-cluster solution 
5 Cancer treatment staff telling me whether I will be able to 
have children 
5 Cancer treatment staff telling me whether I will be 
able to have children 
9 Cancer treatment staff giving me information about sexual 
health 
9 Cancer treatment staff giving me information 
about sexual health 
21 Being able to have privacy  
22 Being able to have pleasant surroundings 21 Being able to have privacy 
23 Being able to have good food 22 Being able to have pleasant surroundings 



























Same as 12-cluster solution 
27 Being able to attend classes (if enrolled in school) 27 Being able to attend classes (if enrolled in school) 
28 Being able to get extensions/special consideration (if 
enrolled in school) 
29 Knowing how much work I would miss 
29 Knowing how much work I would miss 32 Knowing how to ask managers/coworkers for 
support 
30 Being able to get guidance about study options or future 
career paths 
36 Being able to have leisure spaces and activities 
31 Being able to get guidance about financial aid or loan 
repayment options  
 
32 Knowing how to ask managers/coworkers for support 28 Being able to get extensions/special consideration (if 
enrolled in school) 
33 Worrying about my health insurance coverage 30 Being able to get guidance about study options or 
future career paths 
36 Being able to have leisure spaces and activities 31 Being able to get guidance about financial aid or 
loan repayment options  












































Same as 10-cluster solution 
13 Having cancer treatment staff who treated me as an 
individual 
14 Having cancer treatment staff who were respectable 
15 Having cancer treatment staff who were approachable 
and friendly 
16 Having cancer treatment staff who could have a laugh 
with me 
20 Having cancer treatment staff who talked to me in 










































Same as 10-cluster solution 
17 Having cancer treatment staff who explained what they are 
doing in a way I could understand 
18 Having cancer treatment staff who let me ask questions 
19 Having cancer treatment staff who let me make decisions 
about my treatment 
24 Being able to have a choice of cancer care specialists 
25 Being able to have the same cancer treatment staff 
throughout treatment 

































8 Cancer treatment staff telling me the way I feel is 
normal 
8 Cancer treatment staff telling me the way I feel is 
normal 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
12 Having cancer treatment staff who listened to my 
concerns and let me talk about my feelings 
34 Being able to spend time with people my own age  
35 Being able to talk to people my own age who had been 
through a similar experience 
34 Being able to spend time with people my own 
age 
62 Managing to take part in social activities 35 Being able to talk to people my own age who had 
been through a similar experience 













































Same as 10-cluster solution 
37 Finding information that described relaxation 
techniques (e.g., yoga, meditation) 
46 Being able to be independent 


































    
 
38 Feeling anxious or scared 38 Feeling anxious or scared 
39 Feeling depressed 39 Feeling depressed 
40 Worrying about my cancer spreading 43 Worrying about how my family is coping 
41 Worrying about my cancer returning or secondary cancers 44 Finding inner strength 
43 Worrying about how my family is coping 45 Being able to accept my diagnosis 
44 Finding inner strength  
45 Being able to accept my diagnosis 40 Worrying about my cancer spreading 
47 Coping with changes in my relationship to my partner 41 Worrying about my cancer returning or secondary 
cancers 
48 Coping with changes in my relationship to my sibling/s 47 Coping with changes in my relationship to my 
partner 
49 Coping with changes in my relationship to my parent/s 48 Coping with changes in my relationship to my 
sibling/s 
50 Coping with changes in my relationship to my friend/s 49 Coping with changes in my relationship to my 
parent/s 
55 Coping with my parent/s and/or partner being 
overprotective 















































Same as 10-cluster solution 
42 Worrying about whether my cancer treatment has 
worked 
52 Coping with changes in my physical ability 
53 Coping with changes in my appearance 
54 Coping with not being able to do the same things as other 
people my age 












DESIGN TEAM WORKSHOP #2 
February 26, 2019 
12:00-4:00pm EST 






12:00-12:15  Welcome and introductions  
          Project overview & objectives  
 
12:15-12:30 Overview of needs assessment  
Discussion re: response scale   
 
12:30-2:00  Summary of user and contextual requirements 
Delivery specification with storyboard  
 
2:00-2:15  Break 
 
2:15-3:30 Vetting delivery specification with scenarios of use, personas  
 












UCD Aim Method Deliverable 
Review and refine prototype  
 
Usability Testing 
• AYA Survey 
• Cognitive interviews with AYAs 
• Concept mapping with providers/staff 
Evidence of the usability and 
usefulness of the CNQ-YP 
Identify user and contextual 
requirements   
Ethnography 
• Guided tours with AYAs and 
providers/staff from NCCH 
• Semi-structured interviews with 
providers/staff from outside of NCCH 
User and contextual requirements for 
AYA NA-SB’s design and 
implementation  
Design prototypes based on 
user and contextual 
requirements 
Design Team Workshops 
• Workshop #1 
• Workshop #2 
AYA NA-SB prototypes and 
anticipated implementation strategies 
needed 
RESULT A usable and useful PROM linked to 
























        External young adults                  External providers         











In the past month, I have needed information from my cancer 
care team about:  
No need/Need 
met 
Low need Moderate 
need 
High need Very high need 
1 My diagnosis        
2 The short-term side effects of treatment      
3 The long-term side effects of treatment       
4 What will happen when treatment finishes      
5 My disease status         
6 My test results       
7 What to do if I noticed a particular side effect       
 
CANCER CARE TEAM 
 
In the past month, I have needed my cancer treatment team to:  
No need/Need 
met 
Low need Moderate 
need 
High need Very high need 
8 Respect me as an individual, not just a cancer patient      
9 Offer to talk to me in private, without my family       
10 Explain what they were doing in a way I could understand      
11 Encourage me to ask questions       
12 Engage me in decision-making about my treatment and 
respected my decisions  
     




In the past month, I have needed help with: 
No need/Need 
met 
Low need Moderate 
need 
High need Very high 
need 
14 Managing pain       
15 Managing my medications       
16 Managing physical side effects of treatment      
17 Managing feeling tired/ fatigued      








In the past month, I have needed help with: 
No need/Need 
met 
Low need Moderate 
need 
High need Very high 
need 
19 Feeling anxious or scared      
20 Feeling depressed       
21 Having what I need to cope with my diagnosis       
22 Worrying about my cancer spreading       
23 Worrying about my cancer returning or secondary cancers      
24 Worrying about how my family is coping       
25 Coping with changes in my dating or romantic life      
26 Coping with changes in my relationships with my family 
members 
     
27 Coping with changes in my relationships with friends       
28 Feeling independent      
29 Coping with changes in my physical ability       
30 Coping with changes in my appearance      
31 Coping with not being able to do the same things as other 
people my age 
     
32 Managing the emotional side effects of treatment       
33 Being able to make plans or think about the future       
 
SEXUAL & REPRODUCTIVE HEALTH 
 




Low need Moderate 
need 
High need Very high 
need 
34 My risk for infertility and fertility preservation options       
35 Treating infertility and other options for having children (i.e., 
artificial insemination, in vitro fertilization, surrogacy, 
adoption, etc.) 
     
36 How my genetics may or may not have impacted my 
diagnosis and treatment 
     
 
37 Sexuality and intimacy during cancer treatment       
38 Sexual side effects of my treatment (e.g., sexual dysfunction)      






HEALTH BEHAVIORS & WELLNESS 
 
In the past month, I have needed: 
No need/Need 
met 
Low need Moderate need High need Very high 
need 
40 Information about nutrition and exercise       
41 Help getting enough sleep       
42 Resources to quit smoking       
43 Information about drug and alcohol use during cancer 
treatment  
     
44 Spiritual support or faith-based resources       
45 Information on alternative therapies (herbal treatment, 
acupuncture, massage therapy, meditation, etc.) 
     
 
WORK & EDUCATION 
 
In the past month, I have needed help with: 
No need/Need 
met 
Low need Moderate need High need Very high need 
46 Navigating my school life while going through cancer 
treatment 
     
47 Navigating my work life while going through cancer 
treatment  
     
 
PEER SUPPORT & PROGRAMMING 
 
I had the following needs in the past month: 
No need/Need 
met 
Low need Moderate 
need 
High need Very high need 
48 Being able to spend time with people my own age       
49 Being able to talk to people my own age who have been 
through a similar experience 
     
50 Managing to take part in social activities       
 
FINANCES & LOGISTICS 
 
I had the following needs in the past month: 
No need/Need 
met 
Low need Moderate need High need Very high need 
51 Paying my bills       
52 Getting guidance about scholarship or loan repayment 
options  
     
53 Worrying about my health insurance (e.g., 
access/eligibility, coverage, cost) 





54 Getting to and from my cancer care appointments       
55 Having childcare during my cancer care appointments       






User & Contextual Requirements 
Domain  User/contextual factor identified through 
ethnography  






AYAs desire a tool that is actually used to address 
their needs in a timely manner  
AYA NA-SB follow-up actions should be 
delivered in a timely manner ○ 
 Needs change as AYAs move through their treatment 
trajectory. Time points when needs are particularly 
distinct include (1) after diagnosis, (2) end of 
treatment, and (3) somewhere in between 
AYA NA-SB should be administered at 
multiple timepoints, including after 
diagnosis, during treatment, and at the 
end of treatment 
○ 
AYAs feel overwhelmed immediately following 
diagnosis and may not know what they need yet  
AYA NA-SB should not be administered 










AYAs at NCCH rely heavily on social workers to 
address their nonmedical needs  
AYA NA-SB delivery and follow-up should 
be done by those who are currently 
doing the work of assessing and 
addressing AYA needs (at NCCH, social 
workers). Other important 
characteristics include: 
• knowledge of referral pathways 
and relationship with providers 
to whom referrals will be 
triggered 
• rapport with AYAs  
assessment skills  
○ 
oncologists are primarily focused on medical 
concerns during patient visits 
  
NCCH has two social workers dedicated to AYA 
patient care; AYA social workers are already doing the 
work of needs assessment, although 
informally/conversationally; AYA social workers have 







Appointments vary among AYAs, including some 
combination of the following: (1) labs, (2) imaging, (3) 
treatment, (4) clinical appointment 
AYA NA-SB delivery should consider the 





AYA tasks are very different during outpatient visits 
versus inpatient stays  
AYA NA-SB delivery should 
accommodate both inpatient and 
outpatient AYAs  
○ 
Users expressed the importance of not extending 
AYAs’ already long and exhausting appointments.  
AYA NA-SB administration should occur 
during appointment waiting times 
○ 
AYA social workers identify new AYA patients through 
disease group referrals; since the referral process is 
not systematic, not all AYAs are reached 
A process for identifying new AYA 











Adult oncology appointments are scattered across 
the NCCH  
AYA NA-SB administration should 
account for disparate physical locations  
○ 
NCCH is building an AYA-specific infusion space  AYA NA-SB could leverage the new AYA 
space for needs assessment 
administration and/or service provision, 
but privacy is an important consideration 
○ 
AYAs prefer technology, but are not averse to paper 
format 
If possible, AYAs should have the choice 
to complete AYA NA-SB electronically, 
particularly if they are asked to complete 
it outside of the clinic  
○ 
AYAs are active users of MyChart   AYA NA-SB could interface with MyChart  
Providers use EPIC for patient information 
documentation and communication across providers  
If possible, AYA NA-SB should interface 
with EPIC, even if that just means 
retrospectively scanning needs 





AYA providers collaborate with providers across adult 
and pediatric oncology, and across disease groups.  
AYA NA-SB should facilitate 
communication and the sharing of 
information across pediatric and adult 








AYA NA-SB should specify clear referral 
pathways for follow-up on needs 
reported  
 
the extent to which staff buy in to a new initiative or 
change is contingent upon how dramatically it 
impacts current workflow as well as staff members’ 
perception of the initiative’s merits. 
AYA NA-SB development and 
implementation planning should involve 
key stakeholders who will interface with 
the intervention in practice  
○ 
NCCH’s AYA program falls within the Comprehensive 
Cancer Support Program (CCSP). The CCSP has a 
catalogue of resources for patients and families  
AYA NA-SB should leverage CCSP 
resources where applicable 
○ 
Leadership buy-in often hinges on measurable 
impacts  
AYA NA-SB data should be documented 
somewhere to allow for the evaluation 
of its impact, and its use to inform 
program changes  
○ 







Variation between NCCH & other institutions 
Contextual 
feature of 
AYA Program  
UNC Variation 
Structure   Under the umbrella of NCCH’s 
Comprehensive Cancer Support Program 
which is directed by the Vice-Chair of 
General Hospital Psychiatry. There is not 
currently a designated space for AYA 
care. However, an AYA infusion space is 
in development.  
• Some AYA programs have 
designated AYA spaces (e.g., 
infusion centers, inpatient centers), 
but some do not.  
• Some AYA programs are housed 
within pediatric oncology; some are 
housed within adult oncology. The 
extent to which there is interface 
between pediatric and adult 
oncology varies.  
Staffing   Medical director; program director/social 
worker; social worker 
 
Patients rely on social workers for non-
medical needs, saying that their oncology 
providers rarely ask them about non-
medical concerns. 
•  Core members of the AYA care 
team vary across institutions. As 
such, who assesses and addresses 
AYAs’ needs varies. A common 
element of those who do the work 
of AYA needs assessment is an 
expertise on the AYA population.  
Funding   Foundation + grant funding   •  Some AYA programs are largely 
health system supported, while 
others rely on foundation grants 
and other external funding.  
Functions  Coordinating across disease groups and 
across pediatric and adult oncology to 
provide age appropriate services and 
resources to AYAs  
•  Some AYA programs are modeled 
as consultations services while 
others function more as their own 
entity  
How are new 
AYA patients 
identified? 
AYA social workers rely on referrals from 
disease group providers. 
• In general, AYA programs rely on 
referrals from disease group 
providers. However, the reach of 
programs varies, with some AYA 
programs reaching every AYA 
patient and some only reaching a 







Although sometimes AYA social workers 
schedule appointments with AYAs, they 
often just “pop in” while AYAs are in the 
hospital for appointments 
•  AYA programs vary in the extent to 
which AYA visits are scheduled 
versus impromptu but most 
programs “meet AYAs where they 





AYA needs are assessed 
informally/conversationally by the AYA 
social workers 
• Some AYA programs are working 
towards implementing distress 
screening/needs assessment tools  
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Information about patient needs is 
stored as notes in the EHR; each provider 
records their own separate note for each 







Providers communicate about AYAs’ 
needs via phone, text, email, EHR 
messaging, and in-person. 
• Same  
 
How other programs are doing it* 
Stanford Piloted a needs 
assessment developed 
in-house based on 
NCCN guildelines  
- Offered assessment as Qualtrics survey but 9/10 
patients opted to complete it on paper, in the clinic 
- Social worker had follow-up conversation during 
same visit  
FWAYA CanTeen Needs 
Assessment/ Distress 
Thermometer  (month 
2 of implementation) 
- Child Life Specialist or nurse navigator administer 
paper assessment within first 2 weeks of diagnosis, at 
the beginning of patient visit  
- Child Life Specialist or nurse navigator try to get back 
in for follow-up conversation before doctor sees 
patient  
- Referrals made as needed 
o Need for referral determine based on distress 
score (e.g., score of 8+ automatically triggers 
social worker referral) 
- Needs assessment and referrals made documented in 
EPIC, with dot phrases to allow for a traceable trail 
- Timing of re-screening depends on distress level at 
initial screening (this information documented in an 
Excel spreadsheet)  
o Low distress: 6 months 
o Medium distress: 3 months 
o High distress: 1 month  
University 
Hospitals 
Trialing a Care 
consultation Model 
based on NCCN 
Distress Screening Tool  
(1 page, front and 
back) 
- Social worker administers paper form immediately 
after diagnosis 
- Social worker waits in room while they complete and 
then has follow-up conversation  
- Pressing concerns are prioritized; takes several 
sessions to get through whole form  
- Social worker scans document into EMR 
- Social worker and AYA program manager review 
documentation daily to discuss necessary 
referrals/follow-up actions 
- If necessary, social worker follows-up with primary 
treatment team via email about actions made  
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Tufts Survivorship Needs 
Assessment  
- Patient receives iPad when they first check in  
- Quick analysis of assessment before doctor sees 
patient  
o Informs doctor’s conversation  
o Referrals initiated on same day  
* These data were elicited from semi-structured interviews with providers from other AYA programs. In 
some cases, providers described implementation efforts at their own institution. In other cases, they 



















Bill (frequent inpatient stays) 
• 22 years old 
• Osteosarcoma 
• Adult oncology  
• 11-week chemotherapy schedule with some 
off-weeks  
• Stays inpatient after infusion until 




Amy (infrequent appointments) 
• 25 years old 
• Chronic Myeloid Leukemia 
• Adult oncology (BMT clinic) 
• Maintenance treatment (oral chemotherapy) 
• Labs + clinical appointment every 3 months  
 
 
Susie (pediatric oncology) 
• 18 years old  
• Non-Hodgkin Lymphoma  
• Pediatric oncology  
• 4 three-week chemotherapy cycles → 2 
months radiation  
 
 
Matt (quick treatment schedule) 
• 34 years old 
• Testicular cancer 
• Adult oncology (Multidisciplinary Clinic)  







• 22 years old 
• Liver cancer 
• Adult oncology (Surgical Oncology))  
• Monthly chemotherapy to slow disease 
progression 
• Prognosis: <1 year  
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AYAs’ bandwidth to use services/resources offered to them 
Identifying new AYA patients 
Variation in AYAs’ treatment and appointment schedules 
Coordinating across disease groups/ disparate physical locations 
Lack of centralized physical space for AYA programming 
Coordinating across pediatric and adult oncology 
Establishing interface with EMR/ other documentation method 













Intervention Adolescent and Young Adult Needs Assessment & Service Bridge (AYA NA-SB) 
Why To coordinate care for adolescents and young adults (AYAs) with cancer to meet their physical, psychosocial, and practical 
needs 
What AYA completes needs assessment Provider interprets needs assessment 
data and notifies relevant service 
providers 
Service providers render services 
to AYAs 
Materials  Needs assessment  Needs assessment  
Map of referral pathways  
No additional materials required  
Procedure  1. Needs assessment is dropped off 
with AYA 
2. AYA completes needs 
assessment 
3. Needs assessment is picked up 
from AYA   
1. Provider reviews completed needs 
assessment to identify AYA’s needs  
2. For identified needs, provider notifies 
relevant providers using specified 
referral pathways, indicating the 
severity of need (i.e., need vs. 
somewhat need)  
3. Provider documents identified needs 
and providers notified in electronic 
health record (note: in the future, 
needs assessment will be embedded 
as flowsheet in electronic health 
record to enable more systematic 
documentation)  
1. Service provider provides 
service to AYA 
2. Service provider documents 
services provided in the 
electronic health record  
Who Provider dropping off and picking up 
needs assessment should have an 
established relationship with AYAs at 
their institution; seeing AYAs during 
their visits should be part of this 
provider’s existing workflow 
 
(at NCCH, disease group nurse 
navigators)  
Provider triaging needs should have 
relationships with referral pathway 
providers; addressing AYAs’ needs should 




(at NCCH, disease group nurse navigators)  
Follow-up domain 1: primary 
cancer treatment team  
 
Follow-up domain 2: primary 
cancer treatment team 
 
Follow-up domain 3: primary 
cancer treatment team 
 
Follow-up domain 4: AYA social 







Follow-up domain 5 (items 35-36): 
fertility coordinator   
Follow-up domain 5 (items 37-39): 
AYA social worker (or other 
provider with AYA expertise) 
 
Follow-up domain 6:  AYA social 
worker (or other provider with AYA 
expertise) 
 
Follow-up domain 7: AYA social 
worker (or other provider with AYA 
expertise) 
 
Follow-up domain 8: AYA social 
worker (or other provider with AYA 
expertise) 
 
Follow-up domain 9: outpatient 
social work  
 
(note that service providers may 
vary depending on who provides 
relevant services at a given 
institution)  
How  Needs assessments to be administered 
by paper for pilot study; electronic 
administration will be enabled in the 
future  
By electronic health record messaging or 
pager for more urgent concerns 
Using existing care practices   
Where  Dependent on provider’s clinical 
judgment and existing workflow  
Dependent on provider’s clinical judgment 
and existing workflow 
Dependent on provider’s clinical 
judgment and existing workflow 
When  First needs assessment is administered 
within 1 month after diagnosis; 
Daily    Service providers should attempt 





subsequent needs assessments are 
administered at 1-month or 3-month 
intervals (TBD based on feedback 
received during pilot test)  
 
Needs assessment is dropped off with 
AYA at the beginning of their clinical 
appointment; exact timing will depend 
on provider workflow and discretion 
 
Needs assessment is picked up from 
AYA at the end of their clinical 
appointment; exact timing will depend 
on provider workflow and discretion.  
of needs assessment for higher 
needs and within two weeks for 








NEEDS ASSESSMENT  
1. INFORMATION 
 









1 My cancer diagnosis       
2 The short-term side effects of treatment     
3 The long-term side effects of treatment      
4 What will happen when treatment finishes     
5 My disease status        
6 My test results      
7 What to do if I have side effects from my treatment       
8 How my genetics may or may not have impacted my diagnosis and treatment     
 
2. CANCER CARE TEAM 
 





team is doing 
this already 
Not sure 
9 Respecting me as an individual, not just a cancer patient     
10 Offering to talk to me in private, without my family or friends     
11 Explaining what they were doing in a way I can understand     
12 Encouraging me to ask questions      
13 Engaging me in decision-making about my treatment and respecting my 
decisions  
    
14 Asking me about my treatment concerns      
 
3. PHYSICAL HEALTH 
 
I want more help with: 
Agree Somewhat 
agree 
I have enough 
help with this 
concern 
Not sure 
15 Managing pain      
16 Managing my medications      
17 Managing physical side effects of treatment     





19 Managing loss of walking ability      
 
4. EMOTIONAL HEALTH 
 
I want more help with:  
Agree  Somewhat 
agree 
I have enough 
help with this 
concern 
Not sure 
20 Feeling anxious or scared     
21 Feeling depressed      
22 Having what I need to cope with my diagnosis      
23 Worrying about my cancer spreading      
24 Worrying about my cancer returning or getting another type of cancer     
25 Worrying about how my family is coping      
26 Coping with changes in my dating or romantic life     
27 Coping with changes in my relationships with my family members     
28 Coping with changes in my relationships with friends      
29 Feeling independent     
30 Coping with changes in my physical ability      
31 Coping with changes in my appearance     
32 Coping with not being able to do the same things as other people my age     
33 Managing the emotional side effects of treatment      
34 Being able to make plans or think about the future      
 
5. SEXUAL & REPRODUCTIVE HEALTH 
 
I want more information about: 
Agree Somewhat 
agree  




Not sure  
35 My risk of infertility and my fertility preservation options      
36 Treating infertility and other options for having children in the future (i.e., 
sperm/egg freezing, artificial insemination, in vitro fertilization, surrogacy, 
adoption, etc.) 
    
37 Sexuality and intimacy during cancer treatment      
38 Sexual side effects of my treatment (e.g., sexual dysfunction)     







6. HEALTH BEHAVIORS & WELLNESS 
 
I want more information about:  
Agree Somewhat 
agree 





40 Nutrition      
41 Exercise or physical activity     
42 Getting enough or better-quality sleep      
43 Smoking or vaping during cancer treatment     
44 Drug or alcohol use during cancer treatment      
45 Spiritual support or resources      
46 Alternative therapies (herbal treatment, acupuncture, massage therapy, 
meditation, etc.) 
    
 
7. WORK & EDUCATION 
 
I want more help with: 
Agree Somewhat 
agree 
I have enough 
help with this 
concern 
Not sure 
47 Managing my school life while going through cancer treatment     
48 Managing my work life while going through cancer treatment      
 
8. PEER SUPPORT & PROGRAMMING 
 
I want more help with: 
Agree Somewhat 
agree 
I have enough 
help with this 
concern 
Not sure 
49 Being able to spend time with people my own age      
50 Being able to talk to people my own age who have been through a similar cancer 
treatment experience 
    
51 Participating in social activities      
 
9. FINANCES & EVERYDAY NEEDS 
 
I want more help with:  
Agree Somewhat 
agree 
I have enough 
help with this 
concern 
Not sure  
52 Paying my bills      





54 My health insurance (e.g., access/eligibility, coverage, cost)     
55 Getting to and from my cancer care appointments      
56 Having childcare during my cancer care appointments      
57 Having stable housing      
 










MAP OF REFERRAL PATHWAYS  







Implementation strategy Indicate how your institution will do this 
Consider a phased-in approach to implementation, 
for example, by implementing within one disease 
group and expanding outwards 
 
Build buy-in by engaging in implementation planning 
any provider groups who will interface with AYA NA-
SB in practice  
 
Build buy-in among leadership, emphasizing the 
potential benefits of AYA NA-SB for patient care, 
patient-provider communication, provider-provider 
communication, and program development  
 
Obtain a thorough understanding of services and 
resources available at your institution prior to 
implementation, identifying gaps that may hinder 
follow-up on needs reported by AYAs. 
 
Provide education across disease groups and 
identify champions within each disease group to 
facilitate referrals of AYAs to AYA program  
 
Obtain a thorough understanding of services and 
resources available at your institution prior to 
implementation, identifying gaps that may hinder 
follow-up on needs reported by AYAs on the needs 
assessment. For identified gaps, bolster existing 
services or tailor the needs assessment to address 
the subset of needs that your institution has the 
capacity to address.  
 
Explicitly outline referral pathways for each follow-
up domain, identifying primary contacts, current 
workflow, and best method of communication for 
service/resource providers.  
 
Where possible, leverage existing communication 
and documentation channels in AYA NA-SB delivery. 
Modify communication and documentation 
processes as needed to allow for, at a minimum, 
traceable documentation of follow-up on needs.  
 
Leverage staff who are currently assessing and 
addressing the needs of AYA patients at your 
institution and thus, have the necessary expertise 
and time allocated towards these tasks.  
 
Identify approach for ensuring that services and 
resources are provided in a timely manner once 
needs are identified.  
 
Use pilot testing to tailor AYA NA-SB to your 




• Make additional refinements to the needs 
assessment tool to tailor it to your 
institution  
• Determine frequency of needs assessment 
administration that makes sense in your 
institution (1 month versus 3 months)  
• Map out changes needed to your 
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